
<html lang="en"     class="pb-page"  data-request-id="9a185aff-88fa-47b8-ab6f-004c3880899d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm900431g;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2009.52.issue-14"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)" /></meta><meta name="dc.Creator" content="Gerald J.  Roth" /></meta><meta name="dc.Creator" content="Armin  Heckel" /></meta><meta name="dc.Creator" content="Florian  Colbatzky" /></meta><meta name="dc.Creator" content="Sandra  Handschuh" /></meta><meta name="dc.Creator" content="Jörg  Kley" /></meta><meta name="dc.Creator" content="Thorsten  Lehmann-Lintz" /></meta><meta name="dc.Creator" content="Ralf  Lotz" /></meta><meta name="dc.Creator" content="Ulrike  Tontsch-Grunt" /></meta><meta name="dc.Creator" content="Rainer  Walter" /></meta><meta name="dc.Creator" content="Frank  Hilberg" /></meta><meta name="dc.Description" content="Inhibition of tumor angiogenesis through blockade of the vascular endothelial growth factor (VEGF) signaling pathway is a new treatment modality in oncology. Preclinical findings suggest that block..." /></meta><meta name="Description" content="Inhibition of tumor angiogenesis through blockade of the vascular endothelial growth factor (VEGF) signaling pathway is a new treatment modality in oncology. Preclinical findings suggest that block..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 12, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900431g" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900431g" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900431g" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900431g" /></link>
        
    
    

<title>Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900431g" /></meta><meta property="og:title" content="Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0010.jpeg" /></meta><meta property="og:description" content="Inhibition of tumor angiogenesis through blockade of the vascular endothelial growth factor (VEGF) signaling pathway is a new treatment modality in oncology. Preclinical findings suggest that blockade of additional pro-angiogenic kinases, such as fibroblast and platelet-derived growth factor receptors (FGFR and PDGFR), may improve the efficacy of pharmacological cancer treatment. Indolinones substituted in position 6 were identified as selective inhibitors of VEGF-, PDGF-, and FGF-receptor kinases. In particular, 6-methoxycarbonyl-substituted indolinones showed a highly favorable selectivity profile. Optimization identified potent inhibitors of VEGF-related endothelial cell proliferation with additional efficacy on pericyctes and smooth muscle cells. In contrast, no direct inhibition of tumor cell proliferation was observed. Compounds 2 (BIBF 1000) and 3 (BIBF 1120) are orally available and display encouraging efficacy in in vivo tumor models while being well tolerated. The triple angiokinase inhibitor 3 is currently in phase III clinical trials for the treatment of nonsmall cell lung cancer." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900431g"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900431g">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900431g&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900431g&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900431g&amp;href=/doi/10.1021/jm900431g" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 4466-4480</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900414x" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900330x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)<a class="ref internalNav" href="#ac1" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerald+J.++Roth">Gerald J. Roth</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Armin++Heckel">Armin Heckel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florian++Colbatzky">Florian Colbatzky</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Handschuh">Sandra Handschuh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Kley">Jörg Kley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thorsten++Lehmann-Lintz">Thorsten Lehmann-Lintz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ralf++Lotz">Ralf Lotz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ulrike++Tontsch-Grunt">Ulrike Tontsch-Grunt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rainer++Walter">Rainer Walter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Hilberg">Frank Hilberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="fn1"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Chemical Research</span></div><div class="aff-info" id="fn2"><span class="aff-symbol">§</span> <span class="aff-text">Department of Non-Clinical Drug Safety</span></div><div class="aff-info" id="fn3"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Lead Discovery</span></div><div class="aff-info" id="fn4"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Drug Discovery Support</span></div><div class="aff-info" id="fn6"><span class="aff-text">Boehringer Ingelheim Pharma GmbH & Co. KG, D-88397 Biberach, Germany</span></div><div class="aff-info" id="fn5"><span class="aff-symbol">#</span> <span class="aff-text">Boehringer Ingelheim RCV GmbH & Co. KG, A-1121 Vienna, Austria</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +49-7351-540. Fax: +49-7351-540. E-mail: <a href="/cdn-cgi/l/email-protection#0f686a7d6e636b217d607b674f6d606a677d6661686a7d226661686a63676a6662216c6062"><span class="__cf_email__" data-cfemail="ff989a8d9e939bd18d908b97bf9d909a978d9691989a8dd29691989a93979a9692d19c9092">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900431g&amp;href=/doi/10.1021%2Fjm900431g" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 4466–4480</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 12, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 April 2009</li><li><span class="item_label"><b>Published</b> online</span>12 June 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900431g" title="DOI URL">https://doi.org/10.1021/jm900431g</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4466%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGerald%2BJ.%2BRoth%252C%2BArmin%2BHeckel%252C%2BFlorian%2BColbatzky%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D14%26contentID%3Djm900431g%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BIndolinones%2Bas%2BTriple%2BAngiokinase%2BInhibitors%2Band%2Bthe%2BDiscovery%2Bof%2Ba%2BHighly%2BSpecific%2B6-Methoxycarbonyl-Substituted%2BIndolinone%2B%2528BIBF%2B1120%2529%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4480%26publicationDate%3DJuly%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900431g"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6888</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">149</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900431g" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gerald&quot;,&quot;last_name&quot;:&quot;J. Roth&quot;},{&quot;first_name&quot;:&quot;Armin&quot;,&quot;last_name&quot;:&quot;Heckel&quot;},{&quot;first_name&quot;:&quot;Florian&quot;,&quot;last_name&quot;:&quot;Colbatzky&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Handschuh&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Kley&quot;},{&quot;first_name&quot;:&quot;Thorsten&quot;,&quot;last_name&quot;:&quot;Lehmann-Lintz&quot;},{&quot;first_name&quot;:&quot;Ralf&quot;,&quot;last_name&quot;:&quot;Lotz&quot;},{&quot;first_name&quot;:&quot;Ulrike&quot;,&quot;last_name&quot;:&quot;Tontsch-Grunt&quot;},{&quot;first_name&quot;:&quot;Rainer&quot;,&quot;last_name&quot;:&quot;Walter&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Hilberg&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;4466-4480&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900431g&quot;},&quot;abstract&quot;:&quot;Inhibition of tumor angiogenesis through blockade of the vascular endothelial growth factor (VEGF) signaling pathway is a new treatment modality in oncology. Preclinical findings suggest that blockade of additional pro-angiogenic kinases, such as fibroblast and platelet-derived growth factor receptors (FGFR and PDGFR), may improve the efficacy of pharmacological cancer treatment. Indolinones substituted in position 6 were identified as selective inhibitors of VEGF-, PDGF-, and FGF-receptor kinases. In particular, 6-methoxycarbonyl-substituted indolinones showed a highly favorable selectivity profile. Optimization identified potent inhibitors of VEGF-related endothelial cell proliferation with additional efficacy on pericyctes and smooth muscle cells. In contrast, no direct inhibition of tumor cell proliferation was observed. Compounds 2 (BIBF 1000) and 3 (BIBF 1120) are orally available and display encouraging efficacy in in vivo tumor models while being well tolerated. The triple angiokinase inhibitor 3 is c&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900431g&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900431g" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900431g&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900431g" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900431g&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900431g" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900431g&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900431g&amp;href=/doi/10.1021/jm900431g" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900431g" /></input><a href="/doi/pdf/10.1021/jm900431g" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900431g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900431g%26sid%3Dliteratum%253Aachs%26pmid%3D19522465%26genre%3Darticle%26aulast%3DRoth%26date%3D2009%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BIndolinones%2Bas%2BTriple%2BAngiokinase%2BInhibitors%2Band%2Bthe%2BDiscovery%2Bof%2Ba%2BHighly%2BSpecific%2B6-Methoxycarbonyl-Substituted%2BIndolinone%2B%2528BIBF%2B1120%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D14%26spage%3D4466%26epage%3D4480%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibition of tumor angiogenesis through blockade of the vascular endothelial growth factor (VEGF) signaling pathway is a new treatment modality in oncology. Preclinical findings suggest that blockade of additional pro-angiogenic kinases, such as fibroblast and platelet-derived growth factor receptors (FGFR and PDGFR), may improve the efficacy of pharmacological cancer treatment. Indolinones substituted in position 6 were identified as selective inhibitors of VEGF-, PDGF-, and FGF-receptor kinases. In particular, 6-methoxycarbonyl-substituted indolinones showed a highly favorable selectivity profile. Optimization identified potent inhibitors of VEGF-related endothelial cell proliferation with additional efficacy on pericyctes and smooth muscle cells. In contrast, no direct inhibition of tumor cell proliferation was observed. Compounds <b>2</b> (BIBF 1000) and <b>3</b> (BIBF 1120) are orally available and display encouraging efficacy in in vivo tumor models while being well tolerated. The triple angiokinase inhibitor <b>3</b> is currently in phase III clinical trials for the treatment of nonsmall cell lung cancer.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>†</span>  Funding Statement</h4><p class="last">The atomic coordinates for the X-ray structure of compound <b>3</b> have been deposited in the Protein Data Bank: PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3C7Q">3C7Q</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The concept of tumor angiogenesis inhibition, interfering with tumor blood vessel formation, as a new approach for treating cancer was first proposed almost four decades ago.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Several drugs targeting the tumor vasculature, notably the monoclonal antibody to vascular endothelial growth factor (VEGF<div class="NLM_fn" id="fn7">a<p class="last">Abbreviations: VEGFR, vascular endothelial growth factor receptor; FGFR, fibroblast growth factor receptor; PDGFR, platelet-derived growth factor recptor; CDK, cyclin-dependent kinase; HUVEC, human umbilical vein endothelial cell; IGFR, insulin-like growth factor receptor; InsR, insulin receptor; EGFR, epidermal growth factor receptor; HER, human epidermal growth factor receptor; Plk, polo-like kinase; HNSCC, head and neck squamous cell carcinoma; TBTU, <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate; HOBt, hydroxy-benzotriazole.</p></div>) bevacizumab,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> as well as the small-molecule VEGF receptor (VEGFR<a class="ref internalNav" href="#fs6" aria-label="a">a</a><div class="NLM_fn" id="fs6">a<p class="last">Abbreviations: VEGFR, vascular endothelial growth factor receptor; FGFR, fibroblast growth factor receptor; PDGFR, platelet-derived growth factor recptor; CDK, cyclin-dependent kinase; HUVEC, human umbilical vein endothelial cell; IGFR, insulin-like growth factor receptor; InsR, insulin receptor; EGFR, epidermal growth factor receptor; HER, human epidermal growth factor receptor; Plk, polo-like kinase; HNSCC, head and neck squamous cell carcinoma; TBTU, <i>O</i>-(benzotriazol-1-yl)-<i>N,N,N′,N′</i>-tetramethyluronium tetrafluoroborate; HOBT, hydroxy-benzotriazole.</p></div>) inhibitors sorafenib<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and sunitinib,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> have been successfully introduced into clinical practice during the past years. The pivotal role of VEGFR signaling in the formation of blood vessels and its role in disease-associated angiogenesis is well documented.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Other signaling molecules, including platelet-derived growth factor (PDGF) and its receptors (PDGFR), are additional mediators of blood vessel formation and stabilization via pathways that control the proliferation and survival of perivascular cells such as pericytes and smooth muscle cells.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> A potential escape mechanism, whereby tumor cells switch from VEGF to FGF (fibroblast growth factor) signaling upon sustained VEGFR inhibition has been described recently.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Although tumor angiogenesis is an essential mechanism in all solid cancers, a wide variability in response to treatment with antiangiogenic drugs has been observed, both between patients and between tumor types. Clearly, the development of drugs that simultaneously target several pro-angiogenic receptors (angiokinases) at the same time, while retaining a favorable overall kinase selectivity profile, represents a promising avenue toward a more effective and well tolerated cancer treatment.</div><div class="NLM_p">In this paper, we report the identification of substituted indolinones as inhibitors of VEGFR-2 kinase. Optimization of an initial lead <b>1</b> led to <b>2</b> (BIBF 1000) and <b>3</b> (BIBF 1120) (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), compounds targeting VEGFR, FGFR, and PDGFR receptors with low cross-reactivity in the human kinome. The triple angiokinase inhibitor <b>3</b> is currently in phase III clinical trials in nonsmall cell lung cancer.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. VEGFR-2 Hit Compound <b>1</b> and Clinical Candidates <b>2</b> (BIBF 1000) and <b>3</b> (BIBF 1120)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds described in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were typically synthesized starting from the corresponding indolinones and aromatic amines as building blocks. Because indolinones substituted in position 6 are rarely described in literature, different routes of synthesis had to be developed by adapting known procedures, as exemplified for compounds <b>14</b>−<b>17</b> in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The particular synthetic path was based on the accessibility of the starting materials in each case. Aromatic nitration of phenyl-acetic acids followed by reduction of the nitro group in acidic media with subsequent ring closure offered an easy approach, as shown for compound <b>14</b>. Alternatively, the acetic acid moiety could be introduced by vicarious nucleophilic substitution<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> followed by reduction, optional removal of protecting groups and subsequent ring closure, as seen for compounds <b>15</b> and <b>16</b>. Should the respective 2-nitro halo benzenes be available, introduction of malonic ester equivalents followed by decarboxylation was the method of choice,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> as exemplified for compound <b>17</b>. The anilines or cycloalkyl amines used as building blocks in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> were available by standard chemistry summarized in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> starting from commercially available precursors.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 6-Substituted Indolinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NH<sub>4</sub>NO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, −5 °C; (b) H<sub>2</sub>, Pd/C, AcOH, rt; (c) methyl chloroacetate, KO<i>t</i>Bu, DMF, −10 °C, then <b>6</b>, −2 °C; (d) <i>tert</i>-butyl chloroacetate, KO<i>t</i>Bu, DMF, then <b>8</b>, −10 °C; (e) H<sub>2</sub>, Ra−Ni, MeOH, rt; (f) 1 N HCl, MeOH, reflux; (g) dimethyl malonate, KO<i>t</i>Bu, DMSO, rt, then <b>10</b>, 100 °C; (h) LiCl, DMSO, H<sub>2</sub>O, 100 °C; (i) H<sub>2</sub>, Lindlar catalyst, MeOH, rt.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Aniline or Cycloalkylamine Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>N</i>-Methylpiperazine or imidazole or dimethylamine·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, then <b>64</b> or <b>68</b>, rt; (b) H<sub>2</sub>, Pd/C, MeOH, rt; (c) Ac<sub>2</sub>O, 140 °C; (d) 2-chloro-<i>N</i>,<i>N</i>-dimethylethylamine·HCl, K<sub>2</sub>CO<sub>3</sub>, NaI, acetone, 50 °C; (e) MeI, KO<i>t</i>Bu, DMSO, rt; (f) <i>N</i>,<i>N</i>,<i>N</i>′-trimethylpropane-1,3-diamine, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, then <b>79</b> or <b>80</b>, rt; (g) chloroacetyl chloride, NEt<sub>3</sub>, THF, rt; (h) dimethylamine·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, rt; (i) trifluoroacetic acid, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Final Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Ac<sub>2</sub>O, 130 °C; (b) (EtO)<sub>3</sub>CPh, Ac<sub>2</sub>O, 130 °C; (c) (EtO)<sub>3</sub>CPh, Ac<sub>2</sub>O, 120 °C; (d) R<sup>3</sup>NH<sub>2</sub>, DMF, 80-100 °C, then piperidine, rt.</p></p></figure><div class="NLM_p">The majority of the final compounds were synthesized using a two- or three-step sequence: <i>N</i>-acetylation of the corresponding indolinones<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (<b>22</b>−<b>25</b>) activated the 3-position for subsequent condensation with aryl <i>ortho</i>-esters.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Both steps could be combined in a practical one-pot sequence using acetic anhydride as a solvent (<b>26</b>−<b>28</b>). For large-scale synthesis, however, a stepwise procedure is recommended, facilitating workup due to the cleaner reaction progress (<b>29</b>−<b>33</b>). The amino side chains were introduced in the final step by addition and subsequent elimination of alcohol,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> followed by in situ acetyl cleavage (<b>2</b>, <b>3</b>, <b>34</b>−<b>39</b>, <b>49</b>−<b>63</b>). The double-bond geometry in the final compounds is locked in a <i>Z</i>-conformation due to an intramolecular hydrogen bond, as could clearly be detected in the respective NMR spectra (upfield shift of the proton in position 4 of the indolinone core due to magnetic shielding by the central aryl group, see also ref <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>). Because no shielding was visible in the NMR spectra of intermediates <b>26</b>−<b>33</b>, the double bond seemed to adopt the <i>E</i>-conformation in these compounds.</div><div class="NLM_p">Several additional analogues were prepared with modifications at the C-6 position (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Amides and esters <b>1</b> and <b>41</b>−<b>45</b> were obtained by ester cleavage of <b>34</b> and subsequent amide coupling or ester formation. Compounds <b>47</b> and <b>48</b> were accessible by acetylation or condensation reactions of the 6-amino substituted indolinone <b>46</b>, available by reduction of <b>35</b> with Raney nickel.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Specific 6-Substituted Indolinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 1 N NaOH, EtOH, 80 °C; (b) R<sup>4</sup>NH<sub>2</sub>, TBTU, HOBT, NEt<sub>3</sub>, or EtN(iPr)<sub>2</sub>, DMF, rt; (c) CDI, DMF, 80 °C, then MeOH, 50 °C; (d) H<sub>2</sub>, Ra−Ni, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, rt; (e) AcCl, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (f) 2,5-dimethoxy tetrahydrofuran, AcOH, 100 °C.</p></p></figure><div class="NLM_p last">In general, most compounds with basic side chains displayed good aqueous solubility at pH 4.0 and moderate solubility at higher pH values (e.g., for compound <b>2</b>: 690 mg/mL at pH 4.0 and 22 mg/mL at pH 6.0, free base).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71631" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71631" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">When evaluating compounds from our CDK4 kinase inhibitor project in a set of kinase selectivity assays, the 6-amido-substituted indolinone <b>1</b> was identified as a nanomolar inhibitor of VEGFR-2 (IC<sub>50</sub> = 763 nM). Interestingly, this compound was completely devoid of CDK4 inhibition, in contrast to the related 5-amido substituted derivatives.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In addition, no other kinase included in the selectivity evaluation was inhibited (IGF1R, InsR, CDK1, CDK2, CDK4, EGFR, HER2, Plk1: IC<sub>50</sub> > 10 μM).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Compound <b>1</b> was therefore chosen as an interesting starting point, complementing activities from a VEGFR-2 HTS campaign.</div><div class="NLM_p">In a first attempt to evaluate the suitability of this structural class for further investigation, a couple of derivatives with modified basic groups were synthesized by introducing a diverse set of anilines. Unfortunately, all initial derivatives were less active than the hit compound (structures not shown), showing that the 6-amido-substituted indolinone core might not yet be optimal for improving the potency. Compound <b>1</b> was, however, more potent than the corresponding unsubstituted indolinone <b>39</b> and showed a favorable selectivity profile when compared with <b>39</b>, which inhibits CDK4, InsR, and IGF1R in the same selectivity panel.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> We decided to use computational modeling to explore the binding mode of <b>1</b> and especially the role of the 6-amido group in more detail.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Because indolinone-type kinase inhibitors had been reported as ATP pocket binders before,<a onclick="showRef(event, 'ref10 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref13">(10, 13)</a><b>1</b> was positioned in a similar way in the homology model of the VEGFR-2 kinase domain showing the typical canonical hydrogen bonds between the lactam moiety and the hinge region (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). The 6-amido moiety points toward the VEGFR-2 specificity pocket flanked by the gatekeeper Val<sup>916</sup> and Lys<sup>868</sup>, which may explain the favorable selectivity profile of <b>1</b>. In addition, the carbonyl oxygen of the amido group can form an additional hydrogen bond with Lys<sup>868</sup>, probably accounting for the higher potency of <b>1</b> compared with <b>39</b>. The basic side chain points toward the water phase of the enzyme. The specificity pocket is defined by mainly hydrophobic amino acids (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B), suggesting that more lipophilic substituents on the indolinone core than an amido moiety might have the potential for improved potency while retaining high selectivity.</div><figure id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Proposed binding mode of <b>1</b> in VEGFR-2. (A) The hydrogen bonds to the hinge region residues and the proposed additional hydrogen bond of the amide moiety at the indolinone scaffold to Lys<sup>868</sup> are shown. The gatekeeper Val<sup>916</sup> and Phe<sup>1047</sup> from the DFG motif are additionally highlighted. (B) Zoom into the hydrophobic kinase selectivity pocket of the ATP pocket that binds to the back part of the indolinone scaffold and the amide substituent. The coloring of the Connolly surface is shown as follows: hydrophobic (brown), hydrophilic (blue), in between (white).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Various 6-substituted derivatives of <b>1</b> were synthesized to test this hypothesis (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). For clarity of discussion, only a limited set of representatives is discussed within this paper, sufficient to explain structure−activity relationships. To slightly increase lipophilicity while conserving the amide hydrogen bond, substituted amides <b>41</b>−<b>44</b> were tested. Disappointingly, all compounds were slightly less active, probably due to steric hindrance within the specificity pocket. In addition, 6-acetyl substituted <b>38</b> did not show any improvement. Inversion of the amido moiety, as in <b>47</b>, led to complete loss of activity. The significantly more lipophilic 6-ethoxycarbonyl- and 6-methoxycarbonyl-indolinones <b>34</b> and <b>45</b>, however, were considerably more active than <b>1</b>. By far the most active compound in the whole series was the 6-nitro substituted indolinone <b>35</b>, showing single-digit nanomolar activity. Surprisingly, several substituents without carbonyl moieties displayed high activities, too. The 6-chloro, 6-amino, and 6-cyano indolinones <b>36</b>, <b>46</b>, and <b>37</b> were representatives of this group of compounds. In contrast, attaching a pyrrol-1-yl, as in <b>48</b>, led to loss of activity. Taken together, the structure−activity relationships in this series are complex. A subtle interplay between steric requirements, polarity, and hydrogen-bonding capability seemed to be decisive for good potency. Not too bulky, preferably lipophilic substituents with the ability to form an additional hydrogen bond, such as in compounds <b>34</b>, <b>35</b>, and <b>45</b>, represented the best combination. The electronic influence of the substituent on the indolinone core, modifying the ability of the lactam to form hydrogen bonds to the hinge region, may also play a role. However, because electron-withdrawing as well as electron-donating substituents as in <b>46</b> can display high activities, this influence is probably minor.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. VEGFR-2/HUVEC Inhibition of 6-Substituted Indolinones</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0008.gif" alt="" id="_i10" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center">R<sup>1</sup></th><th align="center">VEGFR-2 IC<sub>50</sub> (nM) <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th align="center">HUVEC/VEGF EC<sub>50</sub> (nM) <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top"><td align="center"><b>35</b></td><td align="left">NO<sub>2</sub></td><td align="left">7 ± 9</td><td align="left">60 ± 10</td></tr><tr valign="top"><td align="center"><b>45</b></td><td align="left">COOMe</td><td align="left">36 ± 36</td><td align="left">103 ± 11</td></tr><tr valign="top"><td align="center"><b>34</b></td><td align="left">COOEt</td><td align="left">109 ± 3</td><td align="left">47 ± 21</td></tr><tr valign="top"><td align="center"><b>36</b></td><td align="left">Cl</td><td align="left">129 ± 78</td><td align="left">49 ± 54</td></tr><tr valign="top"><td align="center"><b>46</b></td><td align="left">NH<sub>2</sub></td><td align="left">132 ± 34</td><td align="left">414 ± 323</td></tr><tr valign="top"><td align="center"><b>37</b></td><td align="left">CN</td><td align="left">248 ± 121</td><td align="left">281 ± 98</td></tr><tr valign="top"><td align="center"><b>1</b></td><td align="left">CONH<sub>2</sub></td><td align="left">763 ± 198</td><td align="left">342 ± 176</td></tr><tr valign="top"><td align="center"><b>48</b></td><td align="left">pyrrol-1-yl</td><td align="left">791 ± 349</td><td align="left">585 ± 156</td></tr><tr valign="top"><td align="center"><b>41</b></td><td align="left">CONH<i>i</i>Pr</td><td align="left">1230 ± 620</td><td align="left">1070 ± 565</td></tr><tr valign="top"><td align="center"><b>42</b></td><td align="left">CONMe<sub>2</sub></td><td align="left">1312 ± 719</td><td align="left">542 ± 310</td></tr><tr valign="top"><td align="center"><b>43</b></td><td align="left">CONEtMe</td><td align="left">1447 ± 1751</td><td align="left">718 ± 165</td></tr><tr valign="top"><td align="center"><b>38</b></td><td align="left">COCH<sub>3</sub></td><td align="left">1752 ± 433</td><td align="left">NT <a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top"><td align="center"><b>44</b></td><td align="left">CONHCH<sub>3</sub></td><td align="left">2099 ± 1647</td><td align="left">1907 ± 806</td></tr><tr valign="top"><td align="center"><b>39</b></td><td align="left">H</td><td align="left">2112 ± 1215</td><td align="left">NT <a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top"><td align="center"><b>40</b></td><td align="left">COOH</td><td align="left">>1000</td><td align="left">NT <a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top"><td align="center"><b>47</b></td><td align="left">NHCOCH<sub>3</sub></td><td align="left">>3000</td><td align="left">NT <a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values are averages ± SD of at least three independent determinations. Values “greater than” indicate that half-maximum inhibition was not achieved at the highest concentration tested.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Not tested.</p></div></div></div><div class="NLM_p">The more potent compounds were also evaluated for their ability to inhibit the VEGF-stimulated proliferation of human umbilical vein endothelial cells (HUVEC). In general, the trend for inhibition correlated with the biochemical activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). This demonstrated that the cellular inhibition is specifically dependent on VEGFR-2 mediated signaling rather than on a general cytostatic or cytotoxic effect. To additionally verify this important issue, we tested the effects of compounds <b>34</b>, <b>35</b>, and <b>45</b> on the proliferation of the human epithelial cancer cell line HeLa, which does not express detectable amounts of VEGFR. None of the compounds inhibited proliferation of HeLa cells when tested at similar concentrations to those tested in HUVEC cells (EC<sub>50</sub> > 1 μM).</div><div class="NLM_p">Although we managed to improve the potency of the indolinones by modifying the substituent in position 6 in general, the most active compounds identified were disappointingly not ideal candidates for further optimization at first glance, with <b>35</b> containing a nitro group (mutagenic potential) and <b>45</b> displaying an ester moiety usually prone to metabolic degradation. On the other hand, selectivity testing revealed that <b>45</b> did not inhibit any of 23 kinases tested on a larger kinase panel, whereas <b>35</b> was not as selective.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The angiokinases FGFR-1 and PDGFRα were additionally targeted by <b>45</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), contributing to what we considered an overall very favorable selectivity profile. We were therefore very pleased to learn that despite its ester moiety, <b>45</b> showed significant plasma levels after single oral administration in nude mice (<i>c</i><sub>max</sub> 952 ng/mL, <i>t</i><sub>1/2</sub> 3.5 h, AUC 5246 ng·h/mL, dose 50 mg/kg po). Compound <b>45</b> was therefore chosen as a lead for further optimization.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Profile of 6-Methoxycarbonyl-Substituted Indolinones</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0009.gif" alt="" id="_i12" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col><col align="char" char="" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center"> </th><th class="rowsep1" colspan="5" align="center">IC<sub>50</sub> (nM)</th><th class="rowsep1" align="center">EC<sub>50</sub> (nM)</th></tr><tr valign="top"><th align="center">compd</th><th align="center">R<sup>2</sup></th><th align="center">VEGFR-2 <a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th align="center">FGFR-1<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th align="center">PDGFRα<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th align="center">VEGFR-1 <a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th align="center">VEGFR-3 <a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th align="center">HUVEC/VEGF <a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top"><td align="char"><b>3</b></td><td align="char">4-(NCH<sub>3</sub>)COCH<sub>2</sub>-(4-methyl-piperazin-1-yl)</td><td align="char">5 ± 2</td><td align="char">38 ± 4</td><td align="char">18 ± 0.1</td><td align="char">104 ± 14</td><td align="char">5 ± 1</td><td align="char">10 ± 13</td></tr><tr valign="top"><td align="char"><b>49</b></td><td align="char">4-(NCH<sub>3</sub>)COCH<sub>2</sub>-(imidazol-1-yl)</td><td align="char">6 ± 4</td><td align="char">66 ± 1</td><td align="char">8 ± 0.1</td><td align="char">55 ± 10</td><td align="char">7 ± 1</td><td align="char">52 ± 19</td></tr><tr valign="top"><td align="char"><b>50</b></td><td align="char">4-(NCOCH<sub>3</sub>)CH<sub>2</sub>CONMe<sub>2</sub></td><td align="char">8 ± 4</td><td align="char">54 ± 4</td><td align="char">9 ± 1</td><td align="char">61 ± 6</td><td align="char">6 ± 1</td><td align="char">37 ± 16</td></tr><tr valign="top"><td align="char"><b>51</b></td><td align="char">4-(NCOCH<sub>3</sub>)(CH<sub>2</sub>)<sub>3</sub>NMe<sub>2</sub></td><td align="char">9 ± 6</td><td align="char">17 ± 4</td><td align="char">7 ± 1</td><td align="char">28 ± 1</td><td align="char">3 ± 1</td><td align="char">15 ± 5</td></tr><tr valign="top"><td align="char"><b>52</b></td><td align="char">4-(NCOCH<sub>3</sub>)(CH<sub>2</sub>)<sub>2</sub>NMe<sub>2</sub></td><td align="char">12 ± 4</td><td align="char">18 ± 3</td><td align="char">8 ± 0.3</td><td align="char">35 ± 8</td><td align="char">5 ± 0.3</td><td align="char">15 ± 9</td></tr><tr valign="top"><td align="char"><b>53</b></td><td align="char">4-(NSO<sub>2</sub>CH<sub>3</sub>)(CH<sub>2</sub>)<sub>2</sub>NMe<sub>2</sub></td><td align="char">23 ± 10</td><td align="char">25 ± 5</td><td align="char">12 ± 1</td><td align="char">69 ± 11</td><td align="char">10 ± 1</td><td align="char">14 ± 9</td></tr><tr valign="top"><td align="char"><b>54</b></td><td align="char">4-CO(NCH<sub>3</sub>)(CH<sub>2</sub>)<sub>2</sub>NMe<sub>2</sub></td><td align="char">24 ± 17</td><td align="char">88 ± 8</td><td align="char">11 ± 0.2</td><td align="char">325 ± 45</td><td align="char">59 ± 4</td><td align="char">25 ± 8</td></tr><tr valign="top"><td align="char"><b>45</b></td><td align="char">4-CH<sub>2</sub>(piperidin-1-yl)</td><td align="char">36 ± 36</td><td align="char">71 ± 20</td><td align="char">54 ± 9</td><td align="char">146 ± 13</td><td align="char">32 ± 5</td><td align="char">103 ± 11</td></tr><tr valign="top"><td align="char"><b>2</b></td><td align="char">4-(NCH<sub>3</sub>)COCH<sub>2</sub>NMe<sub>2</sub></td><td align="char">61 ± 17</td><td align="char">50 ± 4</td><td align="char">20 ± 2</td><td align="char">82 ± 7</td><td align="char">10 ± 0.4</td><td align="char">22 ± 11</td></tr><tr valign="top"><td align="char"><b>55</b></td><td align="char">4-CH<sub>2</sub>NMe<sub>2</sub></td><td align="char">64 ± 44</td><td align="char">82 ± 6</td><td align="char">28 ± 3</td><td align="char">173 ± 73</td><td align="char">73 ± 26</td><td align="char">28 ± 11</td></tr><tr valign="top"><td align="char"><b>56</b></td><td align="char">4-NHCOCH<sub>2</sub>-(4-methyl-piperazin-1-yl)</td><td align="char">83 ± 42</td><td align="char">219 ± 3</td><td align="char">164 ± 13</td><td align="char">278 ± 50</td><td align="char">24 ± 5</td><td align="char">83 ± 45</td></tr><tr valign="top"><td align="char"><b>57</b></td><td align="char">4-NHCOCH<sub>2</sub>NMe<sub>2</sub></td><td align="char">119 ± 82</td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">88 ± 64</td></tr><tr valign="top"><td align="char"><b>58</b></td><td align="char">4-(NCH<sub>3</sub>)SO<sub>2</sub>Me</td><td align="char">150 ± 11</td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top"><td align="char"><b>59</b></td><td align="char">4-CH<sub>2</sub>(2-<i>oxo</i>-pyrrolidin-1-yl)</td><td align="char">245 ± 43</td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top"><td align="char"><b>60</b></td><td align="char">3-CO(NCH<sub>3</sub>)(CH<sub>2</sub>)<sub>2</sub>NMe<sub>2</sub></td><td align="char">248 ± 61</td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">172 ± 43</td></tr><tr valign="top"><td align="char"><b>61</b></td><td align="char">H</td><td align="char">∼8000</td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top"><td align="char"><b>62</b></td><td align="char"> </td><td align="char">>10000</td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr><tr valign="top"><td align="char"><b>63</b></td><td align="char"> </td><td align="char">>10000</td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td align="char">NT <a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Values are averages ± SD of at least three independent determinations. Values “greater than” indicate that half-maximum inhibition was not achieved at the highest concentration tested.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Selectivity values are averages ± SD of at least two independent determinations.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Not tested.</p></div></div></div><div class="NLM_p">To further explore structure−activity relationships, the basic side chain pointing toward the water phase of the enzyme was chosen for modification (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). A wide variety of linkers between the aniline core and the basic moiety was tolerated, as seen in <b>51</b>−<b>55</b>. Various basic groups with different p<i>K</i><sub>a</sub> values were tolerated (<b>3</b>, <b>49</b>, <b>45</b>). In general, basicity was not a prerequisite for high activity, as shown in <b>50</b> and <b>59</b>. Nevertheless, neutral compounds were inferior to charged compounds in terms of low solubility and therefore not followed up further. Anilines with smaller substituents (<b>58</b>) or without any substitution (<b>61</b>) were clearly less active. Shifting the substituent from the 4- into the 3-position was also detrimental to activity (<b>60</b> vs <b>54</b>). Side chains positioned in an orthogonal position to the aniline appeared to be more active than side chains that adopt a coplanar geometry (compare <b>56</b> and <b>57</b> with <b>3</b> and <b>2</b>). As an alternative explanation, the additional methyl groups in <b>3</b> and <b>2</b> may increase the potency by picking up lipophilic contacts to the enzyme. The aromatic core of the aniline was essential for activity, as seen when comparing <b>63</b> with <b>57</b>. Although structure−activity relationships were generally shallow in this region, additional potency could be gained by special substituents. Compounds <b>3</b> and <b>49</b>−<b>51</b>, for instance, were active in the single-digit nanomolar region. As revealed by an X-ray structure,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> compound <b>3</b> forms an additional hydrogen bond between the methyl-piperazinyl moiety and Glu<sup>850</sup>, which can explain the excellent IC<sub>50</sub>.</div><div class="NLM_p">All derivatives tested additionally inhibited the angiokinases FGFR-1 and PDGFRα as well as the homologous kinases VEGFR-1 and -3 in the same range as VEGFR-2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), contributing to an overall attractive antiangiogenic target profile. By contrast, selected compounds such as <b>2</b> and <b>3</b> did not inhibit the 23 kinases<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> mentioned before, neither did they inhibit IGF1R, InsR, CDK1, CDK2, CDK4, EGFR, HER2, or Plk1 (IC<sub>50</sub> > 10 μM),<a onclick="showRef(event, 'ref8 ref15'); return false;" href="javascript:void(0);" class="ref ref8 ref15">(8, 15)</a> confirming the low risk of off-target effects for 6-methoxycarbonyl-substituted indolinones in general. Again, correlation of VEGF-stimulated HUVEC proliferation with biochemical data followed the same trend as before (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). As a consequence, our efforts to modify the side chain furnished several highly potent inhibitors of endothelial cell proliferation.</div><div class="NLM_p">Because of their cellular potency and attractive selectivity profiles, compounds <b>2</b> and <b>3</b> were selected for in vivo testing. Both compounds yielded good plasma levels 2 h after oral administration to mice and were almost completely cleared from plasma 24 h after administration (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). As shown for the lead structures, none of the compounds inhibited the proliferation of VEGF-independent cell lines at similar concentrations to those tested in HUVEC cells (EC<sub>50</sub> > 1 μM), particularly HeLa, Calu-6, and FaDu tumor cell lines.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Blood Levels After Single Oral Administration to Mice<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center">dose (mg/kg)</th><th align="center" char="±"><i>c</i><sub>plasma</sub> (nM) (2 h)</th><th align="center" char="±"><i>c</i><sub>plasma</sub> (nM) (24 h)</th></tr></thead><tbody><tr valign="top"><td align="char"><b>2</b></td><td align="center">40</td><td align="char" char="±">1252 ± 177</td><td align="char" char="±">16 ± 7</td></tr><tr valign="top"><td align="char"><b>3</b></td><td align="center">50</td><td align="char" char="±">923 ± 313</td><td align="char" char="±">8 ± 5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">For pharmacokinetic analysis, blood was isolated at indicated points in time from the retroorbital venous plexus of five- to six-week-old athymic NMRI-nu/nu female mice and plasma was analyzed using HPLC-MS/MS methodology. The compounds were administered in 0.5% (w/v) hydroxypropyl methylcellulose solution (free base). Characteristic pharmacokinetic parameters have been evaluated for compound <b>3</b> (CL 173 mL/min/kg, <i>V</i><sub>d</sub> = 32 l/kg, <i>F</i> 45%, <i>c</i><sub>max</sub> (po) 1091 nM, <i>t</i><sub>1/2</sub> (po) 5.0 h, AUC (po) 2746 nM·h, dose: 50 mg/kg po, 10 mg/kg iv).</p></div></div></div><div class="NLM_p">In mice with established human head and neck FaDu tumor xenografts, once or twice daily po treatment with compound <b>2</b> resulted in significant inhibition of tumor growth after 21 days (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Compound <b>2</b> was well tolerated, with no obvious weight loss over the whole treatment period. Ratios of tumor volumes of treated versus control animals (<i>T</i>/<i>C</i>) in this experiment were 31% (50 mg/kg qd), 13% (100 mg/kg qd), and 11% (50 mg/kg bid).</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2.  Compound <b>2</b> inhibits human tumor xenograft growth in a model of human head and neck SCC (FaDu). Effect of <b>2</b> (◼ 100 mg/kg qd, ▲ 2 × 50 mg/kg bid, and ◆ 50 mg/kg qd) or vehicle (○) on growth of tumor xenografts. Xenografts were established sc in athymic NMRI-nu/nu female mice and allowed to reach a volume of ∼50 mm<sup>3</sup> before treatment. Once or twice daily, oral administration of compound <b>2</b> or vehicle then commenced and was continued for the duration of the experiment. Data points represent the mean of five mice, bars represent the SD. The compound was administered in 0.5% (w/v) hydroxypropyl methylcellulose solution.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>2</b> was initially chosen as a preclinical candidate and extensively profiled.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> It was later replaced by <b>3</b>. The efficacy of <b>3</b> was tested in a wide variety of tumor types, summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Efficacy of <b>3</b> in Various Tumor Models</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">model</th><th align="center">derivation</th><th align="center" char=".">dose [mg/kg/d]</th><th align="center">T/C value [%]<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top"><td align="left">FaDu</td><td align="center">HNSCC</td><td align="char" char=".">100</td><td align="left">11</td></tr><tr valign="top"><td align="left"> </td><td align="center"> </td><td align="char" char=".">50</td><td align="left">14/27<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top"><td align="left"> </td><td align="center"> </td><td align="char" char=".">2 × 50</td><td align="left">15</td></tr><tr valign="top"><td align="left"> </td><td align="center"> </td><td align="char" char=".">25</td><td align="left">46</td></tr><tr valign="top"><td align="left"> </td><td align="center"> </td><td align="char" char=".">10</td><td align="left">82</td></tr><tr valign="top"><td align="left">Caki-1</td><td align="center">kidney</td><td align="char" char=".">100</td><td align="left">16</td></tr><tr valign="top"><td align="left"> </td><td align="center"> </td><td align="char" char=".">50</td><td align="left">25</td></tr><tr valign="top"><td align="left"> </td><td align="center"> </td><td align="char" char=".">10</td><td align="left">71</td></tr><tr valign="top"><td align="left">HT-29</td><td align="center">colon</td><td align="char" char=".">100</td><td align="left">16</td></tr><tr valign="top"><td align="left">SKOV-3</td><td align="center">ovary</td><td align="char" char=".">50</td><td align="left">19</td></tr><tr valign="top"><td align="left">Calu-6</td><td align="center">lung</td><td align="char" char=".">50</td><td align="left">24</td></tr><tr valign="top"><td align="left">PAC-120</td><td align="center">prostate</td><td align="char" char=".">100</td><td align="left">34</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Nude mice bearing established human xenografts (0.05−0.1 cm<sup>3</sup> volume) were treated once or twice daily with compound <b>3</b> po or vehicle control. For <i>T</i>/<i>C</i> values, median tumor volumes of each treatment group were compared with the median of the control group at the end of the experiment, depending on tumor growth kinetics. The compound was administered in 0.5% (w/v) hydroxypropyl methylcellulose solution.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Results of two separate experimental series.</p></div></div></div><div class="NLM_p last">A detailed pharmacological evaluation of <b>3</b> has been described elsewhere.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Compound <b>3</b> inhibited growth-dependent proliferation in a wide range of endothelial cells, pericytes, and smooth muscle cells. Inhibition usually resulted in apoptosis. The Src-family of kinases (IC<sub>50</sub> Src 156 nM, Lck 16 nM, Lyn 195 nM) and Flt-3 (IC<sub>50</sub> 26 nM) were identified as additional targets of <b>3</b>. Flt-3 inhibition might be an interesting addition to the compound profile, opening up therapeutic options in acute myelogenous leukemia (AML).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Compound <b>3</b> yielded significant plasma levels after oral administration in various species but is rapidly cleared from plasma by ester cleavage at later points in time. Part of the in vivo efficacy may be attributed to the sustained inhibition of VEGF receptor phosphorylation by <b>3</b>, lasting up to 32 h after compound exposure.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The mechanistic reason for this prolonged inhibition is currently under investigation. It is intriguing to speculate that prolonged receptor blockade in combination with fast in vivo clearance after drug exposition<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> may explain the excellent efficacy of <b>3</b>, being at the same time well tolerated in different species.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32774" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32774" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">6-Methoxycarbonyl-substituted indolinones are potent inhibitors of VEGFR-1/2/3, PDGFRα, and FGFR-1, with low cross-reactivity against a panel of other kinases. This attractive antiangiogenic target profile translates well into cellular efficacy, exemplified by VEGF-specific inhibition of HUVEC proliferation, as well as inhibition of pericytes and smooth muscle cells. At similar concentrations, no direct effects on the proliferation of tumor cell lines can be observed. Typical methoxycarbonyl-substituted compounds are orally available but almost completely cleared from plasma 24 h after administration in mice. Oral application in tumor xenograft experiments leads to complete inhibition of tumor growth after continuous dosing. The triple angiokinase inhibitory pattern in combination with good efficacy in vivo defines a unique pharmacological target profile of this compound class, with potential for improved efficacy in cancer treatment. Compound <b>3</b> (BIBF 1120) is currently being evaluated in phase III clinical trials in the treatment of nonsmall cell lung cancer<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and is in clinical development for other tumor types. Since it was shown that <b>2</b> and <b>3</b> are also highly effective in an animal model of lung fibrosis,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> clinical development of <b>3</b> in idiopathic pulmonary fibrosis was recently initiated.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All starting materials and reagents were either commercially available or their synthesis had been described in the literature before. All purchased chemicals and solvents were used without further purification. Reaction progresses were usually monitored by TLC using Merck silica gel 60 F<sub>254</sub> plates and UV light at 254 nm. All chromatographic purifications were conducted as MPLC using DAVISIL LC60A silica gel (35−70 μm) unless otherwise noted. Yields refer to purified products and were not optimized. <sup>1</sup>H NMR (400 MHz) spectra were recorded on a Bruker DPX 400 spectrometer using DMSO-<i>d</i><sub>6</sub> as solvent and Si(CH<sub>3</sub>)<sub>4</sub> as an internal standard. Low resolution mass spectra (MS) were run on a Micromass platform mass spectrometer. High resolution masses (HRMS) were determined on a Micromass Q-Tof-2 mass spectrometer. Combustion analyses were performed by InfraServ Knapsack on an Elementar Vario Macro System and are within ±0.4% of theoretical values. HPLC retention times were recorded on a Waters 1515 apparatus using a X-terra MS C18 column (2.5 μm, 4.6 mm × 30 mm) eluted with a 3.1 min gradient from 5% to 98% B, wherein A = water/0.1% formic acid and B = acetonitrile/0.1% formic acid.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-Carboxymethyl-3-nitrobenzoic Acid Ethyl Ester (<b>5</b>)</h3><div class="NLM_p last">4-Carboxymethylbenzoic acid ethyl ester<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a><b>4 (</b>20.8 g, 100 mmol) was dissolved in conc sulfuric acid (200 mL) and ammonium nitrate (8.80 g, 110 mmol) was slowly added in a way that the reaction temperature did not exceed −5 °C. Stirring was continued for 2 h at −5 °C. After that time, the mixture was carefully poured into ice water. The precipitate was filtered off, washed with water, and dried at 80 °C to give 22.9 g (91%) of <b>5</b>. <sup>1</sup>H NMR: δ 1.38 (t, 3H), 4.10 (s, 2H), 4.38 (q, 2H), 7.76 (d, 1H), 8.21 (d, 1H), 8.50 (s, 1H), 12.50 (br, 1H). MS: <i>m</i>/<i>z</i> 276 [M + Na]<sup>+</sup>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-Methoxycarbonylmethyl-3-nitrobenzoic Acid Methyl Ester (<b>7</b>)</h3><div class="NLM_p last">Potassium <i>tert</i>-butylate (78.5 g, 700 mmol) was dissolved in dimethylformamide (600 mL) and a solution of methyl chloroacetate (29.0 mL, 330 mmol) and 3-nitrobenzoic acid methyl ester <b>6</b> (54.3 g, 300 mmol) in dimethylformamide (100 mL) was slowly added at −10 °C. Stirring was continued for 10 min at −10 °C. After that time, the mixture was poured into a mixture of ice water (1.0 L) and conc hydrochloric acid (350 mL). The precipitate was filtered off and washed with water. The residue was recrystallized from methanol and dried at 40 °C in vacuum to give 47.8 g (63%) of <b>7</b>. <sup>1</sup>H NMR: δ 3.61 (s, 3H), 3.92 (s, 3H), 4.18 (s, 2H), 7.74 (d, 1H), 8.26 (d, 1H), 8.52 (s, 1H). MS: <i>m</i>/<i>z</i> 276 [M + Na]<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> [4-(2-Methyl-[1,3]dioxolan-2-yl)-2-nitrophenyl]acetic Acid <i>tert</i>-Butyl Ester (<b>9</b>)</h3><div class="NLM_p last">Potassium <i>tert</i>-butylate (7.0 g, 62 mmol) was dissolved in dimethylformamide (50 mL) and a solution of <i>tert</i>-butyl chloroacetate (3.7 mL, 26 mmol) and 2-methyl-2-(3-nitrophenyl)-[1,3]dioxolane<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (<b>8</b>) (5.0 g, 24 mmol) in dimethylformamide (15 mL) was slowly added at −5 °C. Stirring was continued for 10 min at −2 °C. After that time, the mixture was poured into a mixture of ice water (1.6 L) and conc hydrochloric acid (100 mL). Methylene chloride was added, and the organic layer was separated and washed with water. After drying over sodium sulfate, the solvent was evaporated and the residue was purified by column chromatography (silica gel), eluting with methylene chloride/cyclohexane (4/1) to give 2.4 g (31%) of <b>9</b>. <sup>1</sup>H NMR: δ 1.40 (s, 9H), 1.62 (s, 3H), 3.74 (t, 2H), 3.98 (s, 2H), 4.13 (t, 2H), 7.53 (d, 1H), 7.73 (d, 1H), 8.04 (s, 1H). MS: <i>m</i>/<i>z</i> 324 [M + H]<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-(4-Cyano-2-nitrophenyl)malonic Acid Dimethyl Ester (<b>11</b>)</h3><div class="NLM_p last">Potassium <i>tert</i>-butylate (42.0 g, 112 mmol) was dissolved in dimethyl sulfoxide (140 mL) at 20 °C, and dimethyl malonate (44.0 mL, 385 mmol) was slowly added. Stirring was continued for 1 h at ambient temperature. After that time, 4-cyano-2-nitrobenzonitrile <b>10</b> (20.0 g, 110 mmol) was slowly added and the mixture was stirred at 100 °C for 1 h. After being cooled, the mixture was poured into water (1 L) and neutralized with 1 N hydrochloric acid (24 mL). The precipitate was filtered off and washed with water. The residue was taken up in methylene chloride, extracted with water, and dried over sodium sulfate to give 27.0 g (88%) of <b>11</b>. <sup>1</sup>H NMR: δ 3.72 (s, 6H), 5.65 (s, 1H), 7.80 (d, 1H), 8.27 (d, 1H), 8.66 (s, 1H). MS: <i>m</i>/<i>z</i> 301 [M + Na]<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> [2-Amino-4-(2-methyl-[1,3]dioxolan-2-yl)phenyl]acetic Acid <i>tert</i>-Butyl ester (<b>12</b>)</h3><div class="NLM_p last">[4-(2-Methyl-[1,3]dioxolan-2-yl)-2-nitrophenyl]acetic acid <i>tert</i>-butyl ester <b>9</b> (3.1 g, 9.6 mmol) was dissolved in methanol (50 mL) and hydrogenated (50 psi) at room temperature for 4.5 h using 1.6 g Raney nickel as catalyst. After that time, the catalyst was filtered off and the solvent was removed by evaporation to give 2.6 g (92%) of <b>12</b>. <sup>1</sup>H NMR: δ 1.40 (s, 9H), 1.51 (s, 3H), 3.37 (s, 2H), 3.67 (t, 2H), 3.94 (t, 2H), 6.56 (d, 1H), 6.73 (s, 1H), 6.89 (d, 1H). MS: <i>m</i>/<i>z</i> 294 [M + H]<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-(4-Cyano-2-nitrophenyl)acetic Acid Methyl Ester (<b>13</b>)</h3><div class="NLM_p last">2-(4-Cyano-2-nitrophenyl)malonic acid dimethyl ester <b>11</b> (20.0 g, 71.9 mmol) was dissolved in dimethyl sulfoxide (350 mL), and lithium chloride (6.10 g, 143 mmol) and water (1.3 mL) were added. The mixture was stirred for 3.5 h at 100 °C. After being cooled, the mixture was poured into ice water (1.8 L) and stirred for 10 min. The precipitate was filtered off and washed with water. The residue was triturated with water, filtered off, and dried at 60 °C to give 7.77 g (49%) of <b>13</b>. <sup>1</sup>H NMR: δ 3.55 (s, 3H), 4.21 (s, 2H), 7.80 (d, 1H), 8.22 (d, 1H), 8.64 (s, 1H). MS: <i>m</i>/<i>z</i> 219 [M − H]<sup>−</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-<i>oxo</i>-2,3-Dihydro-1<i>H</i>-indole-6-carboxylic Acid Ethyl Ester (<b>14</b>)</h3><div class="NLM_p last">4-Carboxymethyl-3-nitrobenzoic acid ethyl ester <b>5</b> (2.50 g, 10.0 mmol) was dissolved in acetic acid (50 mL) and hydrogenated (50 psi) at room temperature for 1 h using 0.50 g palladium on charcoal (10%) as catalyst. After that time, the catalyst was filtered off and the solvent was removed by evaporation. The residue was triturated with diethyl ether, filtered off, and dried at 100 °C under vacuum to give 1.70 g (83%) of <b>14</b>. <sup>1</sup>H NMR: δ 1.46 (t, 3H), 3.59 (s, 2H), 4.30 (q, 2H), 7.30 (s, 1H) superimposed on 7.32 (d, 1H), 7.58 (d, 1H), 10.55 (s, 1H). MS: <i>m</i>/<i>z</i> 205 [M]<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-<i>oxo</i>-2,3-Dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>15</b>)</h3><div class="NLM_p last">4-Methoxycarbonylmethyl-3-nitrobenzoic acid methyl ester <b>7</b> (38.7 g, 153 mmol) was dissolved in acetic acid (800 mL) and hydrogenated (50 psi) at room temperature for 2.5 h using 5.0 g palladium on charcoal (10%) as catalyst. After that time, the catalyst was filtered off and the solvent was removed by evaporation. The residue was triturated with toluene, filtered off, and dried at 100 °C under vacuum to give 28.6 g (98%) of <b>15</b>. <sup>1</sup>H NMR: δ 3.56 (s, 2H), 3.84 (s, 3H), 7.33 (s, 1H) superimposed on 7.34 (d, 1H), 7.57 (d, 1H), 10.53 (s, 1H). MS: <i>m</i>/<i>z</i> 190 [M − H]<sup>−</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 6-Acetylindolin-2-one (<b>16</b>)</h3><div class="NLM_p last">[2-Amino-4-(2-methyl-[1,3]dioxolan-2-yl)phenyl]acetic acid <i>tert</i>-butyl ester <b>12</b> (780 mg, 2.66 mmol) was dissolved in a mixture of methanol (3 mL) and 1 N hydrochloric acid (15 mL). The mixture was stirred at reflux for 1 h. After being cooled, methylene chloride was added. The organic layer was separated and extracted with water. After drying over sodium sulfate, the solvent was removed by evaporation to give 390 mg (84%) of <b>16</b>. <sup>1</sup>H NMR: δ 2.55 (s, 3H), 3.58 (s, 2H), 7.28 (s, 1H), 7.33 (d, 1H), 7.59 (d, 1H), 10.55 (s, 1H). MS: <i>m</i>/<i>z</i> 176 [M + H]<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 6-Cyanoindolin-2-one (<b>17</b>)</h3><div class="NLM_p last">2-(4-Cyano-2-nitrophenyl)acetic acid methyl ester <b>13</b> (18.7 g, 85.0 mmol) was dissolved in methanol (500 mL) and hydrogenated (44 psi) at room temperature for 4.0 h using 7.0 g Lindlar catalyst. After that time, the catalyst was filtered off and the solvent was removed by evaporation. The residue was taken up in acetic acid (300 mL) and stirred for 0.5 h at 100 °C. After that time, the solvent was removed by evaporation. The residue was washed with water and dried at 70 °C to give 11.5 g (86%) of <b>17</b>. <sup>1</sup>H NMR: δ 3.60 (s, 2H), 7.12 (s, 1H), 7.39 (2xs, 2 × 1H), 10.30 (s, 1H). MS: <i>m</i>/<i>z</i> 157 [M − H]<sup>−</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 6-Nitroindolin-2-one (<b>19</b>)</h3><div class="NLM_p last">3,3-Bis(methoxycarbonyl)-6-nitroindolin-2-one<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>18</b> (5.40 g, 18.4 mmol) was dissolved in a mixture of formic acid (100 mL) and methanesulfonic acid (100 mL) and refluxed at 110 °C for 2.5 h. After that time, the solvents were evaporated and water was added. The precipitate was filtered off, dissolved in dichloromethane/methanol (1:1), and washed with water. The aqueous phase was extracted with dichloromethane/methanol (1:1) and ethyl acetate, and all combined organic layers were dried over sodium sulfate. After filtration over celite, the solvent was removed by evaporation to give 2.30 g (70%) of <b>19</b>. <sup>1</sup>H NMR: δ 3.65 (s, 2H), 7.45 (d, 1H), 7.51 (s, 1H), 7.83 (d, 1H), 10.70 (s, 1H). MS: <i>m</i>/<i>z</i> 178 [M]<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-Acetyl-6-chloroindolin-2-one (<b>22</b>)</h3><div class="NLM_p last">6-Chloroindolin-2-one <b>20</b> (100 g, 168 mmol) was suspended in acetic anhydride (200 mL) and refluxed at 130 °C for 7 h. After that time, the mixture was allowed to cool and the precipitate was filtered off and washed with petroleum ether to give 109 g (87%) of <b>22</b>. <sup>1</sup>H NMR: δ 2.50 (s, 3H), 3.80 (s, 2H), 7.25 (d, 1H), 7.35 (d, 1H), 8.05 (s, 1H). MS: <i>m</i>/<i>z</i> 210 [M + H]<sup>+</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1,6-Diacetylindolin-2-one (<b>23</b>)</h3><div class="NLM_p last">Compound <b>23</b> was prepared using the same procedure as described for the synthesis of <b>22</b> by substituting <b>16</b> for 6-chloroindolin-2-one <b>20</b>. <sup>1</sup>H NMR: δ 2.50 (s, 3H), 2.60 (s, 3H), 3.91 (s, 2H), 7.50 (d, 1H), 7.86 (d, 1H), 8.61 (s, 1H). MS: <i>m</i>/<i>z</i> 240 [M + Na]<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-Acetylindolin-2-one (<b>24</b>)</h3><div class="NLM_p last">Compound <b>24</b> was prepared using the same procedure as described for the synthesis of <b>22</b> by substituting indolin-2-one <b>21</b> for 6-chloroindolin-2-one <b>20</b>. <sup>1</sup>H NMR: δ 2.50 (s, 3H), 3.81 (s, 2H), 7.20 (t, 1H), 7.31 (1xd/1xt, 2 × 1H), 8.07 (d, 1H). MS: <i>m</i>/<i>z</i> 176 [M + H]<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 6-Acetyl-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>25</b>)</h3><div class="NLM_p last">2-<i>oxo</i>-2,3-Dihydro-1<i>H</i>-indole-6-carboxylic acid methyl ester <b>15</b> (11.5 g, 60.2 mmol) was suspended in acetic anhydride (100 mL) and refluxed at 130 °C for 8 h. After that time, the mixture was allowed to cool and the precipitate was filtered off and washed with petroleum ether to give 10.2 g (73%) of <b>25</b>. <sup>1</sup>H NMR: δ 2.56 (s, 3H), 3.87 (s, 3H), 3.88 (s, 2H), 7.47 (d, 1H), 7.80 (d, 1H), 8.62 (s, 1H). MS: <i>m</i>/<i>z</i> 256 [M + Na]<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>E</i>)-1-Acetyl-3-(ethoxy-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Ethyl Ester (<b>26</b>)</h3><div class="NLM_p last">2-<i>oxo</i>-2,3-Dihydro-1<i>H</i>-indole-6-carboxylic acid ethyl ester <b>14</b> (12.9 g, 62.9 mmol) was dissolved in acetic anhydride (130 mL) and <i>ortho</i>-benzoic acid triethyl ester (42.7 mL, 189 mmol) was added. The mixture was stirred at 110 °C for 3.5 h. After that time, the solvent was removed by evaporation. The residue was triturated with petroleum ether, filtered off, and dried at 50 °C under vacuum to give 18.2 g (76%) of <b>26</b>. <sup>1</sup>H NMR: δ 1.32 (m, 2 × 3H), 2.48 (s, 3H), 4.02 (q, 2H), 4.32 (q, 2H), 7.40−7.60 (m, 5H), 7.88 (d, 1H), 8.08 (d, 1H), 8.76 (s, 1H). MS: <i>m</i>/<i>z</i> 380 [M + H]<sup>+</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>E</i>)-1-Acetyl-3-(ethoxy-phenyl-methylene)-6-nitroindolin-2-one (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was prepared using the same procedure as described for the synthesis of <b>26</b> by substituting <b>19</b> for <b>14</b>. <sup>1</sup>H NMR: δ 1.43 (t, 3H), 2.55 (s, 3H), 4.11 (q, 2H), 7.50−7.70 (m, 5H), 8.20 (m, 2 × 1H), 8.93 (s, 1H). MS: <i>m</i>/<i>z</i> 353 [M + H]<sup>+</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>E</i>)-1-Acetyl-6-cyano-3-(ethoxy-phenyl-methylene)-indolin-2-one (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> was prepared using the same procedure as described for the synthesis of <b>26</b> by substituting <b>17</b> for <b>14</b>. <sup>1</sup>H NMR: δ 1.35 (t, 3H), 2.43 (s, 3H), 4.04 (q, 2H), 7.45−7.60 (m, 5H), 7.73 (d, 1H), 8.12 (d, 1H), 8.42 (s, 1H). MS: <i>m</i>/<i>z</i> 355 [M + Na]<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>E</i>)-1-Acetyl-6-chloro-3-(ethoxy-phenyl-methylene)-indolin-2-one (<b>29</b>)</h3><div class="NLM_p last">1-Acetyl-6-chloroindolin-2-one <b>22</b> (41.9 g, 200 mmol) was dissolved in acetic anhydride (150 mL), and <i>ortho</i>-benzoic acid triethyl ester (136 mL, 600 mmol) was added. The mixture was stirred at 120 °C for 6 h. After that time, the solvent was removed by evaporation. The residue was triturated with petroleum ether (100 mL), filtered off, and dried at 80 °C under vacuum to give 38.0 g (56%) of <b>29</b>. <sup>1</sup>H NMR: δ 1.31 (t, 3H), 2.42 (s, 3H), 3.96 (q, 2H), 7.29 (d, 1H), 7.45−7.60 (m, 5H), 7.93 (d, 1H), 8.14 (s, 1H). MS: <i>m</i>/<i>z</i> 342 [M + H]<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>E</i>)-1,6-Diacetyl-3-(ethoxy-phenyl-methylene)-indolin-2-one (<b>30</b>)</h3><div class="NLM_p last">Compound <b>30</b> was prepared using the same procedure as described for the synthesis of <b>29</b> by substituting <b>23</b> for <b>22</b>. <sup>1</sup>H NMR: δ 1.36 (t, 3H), 2.45 (s, 3H), 2.60 (s, 3H), 4.02 (q, 2H), 7.45−7.55 (m, 5H), 7.95 (d, 1H), 8.10 (d, 1H), 8.70 (s, 1H). MS: <i>m</i>/<i>z</i> 350 [M + H]<sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>E</i>)-3-(Ethoxy-phenyl-methylene)-indolin-2-one (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> was prepared using the same procedure as described for the synthesis of <b>29</b> by substituting <b>24</b> for <b>22</b>. <sup>1</sup>H NMR: δ 1.33 (t, 3H), 2.43 (s, 3H), 3.94 (q, 2H), 7.25 (m, 2H), 7.45−7.55 (m, 5H), 7.98 (d, 1H), 8.17 (d, 1H). MS: <i>m</i>/<i>z</i> 330 [M + Na]<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>E</i>)-1-Acetyl-3-(ethoxy-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> was prepared using the same procedure as described for the synthesis of <b>29</b> by substituting <b>25</b> for <b>22</b>. <sup>1</sup>H NMR: δ 1.46 (t, 3H), 2.48 (s, 3H), 3.88 (s, 3H), 4.03 (q, 2H), 7.45−7.60 (m, 5H), 7.88 (d, 1H), 8.09 (d, 1H), 8.74 (s, 1H). MS: <i>m</i>/<i>z</i> 366 [M + H]<sup>+</sup>.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>E</i>)-1-Acetyl-3-(methoxy-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was prepared using the same procedure as described for the synthesis of <b>29</b> by substituting <b>25</b> for <b>22</b> and <i>ortho</i>-benzoic acid triethyl ester for <i>ortho</i>-benzoic acid trimethyl ester. <sup>1</sup>H NMR: δ 2.44 (s, 3H), 3.75 (s, 3H), 3.87 (s, 3H), 7.45−7.60 (m, 5H), 7.86 (d, 1H), 8.06 (d, 1H), 8.73 (s, 1H). MS: <i>m</i>/<i>z</i> 374 [M + Na]<sup>+</sup>.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Ethyl Ester (<b>34</b>)</h3><div class="NLM_p last">(<i>E</i>)-1-Acetyl-3-(ethoxy-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic acid ethyl ester (<b>26</b>) (1.50 g, 3.95 mmol) and 4-piperidin-1-ylmethyl-phenylamine<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (1.13 g, 5.93 mmol) were dissolved in dimethylformamide (15 mL). The mixture was stirred at 100 °C for 0.5 h. After that time, heating was suspended and piperidine (5 mL) was added at room temperature and stirring was continued for 3.0 h. After that time, the solvent was removed by evaporation. The residue was purified by column chromatography (aluminum oxide, activity 2−3) eluting with methylene chloride/ethanol (100/3) to give 1.10 g (58%) of <b>34</b>. <sup>1</sup>H NMR: δ 1.28 (t, 3H), 1.30−1.50 (m, 6H), 2.23 (m, 4H), 3.30 (s, 2H), 4.22 (q, 2H), 5.80 (d, 1H), 6.80 (d, 2H), 7.07 (d, 2H), 7.18 (d, 1H), 7.40−7.65 (m, 6H), 10.92 (s, 1H), 12.22 (s, 1H). MS: <i>m</i>/<i>z</i> 481 [M]<sup>+</sup>. Anal. (C<sub>30</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>Z</i>)-6-Nitro-3-[phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-indolin-2-one (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> was prepared using the same procedure as described for the synthesis of <b>34</b> by substituting <b>27</b> for <b>26</b>. <sup>1</sup>H NMR: δ 1.30−1.50 (m, 6H), 2.20 (m, 4H), 3.30 (s, 2H), 5.80 (d, 1H), 6.84 (d, 2H), 7.08 (d, 2H), 7.45−7.70 (m, 7H), 11.18 (s, 1H), 12.39 (s, 1H). MS: <i>m</i>/<i>z</i> 455 [M + H]<sup>+</sup>. Anal. (C<sub>27</sub>H<sub>26</sub>N<sub>4</sub>O<sub>3</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>Z</i>)-6-Chloro-3-[phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-indolin-2-one (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> was prepared using the same procedure as described for the synthesis of <b>34</b> by substituting <b>29</b> for <b>26</b>. <sup>1</sup>H NMR: δ 1.30−1.50 (m, 6H), 2.20 (m, 4H), 3.18 (s, 2H), 5.70 (d, 1H), 6.57 (d, 1H), 6.77 (d, 2H), 6.85 (s, 1H), 7.05 (d, 2H), 7.40−7.60 (m, 5H), 10.82 (s, 1H), 11.98 (s, 1H). MS: <i>m</i>/<i>z</i> 444 [M + H]<sup>+</sup>. HPLC: >95% (<i>t</i><sub>R</sub> = 2.3 min). HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>26</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup><i>m</i>/<i>e</i> 444.1843, found <i>m</i>/<i>e</i> 444.1839.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>Z</i>)-6-Cyano-3-[phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-indolin-2-one (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> was prepared using the same procedure as described for the synthesis of <b>34</b> by substituting <b>28</b> for <b>26</b>. <sup>1</sup>H NMR: δ 1.30−1.50 (m, 6H), 2.20 (m, 4H), 3.28 (s, 2H), 5.77 (d, 1H), 6.79 (d, 2H), 6.98 (d, 1H), 7.08 (d, 2H), 7.17 (s, 1H), 7.45−7.65 (m, 5H), 11.03 (s, 1H), 12.28 (s, 1H). MS: <i>m</i>/<i>z</i> 435 [M + H]<sup>+</sup>. HPLC: >95% (<i>t</i><sub>R</sub> = 2.2 min). HRMS (ES<sup>+</sup>) calcd for C<sub>28</sub>H<sub>26</sub>N<sub>4</sub>O [M + H]<sup>+</sup><i>m</i>/<i>e</i> 435.2185, found <i>m</i>/<i>e</i> 435.2178.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>Z</i>)-6-Acetyl-3-[phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-indolin-2-one (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> was prepared using the same procedure as described for the synthesis of <b>34</b> by substituting <b>30</b> for <b>26</b>. <sup>1</sup>H NMR: δ 1.30−1.80 (m, 6H), 2.43 (s, 3H), 2.75 (m, 2H), 3.18 (m, 2H), 4.12 (s, 2H), 5.82 (d, 1H), 6.88 (d, 2H), 7.23 (d, 1H), 7.40−7.70 (m, 8H), 11.02 (s, 1H), 12.26 (s, 1H). MS: <i>m</i>/<i>z</i> 451 [M]<sup>+</sup>. Anal. (C<sub>29</sub>H<sub>29</sub>N<sub>3</sub>O<sub>2</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>Z</i>)-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-indolin-2-one (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> was prepared using the same procedure as described for the synthesis of <b>34</b> by substituting <b>31</b> for <b>26</b>. <sup>1</sup>H NMR: δ 1.30−1.50 (m, 6H), 2.10−2.30 (m, 4H), 3.38 (m, 2H), 5.76 (d, 1H), 6.51 (t, 1H), 6.72 (d, 2H), 6.86 (m, 2H), 7.04 (d, 2H), 7.40−7.60 (m, 5H), 10.69 (s, 1H), 12.03 (s, 1H). MS: <i>m</i>/<i>z</i> 409 [M]<sup>+</sup>. Anal. (C<sub>27</sub>H<sub>27</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid (<b>40</b>)</h3><div class="NLM_p last">(<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic acid ethyl ester (<b>34</b>) (800 mg, 1.66 mmol) was dissolved in ethanol (30 mL) and 1 N NaOH (8.3 mL) was added. The mixture was stirred at 80 °C for 1 h. After that time, heating was suspended and the mixture was neutralized using 1 N HCl. The precipitate was filtered off, washed with water, ethanol, and diethyl ether, and dried at 100 °C under vacuum to give 670 mg (89%) of <b>40</b>. <sup>1</sup>H NMR: δ 1.25−1.50 (m, 6H), 2.15−2.30 (m, 4H), 3.30 (s, 2H), 5.78 (d, 1H), 6.77 (d, 2H), 7.05 (d, 2H), 7.14 (d, 1H), 7.40−7.60 (m, 6H), 10.88 (s, 1H), 12.22 (s, 1H). MS: <i>m</i>/<i>z</i> 453 [M]<sup>+</sup>. HPLC: >95% (<i>t</i><sub>R</sub> = 2.0 min). HRMS (ES<sup>+</sup>) calcd for C<sub>28</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup><i>m</i>/<i>e</i> 454.2131, found <i>m</i>/<i>e</i> 454.2123.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Amide (<b>1</b>)</h3><div class="NLM_p last">(<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic acid (<b>40</b>) (907 mg, 2.00 mmol), <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate (TBTU, 771 mg, 2.40 mmol), and hydroxy-benzotriazole (HOBT, 367 mg, 2.40 mmol) were suspended in dimethylformamide (25 mL) and triethylamine (1.0 mL) was added. The mixture was stirred at room temperature for 0.25 h. After that time, the mixture was cooled to 0 °C and ammonia was bubbled through the solution for 15 min in a way that the reaction temperature did not exceed 15 °C. Stirring was continued for 1.5 h at room temperature. The precipitate was filtered off, washed with water, ethanol, and diethyl ether and dried at 100 °C under vacuum to give 578 mg (64%) of <b>1</b>. <sup>1</sup>H NMR: δ 1.30−1.50 (m, 6H), 2.15−2.30 (m, 4H), 3.30 (s, 2H), 5.72 (d, 1H), 6.76 (d, 2H), 7.05 (d, 2H) superimposed on 7.08 (d, 1H), 7.38 (s, 1H), 7.45−7.75 (m, 5H), 10.88 (s, 1H), 12.13 (s, 1H). MS: <i>m</i>/<i>z</i> 452 [M]<sup>+</sup>. Anal. (C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Isopropylamide (<b>41</b>)</h3><div class="NLM_p last">(<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic acid (<b>40</b>) (454 mg, 1.00 mmol), <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate (TBTU, 385 mg, 1.20 mmol), and hydroxy-benzotriazole (HOBT, 184 mg, 1.20 mmol) were suspended in dimethylformamide (10 mL) and <i>N</i>-ethyl diisopropylamine (2.8 mL) was added. Isopropylamine (128 mL, 1.50 mmol) was added, and the mixture was stirred at room temperature for 1 h. After that time, water was added, the precipitate was filtered off, washed with water, acetone, and diethyl ether, and dried at 100 °C under vacuum to give 368 mg (74%) of <b>41</b>. <sup>1</sup>H NMR: δ 1.10 (d, 6H), 1.30−1.50 (m, 6H), 2.15−2.25 (m, 4H), 3.23 (s, 2H), 4.03 (sept, 1H), 5.70 (d, 1H), 6.78 (d, 2H), 7.04 (s, 1H) superimposed on 7.06 (d, 2H), 7.32 (s, 1H), 7.40−7.60 (m, 5H), 10.88 (s, 1H), 12.10 (s, 1H). MS: <i>m</i>/<i>z</i> 494 [M]<sup>+</sup>. Anal. (C<sub>31</sub>H<sub>34</sub>N<sub>4</sub>O<sub>2</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Dimethylamide Hydrochloride (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> was prepared using the same procedure as described for the synthesis of <b>41</b> by substituting dimethylamine hydrochloride for isopropylamine. <sup>1</sup>H NMR: δ 1.30−1.80 (m, 6H), 2.90 (s, 6H) superimposed on 2.60−2.90 (m, 2H), 3.10−3.30 (m, 2H), 4.12 (s, 2H), 5.78 (d, 1H), 6.62 (d, 1H), 6.82 (d, 2H) superimposed on 6.86 (s, 1H), 7.25 (d, 2H), 7.45−7.65 (m, 5H), 9.10 (br, 1H), 10.88 (s, 1H), 12.15 (s, 1H). MS: <i>m</i>/<i>z</i> 480 [M]<sup>+</sup>. HPLC: >95% (<i>t</i><sub>R</sub> = 2.0 min). HRMS (ES<sup>+</sup>) calcd for C<sub>30</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>e</i> 481.2604, found <i>m</i>/<i>e</i> 481.2595.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Ethylmethylamide (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> was prepared using the same procedure as described for the synthesis of <b>41</b> by substituting <i>N</i>-methylethylamine for isopropylamine. <sup>1</sup>H NMR: δ 1.04 (t, 3H), 1.35−1.45 (m, 6H), 2.22 (m, 4H), 2.85 (s, 3H), 3.28 (q, 3H) superimposed on 3.29 (m, 2H), 5.77 (d, 1H), 6.57 (d, 1H), 6.75 (d, 2H), 6.85 (s, 1H), 7.04 (d, 2H), 7.45−7.55 (m, 5H), 10.78 (s, 1H), 12.10 (s, 1H). MS: <i>m</i>/<i>z</i> 494 [M]<sup>+</sup>. Anal. (C<sub>31</sub>H<sub>34</sub>N<sub>4</sub>O<sub>2</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methylamide Hydrochloride (<b>44</b>)</h3><div class="NLM_p last">Compound <b>44</b> was prepared using the same procedure as described for the synthesis of <b>41</b> by substituting methylamine hydrochloride for isopropylamine. <sup>1</sup>H NMR: δ 1.30−1.80 (m, 6H), 2.75 (d, 3H) superimposed on 2.60−2.90 (m, 2H), 3.10−3.30 (m, 2H), 4.09 (m, 2H), 5.74 (d, 1H), 6.83 (d, 1H), 6.82 (d, 2H), 7.15 (d, 1H), 7.30−7.70 (m, 7H), 8.20 (q, 1H), 10.35 (br, 1H), 10.98 (s, 1H), 12.14 (s, 1H). MS: <i>m</i>/<i>z</i> 467 [M + H]<sup>+</sup>. Anal. (C<sub>29</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub>·1.0HCL·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>45</b>)</h3><div class="NLM_p last">(<i>Z</i>)-2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indole-6-carboxylic acid (<b>40</b>) (900 mg, 1.98 mmol) was suspended in dimethylformamide (35 mL), and <i>N</i>,<i>N</i>′-carbonyldiimidazole (385 mg, 2.38 mmol) was added. The mixture was stirred at 80 °C for 14 h. After that time, methanol (20 mL) was added and stirring was continued for 3 h at 50 °C. After that time, the solvent was removed by evaporation. The residue was purified by column chromatography (aluminum oxide, activitiy 2−3) eluting with methylene chloride/methanol (3/1) to give to give 450 mg (49%) of <b>45</b>. <sup>1</sup>H NMR: δ 1.30−1.50 (m, 6H), 2.20 (m, 4H), 3.23 (m, 2H), 3.78 (s, 3H), 5.79 (d, 1H), 6.79 (d, 2H), 7.03 (d, 2H), 7.19 (d, 1H), 7.39 (s, 1H) superimposed on 7.40−7.65 (m, 5H), 10.94 (s, 1H), 12.24 (s, 1H). MS: <i>m</i>/<i>z</i> 468 [M + H]<sup>+</sup>. Anal. (C<sub>29</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>Z</i>)-6-Amino-3-[phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-indolin-2-one (<b>46</b>)</h3><div class="NLM_p last">(<i>Z</i>)-6-Nitro-3-[phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-indolin-2-one (<b>35</b>) (850 mg, 1.87 mmol) was dissolved in methylene chloride (50 mL) and methanol (50 mL) and hydrogenated at room temperature and atmospheric pressure for 24 h using 0.05 g Raney nickel as catalyst. After that time, the catalyst was filtered off and the solvent was removed by evaporation to give 675 mg (85%) of <b>46</b>. <sup>1</sup>H NMR: δ 1.25−1.65 (m, 6H), 2.40−2.70 (m, 4H), 3.30 (s, 2H), 5.55 (d, 1H), 5.78 (dd, 1H), 6.14 (d, 1H), 6.63 (d, 2H), 7.12 (m, 2H), 7.40−7.60 (m, 5H), 10.43 (s, 1H), 11.55 (s, 1H). MS: <i>m</i>/<i>z</i> 425 [M + H]<sup>+</sup>. HPLC: >95% (<i>t</i><sub>R</sub> = 1.6 min). HRMS (ES<sup>+</sup>) calcd for C<sub>27</sub>H<sub>28</sub>N<sub>4</sub>O [M + H]<sup>+</sup><i>m</i>/<i>e</i> 425.2341, found <i>m</i>/<i>e</i> 425.2335.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>Z</i>)-<i>N</i>-{2-<i>oxo</i>-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-2,3-dihydro-1<i>H</i>-indol-6-yl}-acetamide Hydrochloride (<b>47</b>)</h3><div class="NLM_p last">(<i>Z</i>)-6-Amino-3-[phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-indolin-2-one (<b>46</b>) (500 mg, 1.18 mmol) was dissolved in methylene chloride (20 mL), and triethylamine (0.2 mL) was added. Acetylchloride (0.1 mL, 1.2 mmol) was added, and the mixture was stirred for 5 h at ambient temperature. After that time, the solvent was removed by evaporation and the residue was purified by column chromatography (silica gel) eluting with methylene chloride/methanol (4/1) to give 360 mg (66%) of <b>47</b>. <sup>1</sup>H NMR: δ 1.40−1.80 (m, 6H), 1.98 (s, 3H), 2.60−2.90 (m, 2H), 3.30−3.40 (m, 2H), 3.97 (m, 2H), 5.67 (d, 1H), 6.62 (d, 1H), 6.74 (d, 2H), 7.30 (d, 2H), 7.45−7.65 (m, 6H), 9.90 (s, 1H), 10.50 (br, 1H), 10.73 (s, 1H), 11.86 (s, 1H). MS: <i>m</i>/<i>z</i> 467 [M + H]<sup>+</sup>. HPLC: >95% (<i>t</i><sub>R</sub> = 2.1 min). HRMS (ES<sup>+</sup>) calcd for C<sub>29</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>e</i> 467.2447, found <i>m</i>/<i>e</i> 467.2441.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>Z</i>)-3-[Phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-6-pyrrol-1-yl-indolin-2-one (<b>48</b>)</h3><div class="NLM_p last">(<i>Z</i>)-6-Amino-3-[phenyl-(4-piperidin-1-ylmethyl-phenylamino)-methylene]-indolin-2-one (<b>46</b>) (500 mg, 1.18 mmol) were dissolved in acetic acid (20 mL) and 2,5-dimethoxy tetrahydrofuran (160 mL, 1.18 mmol) were added. The mixture was refluxed for 1 h. After that time, the solvent was removed by evaporation. The residue was taken up in water (20 mL) and stirred for 2.0 h at ambient temperature. After that time, the mixture was neutralized with 1 N sodium hydroxide solution. Methylene chloride was added, and the organic layer was separated and dried over sodium sulfate. The solvent was removed by evaporation, and the residue was purified by column chromatography (silica gel) eluting with methylene chloride/methanol (4/1) to give 200 mg (36%) of <b>48</b>. <sup>1</sup>H NMR: δ 1.25−1.55 (m, 6H), 2.20−2.30 (m, 4H), 3.30 (m, 2H), 5.78 (d, 1H), 6.18 (s, 2H), 6.72 (s, 1H), 6.76 (s, 2H), 6.95 (s, 1H), 7.04 (d, 2H), 7.16 (s, 2H), 7.40−7.65 (m, 5H), 10.87 (s, 1H), 11.94 (s, 1H). MS: <i>m</i>/<i>z</i> 475 [M + H]<sup>+</sup>. Anal. (C<sub>31</sub>H<sub>30</sub>N<sub>4</sub>O·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>Z</i>)-3-[(4-{Methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino}-phenylamino)-methylene]-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>3</b>)</h3><div class="NLM_p last">(<i>E</i>)-1-Acetyl-3-(methoxy-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic acid methyl ester (<b>33</b>) (10.5 g, 30.0 mmol) and <i>N</i>-(4-aminophenyl)-<i>N</i>-methyl-2-(4-methylpiperazin-1-yl)acetamide (<b>84</b>, 8.60 g, 33.0 mmol) were dissolved in dimethylformamide (80 mL). The mixture was stirred at 80 °C for 1 h. After that time, heating was suspended and piperidine (6.5 mL) was added at room temperature and stirring was continued for 2.0 h. After that time, water was added and the precipitate was filtered off and washed with water. The residue was triturated with methanol, filtered off, washed with cold methanol and diethyl ether, and dried at 110 °C under vacuum to give 12.4 g (77%) of <b>3</b>. <sup>1</sup>H NMR: δ 2.00−2.35 (m, 11H), 2.70 (s, 2H), 3.06 (s, 3H), 3.76 (s, 3H), 5.82 (d, 1H), 6.87 (d, 2H), 7.11 (d, 2H), 7.17 (d, 1H), 7.40−7.60 (m, 6H), 10.94 (s, 1H), 12.22 (s, 1H). MS: <i>m</i>/<i>z</i> 540 [M + H]<sup>+</sup>. Anal. (C<sub>31</sub>H<sub>33</sub>N<sub>5</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>Z</i>)-3-({4-[(2-Imidazol-1-yl-acetyl)methylamino]-phenylamino}-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>49</b>)</h3><div class="NLM_p last">Compound <b>49</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>85</b> for <b>84</b>. <sup>1</sup>H NMR: δ 3.10 (s, 3H), 3.79 (s, 3H), 4.50 (s, 2H), 5.84 (d, 1H), 6.80 (s, 1H), 6.92 (m, 3H), 7.18 (d, 1H) superimposed on 7.24 (m, 2H), 7.41 (m, 2H), 7.50−7.70 (m, 5H), 11.00 (s, 1H), 12.29 (s, 1H). MS: <i>m</i>/<i>z</i> 508 [M + H]<sup>+</sup>. HPLC: >95% (<i>t</i><sub>R</sub> = 2.4 min). HRMS (ES<sup>+</sup>) calcd for C<sub>29</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>e</i> 508.1985, found <i>m</i>/<i>e</i> 508.1974.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>Z</i>)-3-{[4-(<i>N</i>-Acetyl-dimethylcarbamoylmethyl-amino)-phenylamino]-phenyl-methylene}-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>50</b>)</h3><div class="NLM_p last">Compound <b>50</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>88</b> for <b>84</b>. <sup>1</sup>H NMR: δ 1.71 (s, 3H), 2.78 (s, 3H), 2.92 (s, 3H), 3.78 (s, 3H), 4.33 (s, 2H), 5.82 (d, 1H), 6.84 (d, 2H), 7.19 (d, 1H), 7.41 (s, 1H), 7.50−7.70 (m, 5H), 10.98 (s, 1H), 12.27 (s, 1H). MS: <i>m</i>/<i>z</i> 535 [M + Na]<sup>+</sup>. Anal. (C<sub>29</sub>H<sub>28</sub>N<sub>4</sub>O<sub>5</sub>) C, H, N.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>Z</i>)-3-({4-[<i>N</i>-Acetyl-(3-dimethylaminopropyl)-amino]-phenylamino}-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>51</b>)</h3><div class="NLM_p last">Compound <b>51</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>89</b> for <b>84</b>. <sup>1</sup>H NMR: δ 1.42 (m, 2H), 1.63 (s, 3H), 1.99 (s, 6H), 2.09 (t, 2H), 3.52 (t, 2H), 3.78 (s, 3H), 5.84 (d, 1H), 6.90 (d, 2H), 7.10 (d, 2H), 7.20 (d, 1H), 7.41 (s, 1H), 7.50−7.65 (m, 5H), 10.98 (s, 1H), 12.25 (s, 1H). MS: <i>m</i>/<i>z</i> 513 [M + H]<sup>+</sup>. Anal. (C<sub>30</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>Z</i>)-3-({4-[<i>N</i>-Acetyl-(2-dimethylaminoethyl)-amino]-phenylamino}-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>52</b>)</h3><div class="NLM_p last">Compound <b>52</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>90</b> for <b>84</b>. <sup>1</sup>H NMR: δ 1.62 (s, 3H), 2.02 (s, 6H), 2.13 (t, 2H), 3.58 (t, 2H), 3.78 (s, 3H), 5.86 (d, 1H), 6.88 (d, 2H), 7.10 (d, 2H), 7.18 (d, 1H), 7.41 (s, 1H), 7.50−7.70 (m, 5H), 10.93 (s, 1H), 12.22 (s, 1H). MS: <i>m</i>/<i>z</i> 499 [M + H]<sup>+</sup>. Anal. (C<sub>29</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (<i>Z</i>)-3-({4-[(2-Dimethylaminoethyl)-methanesulfonyl-amino]-phenylamino}-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>53</b>)</h3><div class="NLM_p last">Compound <b>53</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>91</b> for <b>84</b>. <sup>1</sup>H NMR: δ 2.04 (s, 6H), 2.13 (t, 2H), 2.92 (s, 3H), 3.58 (t, 2H), 3.78 (s, 3H), 5.81 (d, 1H), 6.87 (d, 2H), 7.16 (d, 2H) superimposed on 7.19 (d, 1H), 7.41 (s, 1H), 7.50−7.65 (m, 5H), 11.00 (s, 1H), 12.15 (s, 1H). MS: <i>m</i>/<i>z</i> 535 [M + H]<sup>+</sup>. Anal. (C<sub>28</sub>H<sub>30</sub>N<sub>4</sub>O<sub>5</sub>S·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>Z</i>)-3-({4-[(3-Dimethylaminopropyl)-methyl-carbamoyl]-phenylamino}-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>54</b>)</h3><div class="NLM_p last">Compound <b>54</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>93</b> for <b>84</b>. <sup>1</sup>H NMR (2 rotamers): δ 1.52/1.68 (m, 2H), 1.95/2.10 (s, 6H) superimposed on 1.90−2.20 (t, 2H, incompletely resolved), 2.80/2.86 (s, 3H), 3.10/3.35 (t, 2H), 3.79 (s, 3H), 5.87 (d, 1H), 6.68 (d, 2H), 7.19 (d, 2H) superimposed on 7.21 (d, 1H), 7.42 (s, 1H), 7.45−7.65 (m, 5H), 11.00 (s, 1H), 12.25 (s, 1H). MS: <i>m</i>/<i>z</i> 513 [M + H]<sup>+</sup>. HPLC: >95% (<i>t</i><sub>R</sub> = 2.2 min). HRMS (ES<sup>+</sup>) calcd for C<sub>30</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>e</i> 513.2502, found <i>m</i>/<i>e</i> 513.2490.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>Z</i>)-3-({4-[(2-Dimethylamino-acetyl)-methyl-amino]-phenylamino}-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>2</b>)</h3><div class="NLM_p last">Compound <b>2</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>86</b> for <b>84</b>. <sup>1</sup>H NMR: δ 2.03 (s, 6H), 2.68 (s, 2H), 3.33 (s, 3H), 3.78 (s, 3H), 5.82 (d, 1H), 6.89 (d, 2H), 7.12 (d, 2H), 7.19 (d, 1H), 7.41 (s, 1H), 7.45−7.65 (m, 5H), 10.98 (s, 1H), 12.22 (s, 1H). MS: <i>m</i>/<i>z</i> 485 [M + H]<sup>+</sup>. Anal. (C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>Z</i>)-3-[(4-Dimethylaminomethyl-phenylamino)-phenyl-methylene]-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>55</b>)</h3><div class="NLM_p last">Compound <b>55</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>95</b> for <b>84</b>. <sup>1</sup>H NMR: δ 2.05 (s, 6H), 3.22 (s, 2H), 3.77 (s, 3H), 5.82 (d, 1H), 6.90 (d, 2H), 7.06 (d, 2H), 7.19 (d, 1H), 7.41 (s, 1H), 7.45−7.65 (m, 5H), 10.95 (s, 1H), 12.25 (s, 1H). MS: <i>m</i>/<i>z</i> 428 [M + H]<sup>+</sup>. Anal. (C<sub>26</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>Z</i>)-3-({4-[2-(4-Methylpiperazin-1-yl)acetylamino]-phenylamino}-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>56</b>)</h3><div class="NLM_p last">Compound <b>56</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>87</b> for <b>84</b>. <sup>1</sup>H NMR: δ 2.13 (s, 3H), 2.30−2.55 (m, 8H), 3.13 (s, 2H), 3.78 (s, 3H), 5.82 (d, 1H), 6.84 (d, 2H), 7.19 (d, 1H), 7.40−7.65 (m, 8H), 9.60 (s, 1H), 10.92 (s, 1H), 12.18 (s, 1H). MS: <i>m</i>/<i>z</i> 526 [M + H]<sup>+</sup>. Anal. (C<sub>30</sub>H<sub>31</sub>N<sub>5</sub>O<sub>4</sub>·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>Z</i>)-3-{[4-(2-Dimethylaminoacetylamino)-phenylamino]-phenyl-methylene}-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>57</b>)</h3><div class="NLM_p last">Compound <b>57</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <i>N</i>-(4-aminophenyl)-2-dimethylamino-acetamide<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> for <b>84</b>. <sup>1</sup>H NMR: δ 2.20 (s, 6H), 3.00 (s, 2H), 3.78 (s, 3H), 5.81 (d, 1H), 6.83 (d, 2H), 7.19 (d, 1H), 7.40−7.65 (m, 8H), 9.70 (s, 1H), 10.96 (s, 1H), 12.18 (s, 1H). MS: <i>m</i>/<i>z</i> 470 [M]<sup>+</sup>. Anal. (C<sub>27</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>Z</i>)-3-{[4-(<i>N</i>-Methanesulfonyl-methylamino)-phenylamino]-phenyl-methylene}-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>58</b>)</h3><div class="NLM_p last">Compound <b>58</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>92</b> for <b>84</b>. <sup>1</sup>H NMR: δ 2.85 (s, 3H), 3.13 (s, 3H), 3.80 (s, 3H), 5.82 (d, 1H), 6.86 (d, 2H), 7.20 (d, 2H) superimposed on 7.22 (d, 1H), 7.42 (s, 1H), 7.50−7.70 (m, 5H), 10.96 (s, 1H), 12.28 (s, 1H). MS: <i>m</i>/<i>z</i> 478 [M + H]<sup>+</sup>. Anal. (C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub>S) C, H, N.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>Z</i>)-2-<i>oxo</i>-3-{[4-(2-<i>oxo</i>-Pyrrolidin-1-ylmethyl)-phenylamino]-phenyl-methylene}-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>59</b>)</h3><div class="NLM_p last">Compound <b>59</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting 1-(4-aminobenzyl)-pyrrolidin-2-one<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> for <b>84</b>. <sup>1</sup>H NMR: δ 1.88 (m, 2H), 2.26 (t, 2H), 3.17 (t, 2H), 3.78 (s, 3H), 4.23 (s, 3H), 5.81 (d, 1H), 6.82 (d, 2H), 7.03 (d, 2H), 7.19 (d, 1H), 7.42 (s, 1H), 7.50−7.65 (m, 5H), 10.98 (s, 1H), 12.24 (s, 1H). MS: <i>m</i>/<i>z</i> 468 [M + H]<sup>+</sup>. Anal. (C<sub>29</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (<i>Z</i>)-3-({3-[(3-Dimethylaminopropyl)-methyl-carbamoyl]-phenylamino}-phenyl-methylene)-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>60</b>)</h3><div class="NLM_p last">Compound <b>60</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>94</b> for <b>84</b> and <b>32</b> for <b>33</b>. <sup>1</sup>H NMR (2 rotamers): δ 1.45/1.65 (m, 2H), 1.98/2.17 (s, 6H) superimposed on 2.00−2.30 (t, 2H, incompletely resolved), 2.58/2.88 (s, 3H) superimposed on 2.90/3.20 (t, 2H, incompletely resolved), 3.78 (s, 3H), 5.83 (d, 1H), 6.40−7.30 (m, 5H), 7.42 (s, 1H), 7.40−7.65 (m, 5H), 11.00 (s, 1H), 12.14 (s, 1H). MS: <i>m</i>/<i>z</i> 513 [M + H]<sup>+</sup>. Anal. (C<sub>30</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub>·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (<i>Z</i>)-2-<i>oxo</i>-3-(Phenyl-phenylamino-methylene)-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>61</b>)</h3><div class="NLM_p last">Compound <b>61</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting aniline for <b>84</b>. <sup>1</sup>H NMR: δ 3.78 (s, 3H), 5.82 (d, 1H), 6.86 (d, 2H), 7.14 (m, 1H), 7.19 (m, 3H), 7.42 (s, 1H), 7.45−7.65 (m, 5H), 10.94 (s, 1H), 12.24 (s, 1H). MS: <i>m</i>/<i>z</i> 371 [M + H]<sup>+</sup>. Anal. (C<sub>23</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (<i>Z</i>)-3-[(1-Methylpiperidin-4-ylamino)-phenyl-methylene]-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>62</b>)</h3><div class="NLM_p last">Compound <b>62</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting 1-methylpiperidin-4-ylamine for <b>84</b> and <b>32</b> for <b>33</b>. <sup>1</sup>H NMR: δ 1.55 (m, 2H), 1.75−1.85 (m, 4H), 2.08 (s, 3H), 2.57 (m, 2H), 3.11 (m, 1H), 3.78 (s, 3H), 5.46 (d, 1H), 7.16 (d, 1H), 7.38 (s, 1H), 7.50−7.70 (m, 5H), 10.62 (d, 1H) superimposed on 10.66 (s, 1H). MS: <i>m</i>/<i>z</i> 392 [M + H]<sup>+</sup>. Anal. (C<sub>23</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (<i>Z</i>)-3-{[4-(2-Dimethylaminoacetylamino)-cyclohexylamino]-phenyl-methylene}-2-<i>oxo</i>-2,3-dihydro-1<i>H</i>-indole-6-carboxylic Acid Methyl Ester (<b>63</b>)</h3><div class="NLM_p last">Compound <b>63</b> was prepared using the same procedure as described for the synthesis of <b>3</b> by substituting <b>99</b> for <b>84</b>. <sup>1</sup>H NMR: δ 1.10 (m, 2H), 1.48 (m, 2H), 1.70−1.90 (m, 4H), 2.13 (s, 6H), 2.76 (s, 2H), 3.03 (m, 1H), 3.57 (m, 1H), 3.76 (s, 3H), 5.45 (d, 1H), 7.09 (d, 1H), 7.34 (s, 1H) superimposed on 7.35 (d, 1H), 7.45−7.70 (m, 5H), 10.50 (d, 1H), 10.69 (s, 1H). MS: <i>m</i>/<i>z</i> 477 [M + H]<sup>+</sup>. Anal. (C<sub>27</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-Methyl-2-(4-methylpiperazin-1-yl)-<i>N</i>-(4-nitrophenyl)-acetamide (<b>65</b>)</h3><div class="NLM_p last">1-Methylpiperazine (14.8 mL, 133 mmol) and potassium carbonate (37.6 g, 205 mmol) were dissolved in acetone (500 mL), and 2-bromo-<i>N</i>-methyl-<i>N</i>-(4-nitrophenyl)acetamide<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a><b>64</b> (28.0 g, 103 mmol) was gradually added. The mixture was stirred for 3 h at ambient temperature. After that time, the precipitates were filtered off and the solvent was evaporated from the filtrate. The residue was taken up in ethyl acetate and extracted with water. After drying over sodium sulfate, the solvent was removed by evaporation to give 29.5 g (98%) of <b>65</b>. <sup>1</sup>H NMR: δ 2.00−2.40 (m, 11H), 3.12 (s, 2H), 3.31 (s, 3H), 7.64 (d, 2H), 8.26 (d, 2H). MS: <i>m</i>/<i>z</i> 293 [M + H]<sup>+</sup>.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 2-Imidazol-1-yl-<i>N</i>-methyl-<i>N</i>-(4-nitrophenyl)acetamide (<b>66</b>)</h3><div class="NLM_p last">Compound <b>66</b> was prepared using the same procedure as described for the synthesis of <b>65</b> by substituting imidazole for 1-methylpiperazine. <sup>1</sup>H NMR: δ 3.33 (s, 3H), 4.92 (s, 2H), 6.85 (s, 1H), 7.05 (s, 1H), 7.51 (s, 1H), 7.72 (d, 2H), 8.31 (d, 2H). MS: <i>m</i>/<i>z</i> 261 [M + H]<sup>+</sup>.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 2-Dimethylamino-<i>N</i>-methyl-<i>N</i>-(4-nitrophenyl)acetamide (<b>67</b>)</h3><div class="NLM_p last">Compound <b>67</b> was prepared using the same procedure as described for the synthesis of <b>65</b> by substituting dimethylamine hydrochloride for 1-methylpiperazine. <sup>1</sup>H NMR: δ 2.18 (s, 6H), 3.09 (s, 2H), 3.32 (s, 3H), 7.63 (d, 2H), 8.25 (d, 2H). MS: <i>m</i>/<i>z</i> 238 [M + H]<sup>+</sup>.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 2-(4-Methylpiperazin-1-yl)-<i>N</i>-(4-nitrophenyl)acetamide (<b>69</b>)</h3><div class="NLM_p last">Compound <b>69</b> was prepared using the same procedure as described for the synthesis of <b>65</b> by substituting 2-bromo-<i>N</i>-(4-nitrophenyl)acetamide<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (<b>68</b>) for 2-bromo-<i>N</i>-methyl-<i>N</i>-(4-nitrophenyl)acetamide (<b>64</b>). <sup>1</sup>H NMR: δ 2.13 (s, 3H), 2.30−2.55 (m, 8H), 3.18 (s, 2H), 7.90 (d, 2H), 8.22 (d, 2H), 10.32 (s, 1H).</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>N</i>,<i>N</i>-Dimethyl-2-(4-nitrophenylamino)acetamide (<b>70</b>)</h3><div class="NLM_p last">2-(4-Nitrophenylamino)-acetic acid (5.30 g, 27.0 mmol), <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate (TBTU, 10.4 g, 32.4 mmol), hydroxy-benzotriazole (HOBT, 4.97 g, 32.4 mmol), and dimethylamine hydrochloride (13.2 g, 162 mmol) were suspended in dimethylformamide (50 mL), and triethylamine (37.5 mL) was added at 0 °C. The mixture was stirred at room temperature for 8 h. After that time, the precipitate was filtered off, washed with water, and dried at 100 °C to give 4.70 g (78%) of <b>70</b>. <sup>1</sup>H NMR: δ 2.88 (s, 3H), 3.03 (s, 3H), 4.10 (d, 2H), 6.74 (d, 2H), 7.20 (t, 1H), 8.00 (d, 2H). MS: <i>m</i>/<i>z</i> 224 [M + H]<sup>+</sup>.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 2-[Acetyl-(4-nitrophenyl)amino]-<i>N</i>,<i>N</i>-dimethylacetamide (<b>73</b>)</h3><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethyl-2-(4-nitrophenylamino)acetamide (<b>70</b>, 450 mg, 2.00 mmol) was dissolved in acetic anhydride (5 mL). The mixture was stirred at 140 °C for 1.5 h. After that time, the solvent was removed by evaporation. The residue was triturated with diethyl ether, filtered off, and dried at 60 °C under vacuum to give 464 mg (88%) of <b>73</b>. <sup>1</sup>H NMR: δ 1.96 (s, 3H), 2.83 (s, 3H), 2.98 (s, 3H), 4.58 (s, 2H), 7.61 (d, 2H), 8.28 (d, 2H). MS: <i>m</i>/<i>z</i> 288 [M + Na]<sup>+</sup>.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>-(4-nitrophenyl)acetamide (<b>74</b>)</h3><div class="NLM_p last">Compound <b>74</b> was prepared using the same procedure as described for the synthesis of <b>73</b> by substituting <i>N</i>,<i>N</i>-dimethyl-<i>N</i>′-(4-nitrophenyl)-propane-1,3-diamine<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a><b>71</b> for <b>70</b>. <sup>1</sup>H NMR: δ 1.54 (m, 2H), 1.90 (s, 3H), 2.04 (s, 6H), 2.16 (t, 2H), 3.73 (t, 2H), 7.63 (d, 2H), 8.27 (d, 2H). MS: <i>m</i>/<i>z</i> 266 [M + H]<sup>+</sup>.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>N</i>-(2-Dimethylaminoethyl)-<i>N</i>-(4-nitrophenyl)acetamide (<b>75</b>)</h3><div class="NLM_p last">Compound <b>75</b> was prepared using the same procedure as described for the synthesis of <b>73</b> by substituting <i>N</i>,<i>N</i>-dimethyl-<i>N</i>′-(4-nitrophenyl)-ethane-1,2-diamine<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (<b>72</b>) for <b>70</b>. <sup>1</sup>H NMR: δ 1.88 (s, 3H), 2.09 (s, 6H), 2.28 (t, 2H), 3.79 (t, 2H), 7.62 (d, 2H), 8.28 (d, 2H). MS: <i>m</i>/<i>z</i> 252 [M + H]<sup>+</sup>.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>N</i>-(2-Dimethylaminoethyl)-<i>N</i>-(4-nitrophenyl)methanesulfonamide (<b>77</b>)</h3><div class="NLM_p last"><i>N</i>-(4-Nitrophenyl)methanesulfonamide<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (<b>76</b>) (21.6 g, 100 mmol) was dissolved in acetone (1.0 L), and 2-chloro-<i>N</i>,<i>N</i>-dimethylethylamine hydrochloride (21.6 g, 150 mmol), potassium carbonate (35.9 g, 260 mmol), and sodium iodide (3.0 g, 20 mmol) were added. The mixture was stirred at 50 °C for 3 days. After that time, the precipitates were filtered off and the solvent was evaporated from the filtrate. The residue was taken up in ethyl acetate (300 mL) and extracted with water (3 × 200 mL). The organic layer was separated and dried over sodium sulfate. The solvent was removed by evaporation, and the residue was recrystallized from 2-propanol to give 15.2 g (53%) of <b>77</b>. <sup>1</sup>H NMR: δ 2.08 (s, 6H), 2.29 (t, 2H), 3.12 (s, 3H), 3.84 (t, 2H), 7.66 (d, 2H), 8.27 (d, 2H). MS: <i>m</i>/<i>z</i> 288 [M + H]<sup>+</sup>.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>N</i>-Methyl-<i>N</i>-(4-nitrophenyl)methanesulfonamide (<b>78</b>)</h3><div class="NLM_p last"><i>N</i>-(4-Nitrophenyl)methanesulfonamide<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a><b>76</b> (4.32 g, 20.0 mmol) was dissolved in dimethylsulfoxide (40 mL), and potassium <i>tert</i>-butyrate (2.50 g, 22.0 mmol) was added. The mixture was stirred at ambient temperature for 1 h. After that time, a solution of methyl iodide (4.20 g, 18.0 mmol) in dimethylsulfoxide 10 mL) was slowly added. Stirring was continued for 8 h at ambient temperature. After that time, the mixture was poured onto ice water (120 mL) and ethyl acetate was added. The organic layer was separated and extracted with water (3×). Finally, the organic layer was dried over sodium sulfate. The solvent was removed by evaporation, and the residue was triturated with diethyl ether and filtered off to give 4.20 g (91%) of <b>78</b>. <sup>1</sup>H NMR: δ 3.18 (s, 3H), 3.35 (s, 3H), 7.64 (d, 2H), 8.28 (d, 2H). MS: <i>m</i>/<i>z</i> 229 [M − H]<sup>−</sup>.</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>-methyl-4-nitrobenzamide (<b>81</b>)</h3><div class="NLM_p last"><i>N</i>,<i>N</i>,<i>N</i>′-Trimethylpropane-1,3-diamine (4.80 g, 41.3 mmol) was dissolved in methylene chloride (150 mL), and triethylamine (11.5 mL, 82.6 mmol) was added. 4-Nitrobenzoyl chloride <b>79</b> (7.67 g, 41.3 mmol) was added at 0 °C. The mixture was stirred for 5 min at 0 °C and for 20 min at room temperature. After that time, the precipitates were filtered off and the filtrate was extracted three times with water. The organic layer was separated and dried over sodium sulfate. The solvent was removed by evaporation to give 10.33 g (94%) of <b>81</b>. <sup>1</sup>H NMR (2 rotamers): δ 1.61/1.73 (m, 2H), 1.98/2.06 (s, 6H), 2.04/2.28 (t, 2H), 2.86/3.00 (s, 3H), 3.16/3.48 (t, 2H), 7.78 (d, 2H), 8.29 (d, 2H). MS: <i>m</i>/<i>z</i> 266 [M + H]<sup>+</sup>.</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>-methyl-3-nitrobenzamide (<b>82</b>)</h3><div class="NLM_p last">Compound <b>82</b> was prepared using the same procedure as described for the synthesis of <b>81</b> by substituting 3-nitrobenzoyl chloride <b>80</b> for 4-nitrobenzoyl chloride <b>79</b>. <sup>1</sup>H NMR (2 rotamers): δ 1.62/1.78 (m, 2H), 2.00/2.23 (s, 6H), 2.10/2.43 (t, 2H), 2.88/2.98 (s, 3H), 3.19/3.49 (t, 2H), 7.60−7.90 (m, 2H, incompletely resolved), 8.15−8.35 (m, 2H, incompletely resolved). MS: <i>m</i>/<i>z</i> 266 [M + H]<sup>+</sup>.</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Dimethyl-(4-nitrobenzyl)amine (<b>83</b>)</h3><div class="NLM_p last">A solution of dimethylamine in water (40%, 114 mL, 900 mmol) was dissolved in methyl-<i>iso</i>-butylketone (600 mL) and a solution of 4-nitrobenzyl chloride (52.0 g, 300 mmol) in methyl-<i>iso</i>-butylketone (300 mL) was slowly added over 30 min. The mixture was stirred at ambient temperature for 2.0 h and at 35 °C for 0.5 h. After that time, ethyl acetate (100 mL) was added and the organic layer was separated. The organic layer was extracted with brine (4×), separated, and dried over sodium sulfate. The solvent was removed by evaporation, The residue was triturated with diethyl ether, filtered, and the solvent was removed by evaporation to give 55.1 g (99%) of <b>83</b>. <sup>1</sup>H NMR: δ 2.17 (s, 6H), 3.52 (s, 2H), 7.57 (d, 2H), 8.18 (d, 2H). MS: <i>m</i>/<i>z</i> 181 [M + H]<sup>+</sup>.</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>N</i>-(4-Aminophenyl)-<i>N</i>-methyl-2-(4-methylpiperazin-1-yl)acetamide (<b>84</b>)</h3><div class="NLM_p last"><i>N</i>-Methyl-2-(4-methylpiperazin-1-yl)-<i>N</i>-(4-nitrophenyl)acetamide (<b>65</b>, 29.5 g, 101 mmol) was dissolved in methanol (350 mL) and hydrogenated (50 psi) at room temperature for 1.5 h using 3.0 g palladium on charcoal (10%) as catalyst. After that time, the catalyst was filtered off and the solvent was removed by evaporation. The residue was triturated with diethyl ether, filtered off, and dried at 80 °C under vacuum to give 22.1 g (83%) of <b>84</b>. <sup>1</sup>H NMR: δ 2.00−2.40 (m, 11H), 2.79 (s, 2H), 3.04 (s, 3H), 5.20 (s, 2H), 6.55 (d, 2H), 6.90 (d, 2H). MS: <i>m</i>/<i>z</i> 263 [M + H]<sup>+</sup>.</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> <i>N</i>-(4-Aminophenyl)-2-imidazol-1-yl-<i>N</i>-methylacetamide (<b>85</b>)</h3><div class="NLM_p last">Compound <b>85</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>66</b> for <b>65</b>. <sup>1</sup>H NMR: δ 3.12 (s, 3H), 4.54 (s, 2H), 5.33 (s, 2H), 6.62 (d, 2H), 6.82 (s, 1H), 7.01 (s, 1H), 7.07 (d, 2H), 7.46 (s, 1H). MS: <i>m</i>/<i>z</i> 231 [M + H]<sup>+</sup>.</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> <i>N</i>-(4-Aminophenyl)-2-dimethylamino-<i>N</i>-methylacetamide (<b>86</b>)</h3><div class="NLM_p last">Compound <b>86</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>67</b> for <b>65</b>. <sup>1</sup>H NMR: δ 2.21 (s, 6H), 2.78 (s, 2H), 3.14 (s, 3H), 5.25 (s, 2H), 6.54 (d, 2H), 6.91 (d, 2H). MS: <i>m</i>/<i>z</i> 208 [M + H]<sup>+</sup>.</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> <i>N</i>-(4-Aminophenyl)-2-(4-methylpiperazin-1-yl)acetamide (<b>87</b>)</h3><div class="NLM_p last">Compound <b>87</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>69</b> for <b>65</b>. <sup>1</sup>H NMR: δ 2.16 (s, 3H), 2.30−2.55 (m, 8H), 3.04 (s, 2H), 4.80 (br, 2H), 6.51 (d, 2H), 7.24 (d, 2H), 9.19 (s, 1H). MS: <i>m</i>/<i>z</i> 249 [M + H]<sup>+</sup>.</div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 2-[Acetyl-(4-aminophenyl)-amino]-<i>N</i>,<i>N</i>-dimethylacetamide (<b>88</b>)</h3><div class="NLM_p last">Compound <b>88</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>73</b> for <b>65</b>. <sup>1</sup>H NMR: δ 1.73 (s, 3H), 2.80 (s, 3H), 2.91 (s, 3H), 4.30 (s, 2H), 5.20 (s, 2H), 6.53 (d, 2H), 7.02 (d, 2H). MS: <i>m</i>/<i>z</i> 258 [M + Na]<sup>+</sup>.</div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> <i>N</i>-(4-Aminophenyl)-<i>N</i>-(3-dimethylaminopropyl)acetamide (<b>89</b>)</h3><div class="NLM_p last">Compound <b>89</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>74</b> for <b>65</b>. <sup>1</sup>H NMR: δ 1.50 (m, 2H), 1.68 (s, 3H), 1.94 (s, 6H), 2.15 (t, 2H), 3.49 (t, 2H), 5.20 (br, 2H), 6.57 (d, 2H), 6.86 (d, 2H). MS: <i>m</i>/<i>z</i> 236 [M + H]<sup>+</sup>.</div></div><div id="sec5_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> <i>N</i>-(4-Aminophenyl)-<i>N</i>-(2-dimethylaminoethyl)acetamide (<b>90</b>)</h3><div class="NLM_p last">Compound <b>90</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>75</b> for <b>65</b>. <sup>1</sup>H NMR: δ 1.68 (s, 3H), 2.10 (s, 6H), 2.23 (t, 2H), 3.58 (t, 2H), 5.20 (br, 2H), 6.56 (d, 2H), 6.88 (d, 2H). MS: <i>m</i>/<i>z</i> 222 [M + H]<sup>+</sup>.</div></div><div id="sec5_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> <i>N</i>-(4-Aminophenyl)-<i>N</i>-(2-dimethylaminoethyl)methanesulfonamide (<b>91</b>)</h3><div class="NLM_p last">Compound <b>91</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>77</b> for <b>65</b>. <sup>1</sup>H NMR: δ 2.08 (s, 6H), 2.24 (t, 2H), 2.91 (s, 3H), 3.56 (t, 2H), 5.25 (br, 2H), 6.53 (d, 2H), 6.99 (d, 2H). MS: <i>m</i>/<i>z</i> 258 [M + H]<sup>+</sup>.</div></div><div id="sec5_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> <i>N</i>-(4-Aminophenyl)-<i>N</i>-methylmethanesulfonamide (<b>92</b>)</h3><div class="NLM_p last">Compound <b>92</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>78</b> for <b>65</b>. <sup>1</sup>H NMR: δ 2.85 (s, 3H), 3.10 (s, 3H), 5.22 (s, 2H), 6.54 (d, 2H), 7.02 (d, 2H). MS: <i>m</i>/<i>z</i> 200 [M]<sup>+</sup>.</div></div><div id="sec5_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 4-Amino-<i>N</i>-(3-dimethylaminopropyl)-<i>N</i>-methylbenzamide (<b>93</b>)</h3><div class="NLM_p last">Compound <b>93</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>81</b> for <b>65</b>. <sup>1</sup>H NMR: δ 1.66 (m, 2H), 2.08 (s, 6H), 2.17 (t, 2H), 2.91 (s, 3H), 3.30 (t, 2H), 5.40 (s, 2H), 6.53 (d, 2H), 7.10 (d, 2H). MS: <i>m</i>/<i>z</i> 236 [M + H]<sup>+</sup>.</div></div><div id="sec5_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 3-Amino-<i>N</i>-(3-dimethylaminopropyl)-<i>N</i>-methylbenzamide (<b>94</b>)</h3><div class="NLM_p last">Compound <b>94</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>82</b> for <b>65</b>. <sup>1</sup>H NMR (2 rotamers): δ 1.55/1.65 (m, 2H), 2.00/2.12 (s, 6H) superimposed on 2.00−2.30 (t, 2H, incompletely resolved), 2.88/3.00 (s, 3H), 3.20−3.40 (t, 2H, incompletely resolved), 5.35 (br, 2H), 6.40−6.60 (m, 3H, incompletely resolved), 7.0−7.10 (m, 1H, incompletely resolved). MS: <i>m</i>/<i>z</i> 236 [M + H]<sup>+</sup>.</div></div><div id="sec5_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 4-(Dimethylaminomethyl)phenylamine (<b>95</b>)</h3><div class="NLM_p last">Compound <b>95</b> was prepared using the same procedure as described for the synthesis of <b>84</b> by substituting <b>83</b> for <b>65</b> and Raney nickel for palladium on charcoal. <sup>1</sup>H NMR: δ 2.07 (s, 6H), 3.16 (s, 2H), 4.88 (s, 2H), 6.49 (d, 2H), 6.89 (d, 2H). MS: <i>m</i>/<i>z</i> 151 [M + H]<sup>+</sup>.</div></div><div id="sec5_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> <i>trans</i>-[4-(2-Chloroacetylamino)cyclohexyl]carbamic Acid <i>tert</i>-Butyl Ester (<b>97</b>)</h3><div class="NLM_p last"><i>trans</i>-(4-Aminocyclohexyl)carbamic acid <i>tert</i>-butyl ester (<b>96</b>) (2.50 g, 11.7 mmol) was suspended in tetrahydrofuran (500 mL) and triethylamine (2.43 mL, 17.5 mmol) was added. After stirring for 2 h at ambient temperature, chloro acetyl chloride (0.93 mL, 11.7 mmol) was added. The mixture was stirred for 8 h at ambient temperature. After that time, the solvent was removed by evaporation and the residue was taken up in methylene chloride. The organic layer was extracted with 2 N hydrochloric acid and a saturated solution of sodium hydrogen carbonate. The organic layer was separated and dried over sodium sulfate. Finally, the solvent was removed by evaporation to give 3.40 g (99%) of <b>97</b>. <sup>1</sup>H NMR: δ 1.21 (m, 4H), 1.37 (s, 9H), 1.76 (m, 4H), 3.20 (m, 1H), 3.45 (m, 1H), 3.98 (s, 2H), 6.71 (d, 1H), 8.05 (d, 1H). MS: <i>m</i>/<i>z</i> 289 [M − H]<sup>−</sup>.</div></div><div id="sec5_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> <i>trans</i>-{4-[2-(Dimethylamino)acetylamino]-cyclohexyl}-carbamic Acid <i>tert</i>-Butyl Ester (<b>98</b>)</h3><div class="NLM_p last"><i>trans</i>-[4-(2-Chloroacetylamino)cyclohexyl]carbamic acid <i>tert</i>-butyl ester <b>97</b> (2.62 g, 9.00 mmol) was suspended in acetone (50 mL) and potassium carbonate (3.73 mL, 27.0 mmol), and dimethylamine hydrochloride (1.10 g, 13.5 mmol) were added. The mixture was stirred for 8 h at ambient temperature. After that time, the precipitates were filtered off and the solvent was removed by evaporation to give 1.65 g (61%) of <b>98</b>. <sup>1</sup>H NMR: δ 1.20 (m, 4H), 1.36 (s, 9H), 1.74 (m, 4H), 2.17 (s, 6H), 2.73 (s, 2H), 3.18 (m, 1H), 3.50 (m, 1H), 6.67 (d, 1H), 7.44 (d, 1H). MS: <i>m</i>/<i>z</i> 300 [M + H]<sup>+</sup>.</div></div><div id="sec5_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> <i>trans</i>-<i>N</i>-(4-Aminocyclohexyl)-2-(dimethylamino)acetamide (<b>99</b>)</h3><div class="NLM_p last"><i>trans</i>-{4-[2-(Dimethylamino)acetylamino]cyclohexyl}carbamic acid <i>tert</i>-butyl ester <b>98</b> (1.80 g, 6.01 mmol) was dissolved in methylene chloride (50 mL), and trifluoroacetic acid (20.0 mL) was added. The mixture was stirred for 0.5 h at ambient temperature. After that time, the solvent was removed by evaporation and the residue was taken up in methylene chloride/methanol (1:1). The solution was neutralized using a basic MP resin. The solvent was removed by evaporation to give 1.20 g (100%) of <b>99</b>. <sup>1</sup>H NMR: δ 1.34 (m, 4H), 1.70−1.90 (m, 4H), 2.28 (s, 6H), 2.95 (m, 1H) superimposed on 2.98 (s, 2H), 3.17 (br, 2H), 3.53 (m, 1H), 7.62 (d, 1H). MS: <i>m</i>/<i>z</i> 200 [M + H]<sup>+</sup>.</div></div><div id="sec5_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> Computational Methods</h3><div class="NLM_p last">All binding mode models have been built using the MOE (MOE revision 2008.10, Chemical Computing Group Inc., Montreal, Quebec, 2008) software package. The X-ray structure of <b>3</b> in complex with VEGFR-2<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> served as a template for all initial binding conformations (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3C7Q">3C7Q</a>). The final binding mode has been calculated using the MMFF94x force field and a distance dependent dielectric constant. The ligand and a shell of 4 Å around the ligand has been free to move, a second shell of 4 Å has been tethered by a force constant of 100, and the rest of the VEGFR-2 protein has been fixed. All pictures have been rendered using PyMol 1.1r1 (DeLano Scientific LLC).</div></div><div id="sec5_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> In Vitro VEGFR-2 Kinase Assay</h3><div class="NLM_p last">The cytoplasmic kinase domain of VEGFR-2 (residues 797 to 1335 according to sequence deposited in databank SWISS-PROT P35968) was cloned into pFastBac fused to Glutathion-<i>S</i>-transferase (GST). The GST-fusion protein was expressed in SF-9 insect cells and extracted with HEPEX (20 mM HEPES pH 7.4, 100 mM NaCl, 10 mM ss-glycerophosphate, 10 mM <i>para</i>-nitro-phenylphosphate, 30 mM NaF, 5 mM EDTA, 5% glycerol, 1% Triton X-100, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 0.1% SDS, 0.5 μg/mL pepstatin A, 2.5 μg/mL 3,4-dichloroisocoumarin, 2.5 μg/mL <i>trans</i>-epoxysuccinyl-<span class="smallcaps smallerCapital">l</span>-leucyl-<span class="smallcaps smallerCapital">l</span>-amido butane, aprotinin 20 KIU/mL, leupeptin 2 μg/mL, benzamidine 1 mM and 0.002% PMSF). Enzyme activity was assayed in the presence or absence of serial dilutions of the inhibitor performed in 25% DMSO. Each microtiter plate contained internal controls such as blank, maximum reaction, and historical reference compound. All incubations were conducted at room temperature on a rotation shaker. Ten μL of each inhibitor dilution was added to 10 μL of diluted kinase (0.8 μg/mL VEGFR-2, 10 mM Tris pH 7.5, 2 mM EDTA, 2 mg/mL BSA) and preincubated for 1 h. The reaction was started by addition of 30 μL of substrate mix containing 62.4 mM Tris pH 7.5, 2.7 mM DTT, 5.3 mM MnCl<sub>2</sub>, 13.3 mM Mg-acetate, 0.42 mM ATP, 0.83 mg/mL Poly-Glu-Tyr(4:1), and 1.7 μg/mL Poly-Glu-Tyr(4:1)-biotin and incubated for 1 h. The reaction was stopped by addition of 50 μL of 250 mM EDTA, 20 mM HEPES, pH 7.4. Then 90 μL of stopped solution was transferred to a streptavidin plate and incubated for 1−2 h. After three washes with PBS the EU-labeled antibody, PY20 was added (recommended dilution 1:2000 of 0.5 mg/mL labeled antibody in DELFIA assay buffer). Excessive detection antibody was removed by three washes of DELFIA washing buffer. Then 10 minutes before measurement on the multilabel reader VICTOR, each well was incubated with 100 μL of DELFIA enhancement solution. IC<sub>50</sub> values were calculated by using a sigmoidal curve analysis program (Graph Pad Prism) using the nonlinear regression analysis with variable slope.</div></div><div id="sec5_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> In Vitro VEGFR-1, VEGFR-3, FGFR-1, PDGFRα Kinase Assay</h3><div class="NLM_p last">IC<sub>50</sub> in these assays were determined by Invitrogen Ltd., United Kingdom. For details please refer to <a href="http://www.invitrogen.com" class="extLink">www.invitrogen.com</a>.</div></div><div id="sec5_88" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Cellular Assays</h3><div class="NLM_p last">All cellular assays (HUVEC, HeLa, Calu-6, FaDu) were conducted as previously described in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>.</div></div><div id="sec5_89" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> In Vivo Tumor Models</h3><div class="NLM_p last">All in vivo experiments were conducted as previously described in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a> and complied with the Declaration of Helsinki and European Policy Legislations (FELASA and GV-SOLAS) on the Care and Use of Laboratory Animals.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerald J. Roth</span> - <span class="hlFld-Affiliation affiliation">Department of Chemical Research</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4d2a283f2c2129633f2239250d2f2228253f24232a283f6024232a282125282420632e2220"><span class="__cf_email__" data-cfemail="10777562717c743e627f647850727f757862797e7775623d797e77757c7875797d3e737f7d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Armin Heckel</span> - <span class="hlFld-Affiliation affiliation">Department of Chemical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florian Colbatzky</span> - <span class="hlFld-Affiliation affiliation">Department of Non-Clinical Drug Safety</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Handschuh</span> - <span class="hlFld-Affiliation affiliation">Department of Lead Discovery</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Kley</span> - <span class="hlFld-Affiliation affiliation">Department of Chemical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thorsten Lehmann-Lintz</span> - <span class="hlFld-Affiliation affiliation">Department of Chemical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralf Lotz</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery Support</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulrike Tontsch-Grunt</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim RCV GmbH & Co. KG, A-1121 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rainer Walter</span> - <span class="hlFld-Affiliation affiliation">Department of Chemical Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Hilberg</span> - <span class="hlFld-Affiliation affiliation">Boehringer Ingelheim RCV GmbH & Co. KG, A-1121 Vienna, Austria</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm900431g" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06667" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06667" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Elke Honold, Simone Linke, Evelin Rehm, and Josef Zeiler for their excellent technical expertise in the synthesis of most of the final compounds, as well as Nicole Reiners, Saskia Stenkamp, and Thomas Veser for the synthesis of selected compounds. We additionally thank Helmut Wittneben for performing initial computer modeling studies.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">Tumor angiogenesis: therapeutic implications</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1182</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1056%2FNEJM197111182852108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=4938153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1971&pages=1182-1186&author=J.+Folkman&title=Tumor+angiogenesis%3A+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor angiogenesis: therapeutic implications</span></div><div class="casAuthors">Folkman J</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1182-6</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA0C6odtE1LPxQvRxYU81tfW6udTcc2eb56KCLuk_QdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D&md5=efdddcba0c04be542edd51fef2ef27b9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJM197111182852108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197111182852108%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DTumor%2520angiogenesis%253A%2520therapeutic%2520implications%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1971%26volume%3D285%26spage%3D1182%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillan, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span> </span><span class="NLM_article-title">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1038%2Fnrd1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=15136787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=391-400&author=N.+Ferraraauthor=K.+J.+Hillanauthor=H.-P.+Gerberauthor=W.+Novotny&title=Discovery+and+development+of+bevacizumab%2C+an+anti-VEGF+antibody+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span></div><div class="casAuthors">Ferrara, Napoleone; Hillan, Kenneth J.; Gerber, Hans-Peter; Novotny, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The existence of factors that stimulate blood vessel growth, thereby recruiting a neovascular supply to nourish a growing tumor, was postulated many decades ago, although the identification and isolation of these factors proved elusive.  Now, vascular endothelial growth factor (VEGF), which was identified in the 1980s, is recognized as an essential regulator of normal and abnormal blood vessel growth.  In 1993, it was shown that a monoclonal antibody that targeted VEGF results in a dramatic suppression of tumor growth in vivo, which led to the development of bevacizumab (Avastin; Genentech), a humanized variant of this anti-VEGF antibody, as an anticancer agent.  The recent approval of bevacizumab by the US FDA as a first-line therapy for metastatic colorectal cancer validates the ideas that VEGF is a key mediator of tumor angiogenesis and that blocking angiogenesis is an effective strategy to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphaLbfhdBKOLVg90H21EOLACvtfcHk0liUiXAzjvPc8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D&md5=4b1f647db4dfe2a24449cdf59b874e7c</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1381%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DHillan%26aufirst%3DK.%2BJ.%26aulast%3DGerber%26aufirst%3DH.-P.%26aulast%3DNovotny%26aufirst%3DW.%26atitle%3DDiscovery%2520and%2520development%2520of%2520bevacizumab%252C%2520an%2520anti-VEGF%2520antibody%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug.%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Panares, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. A.</span><span> </span><span class="NLM_article-title">Bevacizumab in the management of solid tumors</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1586%2F14737140.7.4.433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=17428164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Wqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=433-445&author=R.+L.+Panaresauthor=A.+A.+Garcia&title=Bevacizumab+in+the+management+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab in the management of solid tumors</span></div><div class="casAuthors">Panares, Roy L.; Garcia, Agustin A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">433-445</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is defined as the formation of new blood vessels from a pre-existing vascular bed.  By supplying nutrients and oxygen and removing waste products in malignant tumors, it is an essential process that regulates cancer growth and dissemination.  This process is regulated by both pro- and antiangiogenic compds.  Vascular endothelial growth factor is one of the most important and best-studied proangiogenic factors.  Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has been shown to inhibit angiogenesis and is proving to be of clin. benefit in a variety of tumor types.  The strongest evidence comes from studies in advanced colorectal and non-small-cell lung cancer, with growing evidence in breast and epithelial ovarian tumors.  The duration and timing of bevacizumab's use is currently the focus of several ongoing clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3gqfS8ed2N7Vg90H21EOLACvtfcHk0liIyZSWzXAPfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Wqs74%253D&md5=27084acb248645b4ff4c7b4fd4b70aab</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1586%2F14737140.7.4.433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.7.4.433%26sid%3Dliteratum%253Aachs%26aulast%3DPanares%26aufirst%3DR.%2BL.%26aulast%3DGarcia%26aufirst%3DA.%2BA.%26atitle%3DBevacizumab%2520in%2520the%2520management%2520of%2520solid%2520tumors%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2007%26volume%3D7%26spage%3D433%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lowinger, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span> </span><span class="NLM_article-title">Design and discovery of small molecules targeting Raf-1 kinase</span> <span class="citation_source-journal">Curr. Pharm. Des</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.2174%2F1381612023393125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=12369855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVGntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2269-2278&author=T.+B.+Lowingerauthor=B.+Riedlauthor=J.+Dumasauthor=R.+A.+Smith&title=Design+and+discovery+of+small+molecules+targeting+Raf-1+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of small molecules targeting raf-1 kinase</span></div><div class="casAuthors">Lowinger, Timothy B.; Riedl, Bernd; Dumas, Jacques; Smith, Roger A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2269-2278</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Raf kinase, an enzyme which acts downstream in the Ras signaling pathway, is involved in cancerous cell proliferation.  Thus, small mol. inhibitors of Raf kinase activity may be important agents for the treatment of cancer.  A novel class of Raf-1 inhibitors was discovered, using a combination of medicinal and combinatorial chem. approaches.  This effort culminated in the identification of the clin. candidate BAY 43-9006, currently undergoing Phase I clin. trials.  The present review summarizes the medicinal chem. development of ureas as highly potent inhibitors of Raf-1 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqviNIBK_IYW7Vg90H21EOLACvtfcHk0liIyZSWzXAPfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVGntrk%253D&md5=a62445c3fb50083175ee4863ae84f6ce</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.2174%2F1381612023393125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023393125%26sid%3Dliteratum%253Aachs%26aulast%3DLowinger%26aufirst%3DT.%2BB.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26atitle%3DDesign%2520and%2520discovery%2520of%2520small%2520molecules%2520targeting%2520Raf-1%2520kinase%26jtitle%3DCurr.%2520Pharm.%2520Des%26date%3D2002%26volume%3D8%26spage%3D2269%26epage%3D2278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wilhelm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simantov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S.</span><span> </span><span class="NLM_article-title">Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1038%2Fnrd2130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=17016424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=835-844&author=S.+Wilhelmauthor=C.+Carterauthor=M.+Lynchauthor=T.+Lowingerauthor=J.+Dumasauthor=R.+A.+Smithauthor=B.+Schwartzauthor=R.+Simantovauthor=S.+Kelley&title=Discovery+and+development+of+sorafenib%3A+a+multikinase+inhibitor+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</span></div><div class="casAuthors">Wilhelm, Scott; Carter, Christopher; Lynch, Mark; Lowinger, Timothy; Dumas, Jacques; Smith, Roger A.; Schwartz, Brian; Simantov, Ronit; Kelley, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">835-844</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the mol. revolution of the 1980s, knowledge of the etiol. of cancer has increased considerably, which has led to the discovery and development of targeted therapies tailored to inhibit cancer-specific pathways.  The introduction and refinement of rapid, high-throughput screening technologies over the past decade has greatly facilitated this targeted discovery and development process.  Here, the authors describe the discovery and continuing development of sorafenib (previously known as BAY 43-9006), the first oral multikinase inhibitor that targets Raf and affects tumor signaling and the tumor vasculature.  The discovery cycle of sorafenib (Nexavar; Bayer Pharmaceuticals) - from initial screening for a lead compd. to FDA approval for the treatment of advanced renal cell carcinoma in Dec. 2005 - was completed in just 11 years, with approval being received ∼5 years after the initiation of the first Phase I trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6WjjfgNSCtbVg90H21EOLACvtfcHk0liIyZSWzXAPfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajsbbM&md5=490d4995170f3a7270ae9bbdd24b12e5</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2130%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DLowinger%26aufirst%3DT.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DSimantov%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520development%2520of%2520sorafenib%253A%2520a%2520multikinase%2520inhibitor%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D835%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Faivre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sargent, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E.</span><span> </span><span class="NLM_article-title">Molecular basis for sunitinib efficacy and future clinical development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=734-745&author=S.+Faivreauthor=G.+Demetriauthor=W.+Sargentauthor=E.+Raymond&title=Molecular+basis+for+sunitinib+efficacy+and+future+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaivre%26aufirst%3DS.%26aulast%3DDemetri%26aufirst%3DG.%26aulast%3DSargent%26aufirst%3DW.%26aulast%3DRaymond%26aufirst%3DE.%26atitle%3DMolecular%2520basis%2520for%2520sunitinib%2520efficacy%2520and%2520future%2520clinical%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D734%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ellis, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span> </span><span class="NLM_article-title">VEGF-targeted therapy: mechanisms of anti-tumour activity</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1038%2Fnrc2403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=18596824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovV2lsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=579-591&author=L.+M.+Ellisauthor=D.+J.+Hicklin&title=VEGF-targeted+therapy%3A+mechanisms+of+anti-tumour+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">VEGF-targeted therapy: mechanisms of anti-tumour activity</span></div><div class="casAuthors">Ellis, Lee M.; Hicklin, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">579-591</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several vascular endothelial growth factor (VEGF)-targeted agents, administered either as single agents or in combination with chemotherapy, have been shown to benefit patients with advanced-stage malignancies.  VEGF-targeted therapies were initially developed with the notion that they would inhibit new blood vessel growth and thus starve tumors of necessary oxygen and nutrients.  It has become increasingly apparent, however, that the therapeutic benefit assocd. with VEGF-targeted therapy is complex, and probably involves multiple mechanisms.  A better understanding of these mechanisms will lead to future advances in the use of these agents in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8uQwKsLU3FbVg90H21EOLACvtfcHk0lh6XDocifGJNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovV2lsro%253D&md5=0eab1dfbcb026754bf8b7e252eafd04a</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2403%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DL.%2BM.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26atitle%3DVEGF-targeted%2520therapy%253A%2520mechanisms%2520of%2520anti-tumour%2520activity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D579%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ferrara, N.</span><span> </span><span class="NLM_article-title">VEGF and the quest for tumour angiogenesis factors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1038%2Fnrc909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=12360282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=795-803&author=N.+Ferrara&title=VEGF+and+the+quest+for+tumour+angiogenesis+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: VEGF and the quest for tumor angiogenesis factors</span></div><div class="casAuthors">Ferrara, Napoleone</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">795-803</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The ability of tumors to induce new blood-vessel formation has been a major focus of cancer research over the past few decades, and vascular endothelial growth factor (VEGF) is now known to be central to this process.  The quest for VEGF and other factors that promote tumor angiogenesis was initiated many decades ago, and a long and complicated path has led to the development of inhibitors of these mols. as anticancer agents.  How did this field begin, and how have we arrived at our present understanding of the role of VEGF in tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFHN1T3vtAELVg90H21EOLACvtfcHk0lh6XDocifGJNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbk%253D&md5=b0f6d2bde63351fae496d743a9a7e4bf</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnrc909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc909%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DVEGF%2520and%2520the%2520quest%2520for%2520tumour%2520angiogenesis%2520factors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D795%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Östman, A.</span><span> </span><span class="NLM_article-title">PDGF-receptors—mediators of autocrine tumor growth and regulators of tumor vasculature and stroma</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1016%2Fj.cytogfr.2004.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=15207817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A280%3ADC%252BD2czgsFegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=275-286&author=A.+%C3%96stman&title=PDGF-receptors%E2%80%94mediators+of+autocrine+tumor+growth+and+regulators+of+tumor+vasculature+and+stroma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma</span></div><div class="casAuthors">Ostman Arne</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & growth factor reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">275-86</span>
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    </div><div class="casAbstract">PDGFs and their cognate tyrosine kinase alpha- and beta-receptors are involved in multiple tumor-associated processes including autocrine growth stimulation of tumor cells, stimulation of tumor angiogenesis and recruitment and regulation of tumor fibroblasts.  The recent development of clinically useful PDGF antagonists, like STI571/Glivec, has increased the interest in PDGF receptors as cancer drug targets.  Autocrine PDGF receptor signaling occurs in certain malignancies characterized by mutational activation of PDGF or PDGF receptors, for instance, dermatofibrosaracoma protuberans, gastrointestinal stromal tumors, and hypereosinophilic syndrome.  The roles of PDGF in regulation of tumor angiogenesis and tumor fibroblasts are more general, and probably occur in most common solid tumors.  Concerning tumor angiogenesis recent studies have predominantly focused on the importance of PDGF receptor signaling for tumor pericyte recruitment.  PDGF receptors in the tumor stroma have also attracted attention as interesting drug targets because of their function as regulators of tumor interstitial fluid pressure, tumor transvascular transport and tumor drug uptake.  In summary, the improved understanding of the role of PDGF signaling in tumor biology, and the introduction of PDGF antagonists, has set the stage for a continued development of PDGF antagonists as novel cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAed3RzDrPsRdUSIfHIn4FfW6udTcc2eaZWlFQQN4TT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czgsFegsA%253D%253D&md5=909b8842f7f5297781226fc85e0e42d5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2004.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2004.03.002%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2596stman%26aufirst%3DA.%26atitle%3DPDGF-receptors%25E2%2580%2594mediators%2520of%2520autocrine%2520tumor%2520growth%2520and%2520regulators%2520of%2520tumor%2520vasculature%2520and%2520stroma%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2004%26volume%3D15%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kuhnert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, B. Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jocson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayak, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, C. J.</span><span> </span><span class="NLM_article-title">Soluble receptor-mediated selective inhibition of VEGFR and PDGFRβ signaling during physiologic and tumor angiogensis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">10185</span><span class="NLM_x">–</span> <span class="NLM_lpage">10190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=10185-10190&author=F.+Kuhnertauthor=B.+Y.+Y.+Tamauthor=B.+Senninoauthor=J.+T.+Grayauthor=J.+Yuanauthor=A.+Jocsonauthor=N.+R.+Nayakauthor=R.+C.+Mulliganauthor=D.+M.+McDonaldauthor=C.+J.+Kuo&title=Soluble+receptor-mediated+selective+inhibition+of+VEGFR+and+PDGFR%CE%B2+signaling+during+physiologic+and+tumor+angiogensis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuhnert%26aufirst%3DF.%26aulast%3DTam%26aufirst%3DB.%2BY.%2BY.%26aulast%3DSennino%26aufirst%3DB.%26aulast%3DGray%26aufirst%3DJ.%2BT.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DJocson%26aufirst%3DA.%26aulast%3DNayak%26aufirst%3DN.%2BR.%26aulast%3DMulligan%26aufirst%3DR.%2BC.%26aulast%3DMcDonald%26aufirst%3DD.%2BM.%26aulast%3DKuo%26aufirst%3DC.%2BJ.%26atitle%3DSoluble%2520receptor-mediated%2520selective%2520inhibition%2520of%2520VEGFR%2520and%2520PDGFR%25CE%25B2%2520signaling%2520during%2520physiologic%2520and%2520tumor%2520angiogensis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D10185%26epage%3D10190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Casanovas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanahan, D.</span><span> </span><span class="NLM_article-title">Drug resistance by evasion of anti-angiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=299-309&author=O.+Casanovasauthor=D.+J.+Hicklinauthor=G.+Bergersauthor=D.+Hanahan&title=Drug+resistance+by+evasion+of+anti-angiogenic+targeting+of+VEGF+signaling+in+late-stage+pancreatic+islet+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCasanovas%26aufirst%3DO.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DBergers%26aufirst%3DG.%26aulast%3DHanahan%26aufirst%3DD.%26atitle%3DDrug%2520resistance%2520by%2520evasion%2520of%2520anti-angiogenic%2520targeting%2520of%2520VEGF%2520signaling%2520in%2520late-stage%2520pancreatic%2520islet%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D8%26spage%3D299%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hilberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krssak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kautschitsch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommergruber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontsch-Grunt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoephel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">4774</span><span class="NLM_x">–</span> <span class="NLM_lpage">4782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=4774-4782&author=F.+Hilbergauthor=G.+J.+Rothauthor=M.+Krssakauthor=S.+Kautschitschauthor=W.+Sommergruberauthor=U.+Tontsch-Gruntauthor=P.+Garin-Chesaauthor=G.+Baderauthor=A.+Zoephelauthor=J.+Quantauthor=A.+Heckelauthor=W.+J.+Rettig&title=BIBF+1120%3A+triple+angiokinase+inhibitor+with+sustained+receptor+blockade+and+good+antitumor+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHilberg%26aufirst%3DF.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DKrssak%26aufirst%3DM.%26aulast%3DKautschitsch%26aufirst%3DS.%26aulast%3DSommergruber%26aufirst%3DW.%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DBader%26aufirst%3DG.%26aulast%3DZoephel%26aufirst%3DA.%26aulast%3DQuant%26aufirst%3DJ.%26aulast%3DHeckel%26aufirst%3DA.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DBIBF%25201120%253A%2520triple%2520angiokinase%2520inhibitor%2520with%2520sustained%2520receptor%2520blockade%2520and%2520good%2520antitumor%2520efficacy%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D4774%26epage%3D4782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mudryk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makosza, M.</span><span> </span><span class="NLM_article-title">A simple and efficient synthesis of alkyl (2-nitroaryl)acetates and alkyl 2-(2-nitroaryl)propanoates via vicarious nucleophilic substitution of hydrogen in nitroarenes by carbanions of alkyl chloroacetates or alykl 2-chloropropanoates</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1055%2Fs-1988-27789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADyaL1MXitFahu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=1007-1009&author=B.+Mudrykauthor=M.+Makosza&title=A+simple+and+efficient+synthesis+of+alkyl+%282-nitroaryl%29acetates+and+alkyl+2-%282-nitroaryl%29propanoates+via+vicarious+nucleophilic+substitution+of+hydrogen+in+nitroarenes+by+carbanions+of+alkyl+chloroacetates+or+alykl+2-chloropropanoates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Reactions of organic anions. 156. A simple and efficient synthesis of alkyl (2-nitroaryl)acetates and alkyl 2-(2-nitroaryl)propanoates via vicarious nucleophilic substitution of hydrogen in nitroarenes by carbanions of alkyl chloroacetates or alkyl 2-chloropropanoates</span></div><div class="casAuthors">Mudryk, B.; Makosza, M.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1007-9</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Reaction of RC6H4NO2 (R = 4-Cl, 4-F, H, 3-CF3) with ClCHR1CO2R2 (R1 = H, Me; R2 = CMe3, Et) gave the 2-nitroarylalkanoates I.  Small amts. of the 4-nitroarylalkanoates II (R = H, CF3, R1 = H, R2 = CMe3; R = H, R1 = Me, R2 = Et) were also formed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQzEGNIYOcPrVg90H21EOLACvtfcHk0ljfM6jGa27zrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXitFahu7g%253D&md5=617a46684ba5e2b0d7dad382e8ba06b0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1055%2Fs-1988-27789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1988-27789%26sid%3Dliteratum%253Aachs%26aulast%3DMudryk%26aufirst%3DB.%26aulast%3DMakosza%26aufirst%3DM.%26atitle%3DA%2520simple%2520and%2520efficient%2520synthesis%2520of%2520alkyl%2520%25282-nitroaryl%2529acetates%2520and%2520alkyl%25202-%25282-nitroaryl%2529propanoates%2520via%2520vicarious%2520nucleophilic%2520substitution%2520of%2520hydrogen%2520in%2520nitroarenes%2520by%2520carbanions%2520of%2520alkyl%2520chloroacetates%2520or%2520alykl%25202-chloropropanoates%26jtitle%3DSynthesis%26date%3D1988%26spage%3D1007%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980123i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2588-2603&author=L.+Sunauthor=N.+Tranauthor=F.+Tangauthor=H.+Appauthor=P.+Hirthauthor=G.+McMahonauthor=C.+Tang&title=Synthesis+and+biological+evaluations+of+3-substituted+indolin-2-ones%3A+a+novel+class+of+tyrosine+kinase+inhibitors+that+exhibit+selectivity+toward+particular+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases</span></div><div class="casAuthors">Sun, Li; Tran, Ngoc; Tang, Flora; App, Harald; Hirth, Peter; McMahon, Gerald; Tang, Cho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2588-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Substituted indolin-2-ones have been designed and synthesized as a novel class of tyrosine kinase inhibitors which exhibit selectivity toward different receptor tyrosine kinases (RTKs).  These compds. have been evaluated for their relative inhibitory properties against a panel of RTKs in intact cells.  By modifying the 3-substituted indolin-2-ones, we have identified compds. which showed selective inhibition of the ligand-dependent autophosphorylation of various RTKs at submicromolar levels in cells.  Structure-activity anal. for these compds. and their relative potency and selectivity to inhibit particular RTKs has detd. that (1) 3-[(five-membered heteroaryl ring)methylidenyl]indolin-2-ones are highly specific against the VEGF (Flk-1) RTK activity, (2) 3-(substituted benzylidenyl)indolin-2-ones contg. bulky group(s) in the Ph ring at the C-3 position of indolin-2-ones showed high selectivity toward the EGF and Her-2 RTKs, and (3) the compd. contg. an extended side chain at the C-3 position of the indolin-2-one exhibited high potency and selectivity when tested against the PDGF and VEGF (Flk-1) RTKs.  Recent published crystallog. data for two of these 3-substituted indolin-2-ones provides a rationale to suggest that these compds. may bind in the ATP binding pocket of RTKs.  The structure-activity anal. supports the use of subsets of these compds. as specific chem. leads for the development of RTK-specific drugs with broad application for the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJoPixq8Am5rVg90H21EOLACvtfcHk0ljfM6jGa27zrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D&md5=536302b717170a630008dac14832204c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm980123i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980123i%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%25203-substituted%2520indolin-2-ones%253A%2520a%2520novel%2520class%2520of%2520tyrosine%2520kinase%2520inhibitors%2520that%2520exhibit%2520selectivity%2520toward%2520particular%2520receptor%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2588%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bordwell, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fried, H. E.</span><span> </span><span class="NLM_article-title">Heterocyclic aromatic anions with 4<i>n</i> + 2 π-electrons</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4218</span><span class="NLM_x">–</span> <span class="NLM_lpage">4223</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00013a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1991&pages=4218-4223&author=F.+G.+Bordwellauthor=H.+E.+Fried&title=Heterocyclic+aromatic+anions+with+4n+%2B+2+%CF%80-electrons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjo00013a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00013a027%26sid%3Dliteratum%253Aachs%26aulast%3DBordwell%26aufirst%3DF.%2BG.%26aulast%3DFried%26aufirst%3DH.%2BE.%26atitle%3DHeterocyclic%2520aromatic%2520anions%2520with%25204n%2520%252B%25202%2520%25CF%2580-electrons%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1991%26volume%3D56%26spage%3D4218%26epage%3D4223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Behringer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissauer, H.</span><span> </span><span class="NLM_article-title">Zur Darstellung des Oxindol-aldehyds(3) (Oxymethylene-oxindols) und einiger funktioneller Abkömmlinge</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1952&pages=774-777&author=H.+Behringerauthor=H.+Weissauer&title=Zur+Darstellung+des+Oxindol-aldehyds%283%29+%28Oxymethylene-oxindols%29+und+einiger+funktioneller+Abk%C3%B6mmlinge"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBehringer%26aufirst%3DH.%26aulast%3DWeissauer%26aufirst%3DH.%26atitle%3DZur%2520Darstellung%2520des%2520Oxindol-aldehyds%25283%2529%2520%2528Oxymethylene-oxindols%2529%2520und%2520einiger%2520funktioneller%2520Abk%25C3%25B6mmlinge%26jtitle%3DChem.%2520Ber.%26date%3D1952%26volume%3D85%26spage%3D774%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bramson, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corona, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gampe, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovejoy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocque, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuyper, L. F.</span><span> </span><span class="NLM_article-title">Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4339</span><span class="NLM_x">–</span> <span class="NLM_lpage">4358</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010117d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvFGnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4339-4358&author=H.+N.+Bramsonauthor=J.+Coronaauthor=S.+T.+Davisauthor=S.+H.+Dickersonauthor=M.+Edelsteinauthor=S.+V.+Fryeauthor=R.+T.+Gampeauthor=P.+A.+Harrisauthor=A.+Hassellauthor=W.+D.+Holmesauthor=R.+N.+Hunterauthor=K.+E.+Lackeyauthor=B.+Lovejoyauthor=M.+J.+Luzzioauthor=V.+Montanaauthor=W.+J.+Rocqueauthor=D.+Rusnakauthor=L.+Shewchukauthor=J.+M.+Vealauthor=D.+H.+Walkerauthor=L.+F.+Kuyper&title=Oxindole-based+inhibitors+of+cyclin-dependent+kinase+2+%28CDK2%29%3A+design%2C+synthesis%2C+enzymatic+activities%2C+and+X-ray+crystallographic+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis</span></div><div class="casAuthors">Bramson, H. Neal; Corona, John; Davis, Stephen T.; Dickerson, Scott H.; Edelstein, Mark; Frye, Stephen V.; Gampe, Robert T., Jr.; Harris, Phil A.; Hassell, Anne; Holmes, William D.; Hunter, Robert N.; Lackey, Karen E.; Lovejoy, Brett; Luzzio, Michael J.; Montana, Val; Rocque, Warren J.; Rusnak, David; Shewchuk, Lisa; Veal, James M.; Walker, Duncan H.; Kuyper, Lee F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4339-4358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two closely related classes of oxindole-based compds., 1H-indole-2,3-dione 3-phenylhydrazones and 3-(anilinomethylene)-1,3-dihydro-2H-indol-2-ones, were shown to potently inhibit cyclin-dependent kinase 2 (CDK2).  The initial lead compd. was prepd. as a homolog of the 3-benzylidene-1,3-dihydro-2H-indol-2-one class of kinase inhibitor.  Crystallog. anal. of the lead compd. bound to CDK2 provided the basis for analog design.  A semiautomated method of ligand docking was used to select compds. for synthesis, and a no. of compds. with low nanomolar inhibitory activity vs. CDK2 were identified.  Enzyme binding determinants for several analogs were evaluated by X-ray crystallog.  Compds. in this series inhibited CDK2 with a potency ∼10-fold greater than that for CDK1.  Members of this class of inhibitor cause an arrest of the cell cycle and have shown potential utility in the prevention of chemotherapy-induced alopecia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppOmtXxUWKlrVg90H21EOLACvtfcHk0lh2_iEZnRM7Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvFGnt7Y%253D&md5=d628549913ca46f9edf6b4692c82419d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm010117d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010117d%26sid%3Dliteratum%253Aachs%26aulast%3DBramson%26aufirst%3DH.%2BN.%26aulast%3DCorona%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DS.%2BT.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DEdelstein%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGampe%26aufirst%3DR.%2BT.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DHassell%26aufirst%3DA.%26aulast%3DHolmes%26aufirst%3DW.%2BD.%26aulast%3DHunter%26aufirst%3DR.%2BN.%26aulast%3DLackey%26aufirst%3DK.%2BE.%26aulast%3DLovejoy%26aufirst%3DB.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DMontana%26aufirst%3DV.%26aulast%3DRocque%26aufirst%3DW.%2BJ.%26aulast%3DRusnak%26aufirst%3DD.%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DWalker%26aufirst%3DD.%2BH.%26aulast%3DKuyper%26aufirst%3DL.%2BF.%26atitle%3DOxindole-based%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25202%2520%2528CDK2%2529%253A%2520design%252C%2520synthesis%252C%2520enzymatic%2520activities%252C%2520and%2520X-ray%2520crystallographic%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4339%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Heckel, A.; Walter, R.; Grell, W.; van Meel, J. C. A.; Redemann, N.</span><span> </span><span class="NLM_article-title">Substituted indolinones having an inhibiting effect on kinases and cyclin/CDK complexes</span>. Patent WO9952869 A1 19991021, CAN 131:299364,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=A.+Heckel&author=R.+Walter&author=W.+Grell&author=J.+C.+A.+van+Meel&author=N.+Redemann&title=Substituted+indolinones+having+an+inhibiting+effect+on+kinases+and+cyclin%2FCDK+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHeckel%26aufirst%3DA.%26atitle%3DSubstituted%2520indolinones%2520having%2520an%2520inhibiting%2520effect%2520on%2520kinases%2520and%2520cyclin%252FCDK%2520complexes%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">Assay conditions as described in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Computational modeling was originally performed using a homology model based on the X-ray structure of FGFR-1. For better accuracy, the representations shown in this paper have been retrospectively modeled using the X-ray structure of VEGFR-2 recently reported in ref (<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">Twenty-three kinases were analyzed at 10 μmol/L with 100 μmol/L ATP as described in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>: GSK3β, ROCKII, DYRK1A, PKCα, MAPK2ERK2, MSK1, PDK1, CHK1, MAPKAPK2, SAPK2AP38, S6K1, SGK, CK1, CK2, PKA, SAPK2BP38β2, SAPK3P38γ, JNK1A1, SAPK4P38δ, PHK, PKBα, CSK, PRAK. In contrast to <b>45</b>, <b>35</b> inhibited CHK1, DYRK1A, MSK1, and PHK in the same panel significantly (<10% CTRL at 10 μmol/L).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bisping, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenning, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessonov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munzert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stelljes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Tidow, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebisch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchinda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serve, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesters, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdel, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienast, J.</span><span> </span><span class="NLM_article-title">Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">2079</span><span class="NLM_x">–</span> <span class="NLM_lpage">2089</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=2079-2089&author=G.+Bispingauthor=M.+Kropffauthor=D.+Wenningauthor=B.+Dreyerauthor=S.+Bessonovauthor=F.+Hilbergauthor=G.+J.+Rothauthor=G.+Munzertauthor=M.+Stefanicauthor=M.+Stelljesauthor=C.+Scheffoldauthor=C.+M%C3%BCller-Tidowauthor=P.+Liebischauthor=N.+Langauthor=J.+Tchindaauthor=H.+L.+Serveauthor=R.+M.+Mestersauthor=W.+E.+Berdelauthor=J.+Kienast&title=Targeting+receptor+kinases+by+a+novel+indolinone+derivative+in+multiple+myeloma%3A+abrogation+of+stroma-derived+interleukin-6+secretion+and+induction+of+apoptosis+in+cytogenetically+defined+subgroups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBisping%26aufirst%3DG.%26aulast%3DKropff%26aufirst%3DM.%26aulast%3DWenning%26aufirst%3DD.%26aulast%3DDreyer%26aufirst%3DB.%26aulast%3DBessonov%26aufirst%3DS.%26aulast%3DHilberg%26aufirst%3DF.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DMunzert%26aufirst%3DG.%26aulast%3DStefanic%26aufirst%3DM.%26aulast%3DStelljes%26aufirst%3DM.%26aulast%3DScheffold%26aufirst%3DC.%26aulast%3DM%25C3%25BCller-Tidow%26aufirst%3DC.%26aulast%3DLiebisch%26aufirst%3DP.%26aulast%3DLang%26aufirst%3DN.%26aulast%3DTchinda%26aufirst%3DJ.%26aulast%3DServe%26aufirst%3DH.%2BL.%26aulast%3DMesters%26aufirst%3DR.%2BM.%26aulast%3DBerdel%26aufirst%3DW.%2BE.%26aulast%3DKienast%26aufirst%3DJ.%26atitle%3DTargeting%2520receptor%2520kinases%2520by%2520a%2520novel%2520indolinone%2520derivative%2520in%2520multiple%2520myeloma%253A%2520abrogation%2520of%2520stroma-derived%2520interleukin-6%2520secretion%2520and%2520induction%2520of%2520apoptosis%2520in%2520cytogenetically%2520defined%2520subgroups%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D2079%26epage%3D2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Reinmuth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rensinghoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raedel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehrman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwöppe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisping, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesters, R. M.</span><span> </span><span class="NLM_article-title">Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=17671690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVagurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=621-626&author=N.+Reinmuthauthor=S.+Rensinghoffauthor=M.+Raedelauthor=N.+Fehrmanauthor=C.+Schw%C3%B6ppeauthor=T.+Kesslerauthor=G.+Bispingauthor=F.+Hilbergauthor=G.+J.+Rothauthor=W.+Berdelauthor=M.+Thomasauthor=R.+M.+Mesters&title=Paracrine+interactions+of+vascular+endothelial+growth+factor+and+platelet-derived+growth+factor+in+endothelial+and+lung+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells</span></div><div class="casAuthors">Reinmuth, Niels; Rensinghoff, Sonja; Raedel, Miriam; Fehrmann, Nicole; Schwoeppe, Christian; Kessler, Torsten; Bisping, Guido; Hilberg, Frank; Roth, Gerald J.; Berdel, Wolfgang; Thomas, Michael; Mesters, Rolf M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621-626</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">While the effects of single growth factors on endothelial cells (ECs) have been extensively studied, the importance of induction of growth factors such as PDGF-BB (platelet derived growth factor) in ECs and its impact on tumor cell functions are only partly understood.  Human umbilical vein endothelial cells (HUVECs) were cultured under serum-free conditions and stimulated by 20 ng/mL VEGF (vascular endothelial growth factor) or 20 ng/mL bFGF (basic fibroblastic growth factor).  As detd. by real-time PCR, both VEGF and bFGF induced a significant (up to 4-fold) increase in PDGF-B RNA expression which was time- and dose-dependent (p<0.05).  Similarly, conditioned medium (CM) from lung cancer cells (A549) which is known to contain multiple growth factors including VEGF and bFGF also induced PDGF-B RNA expression.  Using ELISA assays, VEGF and bFGF significantly increased PDGF-BB protein secretion in HUVECs (p<0.01).  By addn. of BIBF 1000, a novel inhibitor of the VEGF and bFGF receptor kinases, the effect of VEGF on PDGF-B RNA induction was significantly antagonized (p<0.01).  Furthermore, we studied the biol. significance of EC-derived PDGF-BB on lung cancer cells.  Interestingly, HUVEC-derived CM significantly stimulated migration of A549 cells (p<0.001) with a trend to further increased migration with the use of VEGF-stimulated (PDGF-BB rich) CM (p=0.2).  Collectively, endothelial and lung cancer cells seem to interact via various paracrine pathways, e.g. by the reciprocal induction of VEGF and PDGF-BB.  Thus, targeting key mols. would result in expression alterations of multiple factors and alter the biol. functions of both stromal and tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa1-OohY8UJbVg90H21EOLACvtfcHk0lh2_iEZnRM7Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVagurnP&md5=e15d5eab7a494145be0fb0cec88d3102</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReinmuth%26aufirst%3DN.%26aulast%3DRensinghoff%26aufirst%3DS.%26aulast%3DRaedel%26aufirst%3DM.%26aulast%3DFehrman%26aufirst%3DN.%26aulast%3DSchw%25C3%25B6ppe%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DT.%26aulast%3DBisping%26aufirst%3DG.%26aulast%3DHilberg%26aufirst%3DF.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DBerdel%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DMesters%26aufirst%3DR.%2BM.%26atitle%3DParacrine%2520interactions%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520platelet-derived%2520growth%2520factor%2520in%2520endothelial%2520and%2520lung%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2007%26volume%3D31%26spage%3D621%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kulimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oelmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisping, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienast, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesters, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwäble, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munzert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Tidow, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkmeyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büchner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serve, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdel, W. E.</span><span> </span><span class="NLM_article-title">Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3105</span><span class="NLM_x">–</span> <span class="NLM_lpage">3112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1158%2F1535-7163.MCT-06-0323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=17172413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlagsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=3105-3112&author=E.+Kulimovaauthor=E.+Oelmannauthor=G.+Bispingauthor=J.+Kienastauthor=R.+M.+Mestersauthor=J.+Schw%C3%A4bleauthor=F.+Hilbergauthor=G.+J.+Rothauthor=G.+Munzertauthor=M.+Stefanicauthor=B.+Steffenauthor=C.+Brandtsauthor=C.+M%C3%BCller-Tidowauthor=A.+Kolkmeyerauthor=T.+B%C3%BCchnerauthor=H.+Serveauthor=W.+E.+Berdel&title=Growth+inhibition+and+induction+of+apoptosis+in+acute+myeloid+leukemia+cells+by+new+indolinone+derivatives+targeting+fibroblast+growth+factor%2C+platelet-derived+growth+factor%2C+and+vascular+endothelial+growth+factor+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors</span></div><div class="casAuthors">Kulimova, Emma; Oelmann, Elisabeth; Bisping, Guido; Kienast, Joachim; Mesters, Rolf M.; Schwaeble, Joachim; Hilberg, Frank; Roth, Gerald J.; Munzert, Gerd; Stefanic, Martin; Steffen, Bjoern; Brandts, Christian; Mueller-Tidow, Carsten; Kolkmeyer, Astrid; Buechner, Thomas; Serve, Hubert; Berdel, Wolfgang E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3105-3112</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In acute myeloid leukemia (AML), receptor tyrosine kinase ligands promote growth and survival and contribute to AML-assocd. marrow neo-angiogenesis.  We have tested simultaneous inhibition of vascular endothelial growth factor, fibroblast growth factor, and platelet-derived growth factor receptor signaling by novel indolinone derivs. using 14 myeloid, including 11 human leukemic, cell lines.  Compds. inhibited colony formation of all cell lines in a dose-dependent fashion.  Inhibitory concns. for 50% of the colony formation/survival (IC50) for BIBF1000 were <100 nmol/L for 3 of 11, ≤500 nmol/L for 6 of 11, and <1,000 nmol/L for 10 of 11 leukemic cell lines, with one cell line being resistant in the dose range <1,000 nmol/L.  BIBF1120 was less effective with 4 of 11 leukemic cell lines being resistant within the dose range <1,000 nmol/L.  Testing of myeloid 32D cells transfected with empty vector, wild-type Flt3, or Flt3 carrying an internal tandem duplication mutation revealed higher resistance for the internal tandem duplication mutant.  These effects of the compds. were assocd. with inhibition of tyrosine phosphorylation and the mitogen-activated protein kinase pathway.  Furthermore, both compds. induced apoptosis in the sensitive cell lines.  In Mono-Mac1 cells, the compds. had a direct proapoptotic effect that was increasing the proapoptotic effect of 1-β-D-arabinofuranosylcytosine.  The data provide a rationale for clin. evaluation of these tyrosine kinase inhibitors in AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxCviJXgd7y7Vg90H21EOLACvtfcHk0ljJJoHsddhdJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlagsbrL&md5=1d5fc32b0953fa46bfba0ce3b5af58b2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0323%26sid%3Dliteratum%253Aachs%26aulast%3DKulimova%26aufirst%3DE.%26aulast%3DOelmann%26aufirst%3DE.%26aulast%3DBisping%26aufirst%3DG.%26aulast%3DKienast%26aufirst%3DJ.%26aulast%3DMesters%26aufirst%3DR.%2BM.%26aulast%3DSchw%25C3%25A4ble%26aufirst%3DJ.%26aulast%3DHilberg%26aufirst%3DF.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DMunzert%26aufirst%3DG.%26aulast%3DStefanic%26aufirst%3DM.%26aulast%3DSteffen%26aufirst%3DB.%26aulast%3DBrandts%26aufirst%3DC.%26aulast%3DM%25C3%25BCller-Tidow%26aufirst%3DC.%26aulast%3DKolkmeyer%26aufirst%3DA.%26aulast%3DB%25C3%25BCchner%26aufirst%3DT.%26aulast%3DServe%26aufirst%3DH.%26aulast%3DBerdel%26aufirst%3DW.%2BE.%26atitle%3DGrowth%2520inhibition%2520and%2520induction%2520of%2520apoptosis%2520in%2520acute%2520myeloid%2520leukemia%2520cells%2520by%2520new%2520indolinone%2520derivatives%2520targeting%2520fibroblast%2520growth%2520factor%252C%2520platelet-derived%2520growth%2520factor%252C%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D3105%26epage%3D3112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Mross, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmehling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strecker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopfer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Rossi, L.</span><span> </span><span class="NLM_article-title">A clinical phase I, pharmacokinetic (PK), and pharmacodynamic study of twice daily BIBF 1120 in advanced cancer patients</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3031</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=3031&author=K.+B.+Mrossauthor=D.+Gmehlingauthor=A.+Frostauthor=F.+Baasauthor=R.+Streckerauthor=J.+Hennigauthor=P.+Stopferauthor=M.+Stefanicauthor=G.+Stehleauthor=L.+de+Rossi&title=A+clinical+phase+I%2C+pharmacokinetic+%28PK%29%2C+and+pharmacodynamic+study+of+twice+daily+BIBF+1120+in+advanced+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMross%26aufirst%3DK.%2BB.%26aulast%3DGmehling%26aufirst%3DD.%26aulast%3DFrost%26aufirst%3DA.%26aulast%3DBaas%26aufirst%3DF.%26aulast%3DStrecker%26aufirst%3DR.%26aulast%3DHennig%26aufirst%3DJ.%26aulast%3DStopfer%26aufirst%3DP.%26aulast%3DStefanic%26aufirst%3DM.%26aulast%3DStehle%26aufirst%3DG.%26aulast%3Dde%2BRossi%26aufirst%3DL.%26atitle%3DA%2520clinical%2520phase%2520I%252C%2520pharmacokinetic%2520%2528PK%2529%252C%2520and%2520pharmacodynamic%2520study%2520of%2520twice%2520daily%2520BIBF%25201120%2520in%2520advanced%2520cancer%2520patients%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D3031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Von Pawel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschbach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatzemeier, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reck, M.</span><span> </span><span class="NLM_article-title">A double-blind phase II study of BIBF 1120 in patients suffering from relapsed advanced non-small cell lung cancer (NSCLC)</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">7635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=7635&author=J.+Von+Pawelauthor=R.+Kaiserauthor=C.+Eschbachauthor=M.+Stefanicauthor=J.+Loveauthor=U.+Gatzemeierauthor=M.+Reck&title=A+double-blind+phase+II+study+of+BIBF+1120+in+patients+suffering+from+relapsed+advanced+non-small+cell+lung+cancer+%28NSCLC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BPawel%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DR.%26aulast%3DEschbach%26aufirst%3DC.%26aulast%3DStefanic%26aufirst%3DM.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DGatzemeier%26aufirst%3DU.%26aulast%3DReck%26aufirst%3DM.%26atitle%3DA%2520double-blind%2520phase%2520II%2520study%2520of%2520BIBF%25201120%2520in%2520patients%2520suffering%2520from%2520relapsed%2520advanced%2520non-small%2520cell%2520lung%2520cancer%2520%2528NSCLC%2529%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D7635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Chaudhary, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Quernheim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zissel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnapp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span> </span><span class="NLM_article-title">Inhibition of PDGF, VEGF, and FGF signalling attenuates fibrosis</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1183%2F09031936.00152106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=17301095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=976-985&author=N.+I.+Chaudharyauthor=G.+J.+Rothauthor=F.+Hilbergauthor=J.+M%C3%BCller-Quernheimauthor=A.+Prasseauthor=G.+Zisselauthor=A.+Schnappauthor=J.+E.+Park&title=Inhibition+of+PDGF%2C+VEGF%2C+and+FGF+signalling+attenuates+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis</span></div><div class="casAuthors">Chaudhary, N. I.; Roth, G. J.; Hilberg, F.; Mueller-Quernheim, J.; Prasse, A.; Zissel, G.; Schnapp, A.; Park, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">976-985</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">BIBF 1000 is a small mol. inhibitor targeting the receptor kinases of platelet-derived growth factor (PDGF), basic fibroblast growth factor and vascular endothelial growth factor, which have known roles in the pathogenesis of pulmonary fibrosis.  The anti-fibrotic potential of BIBF 1000 was detd. in a rat model of bleomycin-induced lung fibrosis and in an ex vivo fibroblast differentiation assay.  Rats exposed to a single intra-tracheal injection of bleomycin were treated with BIBF 1000 starting 10 days after bleomycin administration.  To gauge for anti-fibrotic activity, collagen deposition and pro-fibrotic growth factor gene expression was analyzed in isolated lungs.  Furthermore, the activity of BIBF 1000 was compared with imatinib mesylate (combined PDGF receptor, c-kit and c-abl kinase inhibitor) and SB-431542 (transforming growth factor (TGF)-β receptor I kinase inhibitor) in an ex vivo TGF-β-driven fibroblast to myofibroblast differentiation assay, performed in primary human bronchial fibroblasts.  Treatment of rats with BIBF 1000 resulted in the attenuation of fibrosis as assessed by the redn. of collagen deposition and the inhibition of pro-fibrotic gene expression.  In the cellular assay both SB-431542 and BIBF 1000 showed dose-dependent inhibition of TGF-β-induced differentiation, whereas imatinib mesylate was inactive.  BIBF 1000, or related small mols. with a similar kinase inhibition profile, may represent a novel therapeutic approach for the treatment of idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKuwMAPritBrVg90H21EOLACvtfcHk0ljJJoHsddhdJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFOhurw%253D&md5=fdaef254b5e6a2d950ffb47cdf2d3bbb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1183%2F09031936.00152106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00152106%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DN.%2BI.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DHilberg%26aufirst%3DF.%26aulast%3DM%25C3%25BCller-Quernheim%26aufirst%3DJ.%26aulast%3DPrasse%26aufirst%3DA.%26aulast%3DZissel%26aufirst%3DG.%26aulast%3DSchnapp%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26atitle%3DInhibition%2520of%2520PDGF%252C%2520VEGF%252C%2520and%2520FGF%2520signalling%2520attenuates%2520fibrosis%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2007%26volume%3D29%26spage%3D976%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Grell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurnaus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griss, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittneben, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, P.</span><span> </span><span class="NLM_article-title">Repaglinide and related hypoglycemic benzoic acid derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5219</span><span class="NLM_x">–</span> <span class="NLM_lpage">5246</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9810349" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5219-5246&author=W.+Grellauthor=R.+Hurnausauthor=G.+Grissauthor=R.+Sauterauthor=E.+Rupprechtauthor=M.+Markauthor=P.+Lugerauthor=H.+Narauthor=H.+Wittnebenauthor=P.+M%C3%BCller&title=Repaglinide+and+related+hypoglycemic+benzoic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9810349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9810349%26sid%3Dliteratum%253Aachs%26aulast%3DGrell%26aufirst%3DW.%26aulast%3DHurnaus%26aufirst%3DR.%26aulast%3DGriss%26aufirst%3DG.%26aulast%3DSauter%26aufirst%3DR.%26aulast%3DRupprecht%26aufirst%3DE.%26aulast%3DMark%26aufirst%3DM.%26aulast%3DLuger%26aufirst%3DP.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DWittneben%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DP.%26atitle%3DRepaglinide%2520and%2520related%2520hypoglycemic%2520benzoic%2520acid%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5219%26epage%3D5246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Petersen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, J.</span><span> </span><span class="NLM_article-title">Phenazines and natural products; novel synthesis of saphenic acid</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_fpage">1763</span><span class="NLM_x">–</span> <span class="NLM_lpage">1766</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1055%2Fs-1999-3587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVKht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1763-1766&author=L.+Petersenauthor=K.+J.+Jensenauthor=J.+Nielsen&title=Phenazines+and+natural+products%3B+novel+synthesis+of+saphenic+acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Phenazines and natural products. Novel synthesis of saphenic acid</span></div><div class="casAuthors">Petersen, Lars; Jensen, Knud J.; Nielsen, John</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1763-1766</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Saphenic acid, 6-(1-hydroxyethyl)-1-phenazinecarboxylate, was synthesized from readily accessible starting materials.  The desired product was obtained with 22% overall yield in 4 steps with the key steps being formation of a diphenylamine, followed by cyclization under alk. and reducting conditions.  Assignments of 1H NMR spectra were achieved by homo- and heteronuclear 1D and 2D correlations.  Double pulsed field gradient spin-echo 1D NOESY proved esp. valuable for assignment of arom. protons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLbF98L1QNTbVg90H21EOLACvtfcHk0ljXsTgo4P-INA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVKht7s%253D&md5=d63c745a6a4540ab3c2875aa0a980316</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-1999-3587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1999-3587%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DL.%26aulast%3DJensen%26aufirst%3DK.%2BJ.%26aulast%3DNielsen%26aufirst%3DJ.%26atitle%3DPhenazines%2520and%2520natural%2520products%253B%2520novel%2520synthesis%2520of%2520saphenic%2520acid%26jtitle%3DSynthesis%26date%3D1999%26spage%3D1763%26epage%3D1766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Tercel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Synthesis of nitrogen and sulfur analogues of the seco-CI alkylating agent</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1998&pages=509-519&author=M.+Tercelauthor=W.+A.+Denny&title=Synthesis+of+nitrogen+and+sulfur+analogues+of+the+seco-CI+alkylating+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTercel%26aufirst%3DM.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520of%2520nitrogen%2520and%2520sulfur%2520analogues%2520of%2520the%2520seco-CI%2520alkylating%2520agent%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%26date%3D1998%26volume%3D1%26spage%3D509%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Varma, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, K. K.</span><span> </span><span class="NLM_article-title">Synthesis of 3-[4-(<i>N</i>-morpholino/-piperidino-methyl)phenylaminomethyl]-benzazoles as potential antibacterial agents</span> <span class="citation_source-journal">Indian J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">25B</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25B&publication_year=1986&pages=877-879&author=R.+S.+Varmaauthor=K.+K.+Verma&title=Synthesis+of+3-%5B4-%28N-morpholino%2F-piperidino-methyl%29phenylaminomethyl%5D-benzazoles+as+potential+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarma%26aufirst%3DR.%2BS.%26aulast%3DVerma%26aufirst%3DK.%2BK.%26atitle%3DSynthesis%2520of%25203-%255B4-%2528N-morpholino%252F-piperidino-methyl%2529phenylaminomethyl%255D-benzazoles%2520as%2520potential%2520antibacterial%2520agents%26jtitle%3DIndian%2520J.%2520Chem.%26date%3D1986%26volume%3D25B%26spage%3D877%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Moorhouse, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, J. E.</span><span> </span><span class="NLM_article-title">Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">15972</span><span class="NLM_x">–</span> <span class="NLM_lpage">15973</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0661919" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=15972-15973&author=A.+D.+Moorhouseauthor=A.+M.+Santosauthor=M.+Gunaratnamauthor=M.+Mooreauthor=S.+Neidleauthor=J.+E.+Moses&title=Stabilization+of+G-quadruplex+DNA+by+highly+selective+ligands+via+click+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja0661919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0661919%26sid%3Dliteratum%253Aachs%26aulast%3DMoorhouse%26aufirst%3DA.%2BD.%26aulast%3DSantos%26aufirst%3DA.%2BM.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DNeidle%26aufirst%3DS.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26atitle%3DStabilization%2520of%2520G-quadruplex%2520DNA%2520by%2520highly%2520selective%2520ligands%2520via%2520click%2520chemistry%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D15972%26epage%3D15973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Reppe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Äthinylierung, V. I.</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1955</span><span class="NLM_x">, </span> <span class="NLM_volume">596</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Reppe%2C+W.%3B+%C3%84thinylierung%2C+V.+I.Justus+Liebigs+Ann.+Chem.+1955%2C+596%2C+158%E2%80%93224"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReppe%26aufirst%3DW.%26aulast%3D%25C3%2584thinylierung%26aufirst%3DV.%2BI.%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1955%26volume%3D596%26spage%3D158%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gilman, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternbach, L. H.</span><span> </span><span class="NLM_article-title">An extension of the Smiles rearrangement. The displacement of an aromatic amide group by an amine nitrogen</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00942a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=373-377&author=N.+W.+Gilmanauthor=P.+Levitanauthor=L.+H.+Sternbach&title=An+extension+of+the+Smiles+rearrangement.+The+displacement+of+an+aromatic+amide+group+by+an+amine+nitrogen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo00942a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00942a035%26sid%3Dliteratum%253Aachs%26aulast%3DGilman%26aufirst%3DN.%2BW.%26aulast%3DLevitan%26aufirst%3DP.%26aulast%3DSternbach%26aufirst%3DL.%2BH.%26atitle%3DAn%2520extension%2520of%2520the%2520Smiles%2520rearrangement.%2520The%2520displacement%2520of%2520an%2520aromatic%2520amide%2520group%2520by%2520an%2520amine%2520nitrogen%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D373%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinov, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, W. A.</span><span> </span><span class="NLM_article-title">Structure−activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4898</span><span class="NLM_x">–</span> <span class="NLM_lpage">4908</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070564e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4898-4908&author=H.+Xieauthor=D.+Ngauthor=S.+N.+Savinovauthor=B.+Deyauthor=P.+D.+Kwongauthor=R.+Wyattauthor=A.+B.+Smithauthor=W.+A.+Hendrickson&title=Structure%E2%88%92activity+relationships+in+the+binding+of+chemically+derivatized+CD4+to+gp120+from+human+immunodeficiency+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm070564e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070564e%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DD.%26aulast%3DSavinov%26aufirst%3DS.%2BN.%26aulast%3DDey%26aufirst%3DB.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DWyatt%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHendrickson%26aufirst%3DW.%2BA.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520in%2520the%2520binding%2520of%2520chemically%2520derivatized%2520CD4%2520to%2520gp120%2520from%2520human%2520immunodeficiency%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4898%26epage%3D4908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Gabbay, E. J.</span><span> </span><span class="NLM_article-title">Topography of nucleic acid helices in solutions. XII. The origin of the oppositely induced circular dichroism of reporter molecules bound to ribo- and deoxyribonucleic acid</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">5136</span><span class="NLM_x">–</span> <span class="NLM_lpage">5150</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01046a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1969&pages=5136-5150&author=E.+J.+Gabbay&title=Topography+of+nucleic+acid+helices+in+solutions.+XII.+The+origin+of+the+oppositely+induced+circular+dichroism+of+reporter+molecules+bound+to+ribo-+and+deoxyribonucleic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja01046a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01046a035%26sid%3Dliteratum%253Aachs%26aulast%3DGabbay%26aufirst%3DE.%2BJ.%26atitle%3DTopography%2520of%2520nucleic%2520acid%2520helices%2520in%2520solutions.%2520XII.%2520The%2520origin%2520of%2520the%2520oppositely%2520induced%2520circular%2520dichroism%2520of%2520reporter%2520molecules%2520bound%2520to%2520ribo-%2520and%2520deoxyribonucleic%2520acid%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1969%26volume%3D91%26spage%3D5136%26epage%3D5150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kil, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, M.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundberg, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumberg, P. M.</span><span> </span><span class="NLM_article-title">Analysis of structure−activity relationships with the <i>N</i>-(3-acyloxy-2-benzylpropyl)-<i>N</i>′-[4-(methylsulfonylamino)benzyl]thiourea template for vanilloid receptor 1 antagonism</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3411</span><span class="NLM_x">–</span> <span class="NLM_lpage">3420</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=3411-3420&author=J.+Leeauthor=S.+Y.+Kimauthor=J.+Leeauthor=M.+Kangauthor=M.-J.+Kilauthor=H.-K.+Choiauthor=M.-K.+Jinauthor=Y.+Wangauthor=A.+Tothauthor=L.+V.+Pearceauthor=D.+J.+Lundbergauthor=R.+Tranauthor=P.+M.+Blumberg&title=Analysis+of+structure%E2%88%92activity+relationships+with+the+N-%283-acyloxy-2-benzylpropyl%29-N%E2%80%B2-%5B4-%28methylsulfonylamino%29benzyl%5Dthiourea+template+for+vanilloid+receptor+1+antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DKil%26aufirst%3DM.-J.%26aulast%3DChoi%26aufirst%3DH.-K.%26aulast%3DJin%26aufirst%3DM.-K.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DToth%26aufirst%3DA.%26aulast%3DPearce%26aufirst%3DL.%2BV.%26aulast%3DLundberg%26aufirst%3DD.%2BJ.%26aulast%3DTran%26aufirst%3DR.%26aulast%3DBlumberg%26aufirst%3DP.%2BM.%26atitle%3DAnalysis%2520of%2520structure%25E2%2588%2592activity%2520relationships%2520with%2520the%2520N-%25283-acyloxy-2-benzylpropyl%2529-N%25E2%2580%25B2-%255B4-%2528methylsulfonylamino%2529benzyl%255Dthiourea%2520template%2520for%2520vanilloid%2520receptor%25201%2520antagonism%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D3411%26epage%3D3420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':[],'ref16':[],'ref17':[],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 149 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yujiao Wei, Yanting Tang, Yunyun Zhou, Yuyu Yang, Yetong Cui, Xuan Wang, Yubo Wang, Yulin Liu, Ning Liu, Qianqian Wang, Chong Li, Hao Ruan, Honggang Zhou, Mingming Wei, Guang Yang, <span class="NLM_string-name hlFld-ContribAuthor">Cheng Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of a Novel 2H-Pyrazolo[3,4-d]pyrimidine Derivative as a Potent Irreversible Pan-Fibroblast Growth Factor Receptor Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9078-9099. <a href="https://doi.org/10.1021/acs.jmedchem.1c00174" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00174%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252Ba%252BNovel%252B2H-Pyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252BDerivative%252Bas%252Ba%252BPotent%252BIrreversible%252BPan-Fibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitor%26aulast%3DWei%26aufirst%3DYujiao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D31012021%26date%3D15062021%26volume%3D64%26issue%3D13%26spage%3D9078%26epage%3D9099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Girish
Singh Bisht, <span class="NLM_string-name hlFld-ContribAuthor">Boopathy Gnanaprakasam</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-Metal-Free Addition Reaction for the Synthesis of 3-(Aminobenzylidene/aminoalkylidene)indolin-2-ones and Its Synthetic Applications. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (21)
                                     , 13516-13527. <a href="https://doi.org/10.1021/acs.joc.9b01771" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01771%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTransition-Metal-Free%252BAddition%252BReaction%252Bfor%252Bthe%252BSynthesis%252Bof%252B3-%252528Aminobenzylidene%25252Faminoalkylidene%252529indolin-2-ones%252Band%252BIts%252BSynthetic%252BApplications%26aulast%3DBisht%26aufirst%3DGirish%2BSingh%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01072019%26date%3D10102019%26date%3D26092019%26volume%3D84%26issue%3D21%26spage%3D13516%26epage%3D13527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuming Wang, Lijun Li, Jun Fan, Yang Dai, Alan Jiang, Meiyu Geng, Jing Ai, <span class="NLM_string-name hlFld-ContribAuthor">Wenhu Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9085-9104. <a href="https://doi.org/10.1021/acs.jmedchem.7b01843" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01843</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01843%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252BIrreversible%252BPan-Fibroblast%252BGrowth%252BFactor%252BReceptor%252B%252528FGFR%252529%252BInhibitors%26aulast%3DWang%26aufirst%3DYuming%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D14122017%26date%3D16032018%26date%3D09032018%26volume%3D61%26issue%3D20%26spage%3D9085%26epage%3D9104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sumit Kumar, Sourav Taru Saha, Liang Gu, Gabriella Palma, Shanen Perumal, Ashona Singh-Pillay, Parvesh Singh, Amit Anand, Mandeep Kaur, <span class="NLM_string-name hlFld-ContribAuthor">Vipan Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">1H-1,2,3-Triazole Tethered Nitroimidazole–Isatin Conjugates: Synthesis, Docking, and Anti-Proliferative Evaluation against Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (9)
                                     , 12106-12113. <a href="https://doi.org/10.1021/acsomega.8b01513" title="DOI URL">https://doi.org/10.1021/acsomega.8b01513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b01513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b01513%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3D1H-1%25252C2%25252C3-Triazole%252BTethered%252BNitroimidazole%2525E2%252580%252593Isatin%252BConjugates%25253A%252BSynthesis%25252C%252BDocking%25252C%252Band%252BAnti-Proliferative%252BEvaluation%252Bagainst%252BBreast%252BCancer%26aulast%3DKumar%26aufirst%3DSumit%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02072018%26date%3D12092018%26volume%3D3%26issue%3D9%26spage%3D12106%26epage%3D12113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian A.  Kuttruff</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Tom  Bretschneider</span>, <span class="hlFld-ContribAuthor ">Stefan  Hoerer</span>, <span class="hlFld-ContribAuthor ">Sandra  Handschuh</span>, <span class="hlFld-ContribAuthor ">Bernd  Nosse</span>, <span class="hlFld-ContribAuthor ">Helmut  Romig</span>, <span class="hlFld-ContribAuthor ">Paul  Nicklin</span>, and <span class="hlFld-ContribAuthor ">Gerald J.  Roth</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly Reduces LPA Levels in Vivo. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (12)
                                     , 1252-1257. <a href="https://doi.org/10.1021/acsmedchemlett.7b00312" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00312%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BBI-2545%25253A%252BA%252BNovel%252BAutotaxin%252BInhibitor%252BThat%252BSignificantly%252BReduces%252BLPA%252BLevels%252Bin%252BVivo%26aulast%3DKuttruff%26aufirst%3DChristian%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D05082017%26date%3D08112017%26date%3D14112017%26date%3D14122017%26date%3D08112017%26volume%3D8%26issue%3D12%26spage%3D1252%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenhua  Huang</span>, <span class="hlFld-ContribAuthor ">Heran  Li</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Fangzheng  Lu</span>, <span class="hlFld-ContribAuthor ">Mei  Hong</span>, <span class="hlFld-ContribAuthor ">Zhigang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaocui  Guo</span>, <span class="hlFld-ContribAuthor ">Yuanju  Zhu</span>, <span class="hlFld-ContribAuthor ">Sanming  Li</span>, and <span class="hlFld-ContribAuthor ">Hongzhuo  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Indolinone-Based Multikinase Inhibitors as Potential Therapeutics for Idiopathic Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 1142-1147. <a href="https://doi.org/10.1021/acsmedchemlett.7b00164" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00164%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BIndolinone-Based%252BMultikinase%252BInhibitors%252Bas%252BPotential%252BTherapeutics%252Bfor%252BIdiopathic%252BPulmonary%252BFibrosis%26aulast%3DHuang%26aufirst%3DZhenhua%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06052017%26date%3D30092017%26date%3D10102017%26date%3D09112017%26date%3D30092017%26volume%3D8%26issue%3D11%26spage%3D1142%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Yulan  Wang</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Xianjie  Chen</span>, <span class="hlFld-ContribAuthor ">Yinglei  Gao</span>, <span class="hlFld-ContribAuthor ">Chunpu  Li</span>, <span class="hlFld-ContribAuthor ">Yulong  He</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6018-6035. <a href="https://doi.org/10.1021/acs.jmedchem.7b00076" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00076%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BEvaluation%252Bof%252BNovel%252BMultisubstituted%252BPyridin-3-amine%252BDerivatives%252Bas%252BMultitargeted%252BProtein%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNon-Small%252BCell%252BLung%252BCancer%26aulast%3DZhu%26aufirst%3DWei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23012017%26date%3D17072017%26date%3D27072017%26date%3D22062017%26volume%3D60%26issue%3D14%26spage%3D6018%26epage%3D6035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Min  Liu</span>, <span class="hlFld-ContribAuthor ">Kunal  Nepali</span>, and <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>  . </span><span class="cited-content_cbyCitation_article-title">Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 527-553. <a href="https://doi.org/10.1021/acs.jmedchem.6b00935" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00935%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdiopathic%252BPulmonary%252BFibrosis%25253A%252BCurrent%252BStatus%25252C%252BRecent%252BProgress%25252C%252Band%252BEmerging%252BTargets%26aulast%3DLiu%26aufirst%3DYi-Min%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D22062016%26date%3D29112016%26date%3D26012017%26date%3D14112016%26volume%3D60%26issue%3D2%26spage%3D527%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Yan</span>, <span class="hlFld-ContribAuthor ">Xinyi  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Bin  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinying  Yang</span>, <span class="hlFld-ContribAuthor ">Jun  Fan</span>, <span class="hlFld-ContribAuthor ">Yinglei  Gao</span>, <span class="hlFld-ContribAuthor ">Fanwang  Meng</span>, <span class="hlFld-ContribAuthor ">Yuming  Wang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, and <span class="hlFld-ContribAuthor ">Wenhu  Duan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-(5′-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (14)
                                     , 6690-6708. <a href="https://doi.org/10.1021/acs.jmedchem.6b00056" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00056%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-%2525285%2525E2%252580%2525B2-Substituted%252529-Benzimidazole-5-%2525281-%2525283%25252C5-dichloropyridin-4-yl%252529ethoxy%252529-1H-indazoles%252Bas%252BPotent%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DYan%26aufirst%3DWei%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D13012016%26date%3D06072016%26date%3D28072016%26date%3D27062016%26volume%3D59%26issue%3D14%26spage%3D6690%26epage%3D6708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gerald J.  Roth</span>, <span class="hlFld-ContribAuthor ">Rudolf  Binder</span>, <span class="hlFld-ContribAuthor ">Florian  Colbatzky</span>, <span class="hlFld-ContribAuthor ">Claudia  Dallinger</span>, <span class="hlFld-ContribAuthor ">Rozsa  Schlenker-Herceg</span>, <span class="hlFld-ContribAuthor ">Frank  Hilberg</span>, <span class="hlFld-ContribAuthor ">Stefan-Lutz  Wollin</span>, and <span class="hlFld-ContribAuthor ">Rolf  Kaiser</span>  . </span><span class="cited-content_cbyCitation_article-title">Nintedanib: From Discovery to the Clinic. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (3)
                                     , 1053-1063. <a href="https://doi.org/10.1021/jm501562a" title="DOI URL">https://doi.org/10.1021/jm501562a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501562a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501562a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNintedanib%25253A%252BFrom%252BDiscovery%252Bto%252Bthe%252BClinic%26aulast%3DRoth%26aufirst%3DGerald%2BJ.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D09102014%26date%3D14012015%26date%3D12022015%26date%3D04122014%26volume%3D58%26issue%3D3%26spage%3D1053%26epage%3D1063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Ku</span>, <span class="hlFld-ContribAuthor ">Stephanie  Heinzlmeir</span>, <span class="hlFld-ContribAuthor ">Dominic  Helm</span>, <span class="hlFld-ContribAuthor ">Guillaume  Médard</span>, and <span class="hlFld-ContribAuthor ">Bernhard  Kuster</span>  . </span><span class="cited-content_cbyCitation_article-title">New Affinity Probe Targeting VEGF Receptors for Kinase Inhibitor Selectivity Profiling by Chemical Proteomics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteome Research</span><span> <strong>2014,</strong> <em>13 </em>
                                    (5)
                                     , 2445-2452. <a href="https://doi.org/10.1021/pr401247t" title="DOI URL">https://doi.org/10.1021/pr401247t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/pr401247t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fpr401247t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteome%2520Research%26atitle%3DNew%252BAffinity%252BProbe%252BTargeting%252BVEGF%252BReceptors%252Bfor%252BKinase%252BInhibitor%252BSelectivity%252BProfiling%252Bby%252BChemical%252BProteomics%26aulast%3DKu%26aufirst%3DXin%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16122013%26date%3D22042014%26date%3D02052014%26date%3D09042014%26volume%3D13%26issue%3D5%26spage%3D2445%26epage%3D2452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Musumeci</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>, <span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, and <span class="hlFld-ContribAuthor ">Silvia  Schenone</span>  . </span><span class="cited-content_cbyCitation_article-title">Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (24)
                                     , 10797-10822. <a href="https://doi.org/10.1021/jm301085w" title="DOI URL">https://doi.org/10.1021/jm301085w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301085w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301085w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVascular%252BEndothelial%252BGrowth%252BFactor%252B%252528VEGF%252529%252BReceptors%25253A%252BDrugs%252Band%252BNew%252BInhibitors%26aulast%3DMusumeci%26aufirst%3DFrancesca%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25072012%26date%3D06112012%26date%3D27122012%26date%3D25102012%26volume%3D55%26issue%3D24%26spage%3D10797%26epage%3D10822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vito  Guagnano</span>, <span class="hlFld-ContribAuthor ">Pascal  Furet</span>, <span class="hlFld-ContribAuthor ">Carsten  Spanka</span>, <span class="hlFld-ContribAuthor ">Vincent  Bordas</span>, <span class="hlFld-ContribAuthor ">Mickaël  Le Douget</span>, <span class="hlFld-ContribAuthor ">Christelle  Stamm</span>, <span class="hlFld-ContribAuthor ">Josef  Brueggen</span>, <span class="hlFld-ContribAuthor ">Michael R.  Jensen</span>, <span class="hlFld-ContribAuthor ">Christian  Schnell</span>, <span class="hlFld-ContribAuthor ">Herbert  Schmid</span>, <span class="hlFld-ContribAuthor ">Markus  Wartmann</span>, <span class="hlFld-ContribAuthor ">Joerg  Berghausen</span>, <span class="hlFld-ContribAuthor ">Peter  Drueckes</span>, <span class="hlFld-ContribAuthor ">Alfred  Zimmerlin</span>, <span class="hlFld-ContribAuthor ">Dirksen  Bussiere</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, and <span class="hlFld-ContribAuthor ">Diana  Graus Porta</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (20)
                                     , 7066-7083. <a href="https://doi.org/10.1021/jm2006222" title="DOI URL">https://doi.org/10.1021/jm2006222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2006222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2006222%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-%2525282%25252C6-Dichloro-3%25252C5-dimethoxy-phenyl%252529-1-%25257B6-%25255B4-%2525284-ethyl-piperazin-1-yl%252529-phenylamino%25255D-pyrimidin-4-yl%25257D-1-methyl-urea%252B%252528NVP-BGJ398%252529%25252C%252BA%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252Bthe%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252BFamily%252Bof%252BReceptor%252BTyrosine%252BKinase%26aulast%3DGuagnano%26aufirst%3DVito%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D17052011%26date%3D21092011%26date%3D27102011%26volume%3D54%26issue%3D20%26spage%3D7066%26epage%3D7083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gerald J.  Roth</span>, <span class="hlFld-ContribAuthor ">Armin  Heckel</span>, <span class="hlFld-ContribAuthor ">Trixi  Brandl</span>, <span class="hlFld-ContribAuthor ">Matthias  Grauert</span>, <span class="hlFld-ContribAuthor ">Stefan  Hoerer</span>, <span class="hlFld-ContribAuthor ">Joerg T.  Kley</span>, <span class="hlFld-ContribAuthor ">Gisela  Schnapp</span>, <span class="hlFld-ContribAuthor ">Patrick  Baum</span>, <span class="hlFld-ContribAuthor ">Detlev  Mennerich</span>, <span class="hlFld-ContribAuthor ">Andreas  Schnapp</span>, and <span class="hlFld-ContribAuthor ">John E.  Park</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Indolinones as Inhibitors of the Transforming Growth Factor β Receptor I (TGFβRI). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (20)
                                     , 7287-7295. <a href="https://doi.org/10.1021/jm100812a" title="DOI URL">https://doi.org/10.1021/jm100812a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100812a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100812a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BIndolinones%252Bas%252BInhibitors%252Bof%252Bthe%252BTransforming%252BGrowth%252BFactor%252B%2525CE%2525B2%252BReceptor%252BI%252B%252528TGF%2525CE%2525B2RI%252529%26aulast%3DRoth%26aufirst%3DGerald%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D10032010%26date%3D04102010%26date%3D28102010%26volume%3D53%26issue%3D20%26spage%3D7287%26epage%3D7295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Liu</span>, <span class="hlFld-ContribAuthor ">Ashleigh M.  Philp</span>, <span class="hlFld-ContribAuthor ">Tamera  Corte</span>, <span class="hlFld-ContribAuthor ">Mark A.  Travis</span>, <span class="hlFld-ContribAuthor ">Heidi  Schilter</span>, <span class="hlFld-ContribAuthor ">Nicole G.  Hansbro</span>, <span class="hlFld-ContribAuthor ">Chris J.  Burns</span>, <span class="hlFld-ContribAuthor ">Mathew S.  Eapen</span>, <span class="hlFld-ContribAuthor ">Sukhwinder S.  Sohal</span>, <span class="hlFld-ContribAuthor ">Janette K.  Burgess</span>, <span class="hlFld-ContribAuthor ">Philip M.  Hansbro</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic targets in lung tissue remodelling and fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>225 </em>, 107839. <a href="https://doi.org/10.1016/j.pharmthera.2021.107839" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2021.107839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2021.107839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2021.107839%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DTherapeutic%252Btargets%252Bin%252Blung%252Btissue%252Bremodelling%252Band%252Bfibrosis%26aulast%3DLiu%26aufirst%3DGang%26date%3D2021%26volume%3D225%26spage%3D107839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José F.  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Anji  Zhang</span>, <span class="hlFld-ContribAuthor ">Jonathan  Bajohr</span>, <span class="hlFld-ContribAuthor ">Andrew  Whyte</span>, <span class="hlFld-ContribAuthor ">Bijan  Mirabi</span>, <span class="hlFld-ContribAuthor ">Mark  Lautens</span>. </span><span class="cited-content_cbyCitation_article-title">Cycloisomerization of Carbamoyl Chlorides in Hexafluorisopropanol: Stereoselective Synthesis of Chlorinated Methylene Oxindoles and Quinolinones. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>41 </em><a href="https://doi.org/10.1002/anie.202103323" title="DOI URL">https://doi.org/10.1002/anie.202103323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202103323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202103323%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCycloisomerization%252Bof%252BCarbamoyl%252BChlorides%252Bin%252BHexafluorisopropanol%25253A%252BStereoselective%252BSynthesis%252Bof%252BChlorinated%252BMethylene%252BOxindoles%252Band%252BQuinolinones%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DJos%25C3%25A9%2BF.%26date%3D2021%26date%3D2021%26volume%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José F.  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Anji  Zhang</span>, <span class="hlFld-ContribAuthor ">Jonathan  Bajohr</span>, <span class="hlFld-ContribAuthor ">Andrew  Whyte</span>, <span class="hlFld-ContribAuthor ">Bijan  Mirabi</span>, <span class="hlFld-ContribAuthor ">Mark  Lautens</span>. </span><span class="cited-content_cbyCitation_article-title">Cycloisomerization of Carbamoyl Chlorides in Hexafluorisopropanol: Stereoselective Synthesis of Chlorinated Methylene Oxindoles and Quinolinones. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>41 </em><a href="https://doi.org/10.1002/ange.202103323" title="DOI URL">https://doi.org/10.1002/ange.202103323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202103323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202103323%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DCycloisomerization%252Bof%252BCarbamoyl%252BChlorides%252Bin%252BHexafluorisopropanol%25253A%252BStereoselective%252BSynthesis%252Bof%252BChlorinated%252BMethylene%252BOxindoles%252Band%252BQuinolinones%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DJos%25C3%25A9%2BF.%26date%3D2021%26date%3D2021%26volume%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyan  Du</span>, <span class="hlFld-ContribAuthor ">Jie  Jiang</span>, <span class="hlFld-ContribAuthor ">Qibiao  Wu</span>, <span class="hlFld-ContribAuthor ">Nathaniel J.  Henning</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Donovan</span>, <span class="hlFld-ContribAuthor ">Hong  Yue</span>, <span class="hlFld-ContribAuthor ">Jianwei  Che</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Eric S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Nabeel  Bardeesy</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (29)
                                     , 16041-16047. <a href="https://doi.org/10.1002/ange.202101328" title="DOI URL">https://doi.org/10.1002/ange.202101328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202101328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202101328%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BDegrader%252Bfor%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B1%25252F2%26aulast%3DDu%26aufirst%3DGuangyan%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D29%26spage%3D16041%26epage%3D16047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyan  Du</span>, <span class="hlFld-ContribAuthor ">Jie  Jiang</span>, <span class="hlFld-ContribAuthor ">Qibiao  Wu</span>, <span class="hlFld-ContribAuthor ">Nathaniel J.  Henning</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Donovan</span>, <span class="hlFld-ContribAuthor ">Hong  Yue</span>, <span class="hlFld-ContribAuthor ">Jianwei  Che</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Eric S.  Fischer</span>, <span class="hlFld-ContribAuthor ">Nabeel  Bardeesy</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (29)
                                     , 15905-15911. <a href="https://doi.org/10.1002/anie.202101328" title="DOI URL">https://doi.org/10.1002/anie.202101328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202101328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202101328%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BDegrader%252Bfor%252BFibroblast%252BGrowth%252BFactor%252BReceptor%252B1%25252F2%26aulast%3DDu%26aufirst%3DGuangyan%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D29%26spage%3D15905%26epage%3D15911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Fu</span>, <span class="hlFld-ContribAuthor ">Tao  Gong</span>, <span class="hlFld-ContribAuthor ">Jiaywei  Tsauo</span>, <span class="hlFld-ContribAuthor ">Mingchen  Sang</span>, <span class="hlFld-ContribAuthor ">He  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingui  Li</span>, <span class="hlFld-ContribAuthor ">Xiao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Nintedanib, a multitarget tyrosine kinase inhibitor, suppresses postoperative peritoneal adhesion formation in a rat model. </span><span class="cited-content_cbyCitation_journal-name">Surgery</span><span> <strong>2021,</strong> <em>112 </em><a href="https://doi.org/10.1016/j.surg.2021.03.055" title="DOI URL">https://doi.org/10.1016/j.surg.2021.03.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.surg.2021.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.surg.2021.03.055%26sid%3Dliteratum%253Aachs%26jtitle%3DSurgery%26atitle%3DNintedanib%25252C%252Ba%252Bmultitarget%252Btyrosine%252Bkinase%252Binhibitor%25252C%252Bsuppresses%252Bpostoperative%252Bperitoneal%252Badhesion%252Bformation%252Bin%252Ba%252Brat%252Bmodel%26aulast%3DFu%26aufirst%3DYan%26date%3D2021%26volume%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Angiogenesis Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-66. <a href="https://doi.org/10.1002/0471266949.bmc271" title="DOI URL">https://doi.org/10.1002/0471266949.bmc271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc271%26sid%3Dliteratum%253Aachs%26atitle%3DAngiogenesis%252BInhibitors%26aulast%3DShi%26aufirst%3DLei%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D66%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiong  Chen</span>, <span class="hlFld-ContribAuthor ">Menglin  Li</span>, <span class="hlFld-ContribAuthor ">Manru  Li</span>, <span class="hlFld-ContribAuthor ">Dongmei  Wang</span>, <span class="hlFld-ContribAuthor ">Jinlan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Harnessing affinity-based protein profiling to reveal a novel target of nintedanib. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (25)
                                     , 3139-3142. <a href="https://doi.org/10.1039/D1CC00354B" title="DOI URL">https://doi.org/10.1039/D1CC00354B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC00354B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC00354B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DHarnessing%252Baffinity-based%252Bprotein%252Bprofiling%252Bto%252Breveal%252Ba%252Bnovel%252Btarget%252Bof%252Bnintedanib%26aulast%3DChen%26aufirst%3DXiong%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D25%26spage%3D3139%26epage%3D3142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindasami  Periyasami</span>, <span class="hlFld-ContribAuthor ">Ponmurugan  Karuppiah</span>, <span class="hlFld-ContribAuthor ">Antony  Stalin</span>, <span class="hlFld-ContribAuthor ">Saradh  Prasad</span>, <span class="hlFld-ContribAuthor ">Mostafizur  Rahaman</span>, <span class="hlFld-ContribAuthor ">Abdul-Aziz  Alrehaili</span>, <span class="hlFld-ContribAuthor ">Naif Abdullah  Al-Dhabi</span>, <span class="hlFld-ContribAuthor ">Ali  Aldalbahi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, absorption, emission and solvatochromic investigation of bioactive isatin tethered acridinedione conjugates. </span><span class="cited-content_cbyCitation_journal-name">Materials Today Communications</span><span> <strong>2021,</strong> <em>26 </em>, 102109. <a href="https://doi.org/10.1016/j.mtcomm.2021.102109" title="DOI URL">https://doi.org/10.1016/j.mtcomm.2021.102109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mtcomm.2021.102109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mtcomm.2021.102109%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Today%2520Communications%26atitle%3DSynthesis%25252C%252Babsorption%25252C%252Bemission%252Band%252Bsolvatochromic%252Binvestigation%252Bof%252Bbioactive%252Bisatin%252Btethered%252Bacridinedione%252Bconjugates%26aulast%3DPeriyasami%26aufirst%3DGovindasami%26date%3D2021%26volume%3D26%26spage%3D102109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lukáš  Marek</span>, <span class="hlFld-ContribAuthor ">Lukáš  Kolman</span>, <span class="hlFld-ContribAuthor ">Jiří  Váňa</span>, <span class="hlFld-ContribAuthor ">Jan  Svoboda</span>, <span class="hlFld-ContribAuthor ">Jiří  Hanusek</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of (
              Z
              )-3-[amino(phenyl)methylidene]-1,3-dihydro-2
              H
              -indol-2-ones using an Eschenmoser coupling reaction. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>17 </em>, 527-539. <a href="https://doi.org/10.3762/bjoc.17.47" title="DOI URL">https://doi.org/10.3762/bjoc.17.47</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.17.47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.17.47%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B%252528%252BZ%252B%252529-3-%25255Bamino%252528phenyl%252529methylidene%25255D-1%25252C3-dihydro-2%252BH%252B-indol-2-ones%252Busing%252Ban%252BEschenmoser%252Bcoupling%252Breaction%26aulast%3DMarek%26aufirst%3DLuk%25C3%25A1%25C5%25A1%26date%3D2021%26date%3D2021%26volume%3D17%26spage%3D527%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Namrata  Vijayvergia</span>, <span class="hlFld-ContribAuthor ">Arvind  Dasari</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Therapies in the Management of Well-Differentiated Digestive and Lung Neuroendocrine Neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Current Treatment Options in Oncology</span><span> <strong>2020,</strong> <em>21 </em>
                                    (12)
                                     <a href="https://doi.org/10.1007/s11864-020-00794-0" title="DOI URL">https://doi.org/10.1007/s11864-020-00794-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11864-020-00794-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11864-020-00794-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Treatment%2520Options%2520in%2520Oncology%26atitle%3DTargeted%252BTherapies%252Bin%252Bthe%252BManagement%252Bof%252BWell-Differentiated%252BDigestive%252Band%252BLung%252BNeuroendocrine%252BNeoplasms%26aulast%3DVijayvergia%26aufirst%3DNamrata%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masako  Yumura</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Nagano</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Nishimura</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Multitarget Therapies for Lung Cancer and Respiratory Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (17)
                                     , 3987. <a href="https://doi.org/10.3390/molecules25173987" title="DOI URL">https://doi.org/10.3390/molecules25173987</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25173987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25173987%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNovel%252BMultitarget%252BTherapies%252Bfor%252BLung%252BCancer%252Band%252BRespiratory%252BDisease%26aulast%3DYumura%26aufirst%3DMasako%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D17%26spage%3D3987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuqin  Yao</span>, <span class="hlFld-ContribAuthor ">Zhuowei  Liu</span>, <span class="hlFld-ContribAuthor ">Manyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhengxia  Chen</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuxi  Wang</span>, <span class="hlFld-ContribAuthor ">Chengjian  Zhao</span>, <span class="hlFld-ContribAuthor ">Chaofeng  Long</span>, <span class="hlFld-ContribAuthor ">Xiaoxin  Chen</span>, <span class="hlFld-ContribAuthor ">Jinliang  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and pharmacological evaluation of 4-(3-chloro-4-(3-cyclopropylthioureido)-2-fluorophenoxy)-7-methoxyquinoline-6-carboxamide (WXFL-152): a novel triple angiokinase inhibitor for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (8)
                                     , 1453-1475. <a href="https://doi.org/10.1016/j.apsb.2020.04.002" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252B4-%2525283-chloro-4-%2525283-cyclopropylthioureido%252529-2-fluorophenoxy%252529-7-methoxyquinoline-6-carboxamide%252B%252528WXFL-152%252529%25253A%252Ba%252Bnovel%252Btriple%252Bangiokinase%252Binhibitor%252Bfor%252Bcancer%252Btherapy%26aulast%3DYao%26aufirst%3DYuqin%26date%3D2020%26volume%3D10%26issue%3D8%26spage%3D1453%26epage%3D1475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gali  Epstein-Shochet</span>, <span class="hlFld-ContribAuthor ">Stephen  Pham</span>, <span class="hlFld-ContribAuthor ">Steven  Beck</span>, <span class="hlFld-ContribAuthor ">Safaa  Naiel</span>, <span class="hlFld-ContribAuthor ">Olivia  Mekhael</span>, <span class="hlFld-ContribAuthor ">Spencer  Revill</span>, <span class="hlFld-ContribAuthor ">Aaron  Hayat</span>, <span class="hlFld-ContribAuthor ">Megan  Vierhout</span>, <span class="hlFld-ContribAuthor ">Becky  Bardestein-Wald</span>, <span class="hlFld-ContribAuthor ">David  Shitrit</span>, <span class="hlFld-ContribAuthor ">Kjetil  Ask</span>, <span class="hlFld-ContribAuthor ">A. Bruce  Montgomery</span>, <span class="hlFld-ContribAuthor ">Martin R.  Kolb</span>, <span class="hlFld-ContribAuthor ">Mark W.  Surber</span>. </span><span class="cited-content_cbyCitation_article-title">Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationship. </span><span class="cited-content_cbyCitation_journal-name">Pulmonary Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>63 </em>, 101933. <a href="https://doi.org/10.1016/j.pupt.2020.101933" title="DOI URL">https://doi.org/10.1016/j.pupt.2020.101933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pupt.2020.101933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pupt.2020.101933%26sid%3Dliteratum%253Aachs%26jtitle%3DPulmonary%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DInhalation%25253A%252BA%252Bmeans%252Bto%252Bexplore%252Band%252Boptimize%252Bnintedanib%252527s%252Bpharmacokinetic%25252Fpharmacodynamic%252Brelationship%26aulast%3DEpstein-Shochet%26aufirst%3DGali%26date%3D2020%26volume%3D63%26spage%3D101933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linlin  Xue</span>, <span class="hlFld-ContribAuthor ">Dexin  Deng</span>, <span class="hlFld-ContribAuthor ">Shoujun  Zheng</span>, <span class="hlFld-ContribAuthor ">Minghai  Tang</span>, <span class="hlFld-ContribAuthor ">Zhuang  Yang</span>, <span class="hlFld-ContribAuthor ">Heying  Pei</span>, <span class="hlFld-ContribAuthor ">Yong  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Yang</span>, <span class="hlFld-ContribAuthor ">Kongjun  Liu</span>, <span class="hlFld-ContribAuthor ">Haoyu  Ye</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-β/smad dependent and independent pathway. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>197 </em>, 112259. <a href="https://doi.org/10.1016/j.ejmech.2020.112259" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112259%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bdiscovery%252Bof%252B2%2525281H%252529-quinolone%252Bderivatives%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Bfibrosis%252Bthrough%252Binhibition%252Bof%252BTGF-%2525CE%2525B2%25252Fsmad%252Bdependent%252Band%252Bindependent%252Bpathway%26aulast%3DXue%26aufirst%3DLinlin%26date%3D2020%26volume%3D197%26spage%3D112259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingliang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuchen  Wang</span>, <span class="hlFld-ContribAuthor ">Yuanrong  Fan</span>, <span class="hlFld-ContribAuthor ">Xingye  Chen</span>, <span class="hlFld-ContribAuthor ">Yan  Yang</span>, <span class="hlFld-ContribAuthor ">Yi  Hua</span>, <span class="hlFld-ContribAuthor ">Wuchen  Xie</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Weifang  Tang</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, <span class="hlFld-ContribAuthor ">Haichun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Protein–ligand interaction-guided discovery of novel VEGFR-2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (9)
                                     , 2559-2574. <a href="https://doi.org/10.1080/07391102.2019.1635915" title="DOI URL">https://doi.org/10.1080/07391102.2019.1635915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1635915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1635915%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DProtein%2525E2%252580%252593ligand%252Binteraction-guided%252Bdiscovery%252Bof%252Bnovel%252BVEGFR-2%252Binhibitors%26aulast%3DZhang%26aufirst%3DYanmin%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D9%26spage%3D2559%26epage%3D2574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karthick  Muthuvel</span>, <span class="hlFld-ContribAuthor ">Shanmugam  Karthik</span>, <span class="hlFld-ContribAuthor ">Thirumanavelan  Gandhi</span>. </span><span class="cited-content_cbyCitation_article-title">DBU‐Promoted α‐Acylation of 2‐Oxindoles through Acyl C−C Bond Cleavage: Imidazolium Salts as an Emerging Acylating Agent. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>9 </em>
                                    (5)
                                     , 769-772. <a href="https://doi.org/10.1002/ajoc.202000139" title="DOI URL">https://doi.org/10.1002/ajoc.202000139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202000139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202000139%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDBU%2525E2%252580%252590Promoted%252B%2525CE%2525B1%2525E2%252580%252590Acylation%252Bof%252B2%2525E2%252580%252590Oxindoles%252Bthrough%252BAcyl%252BC%2525E2%252588%252592C%252BBond%252BCleavage%25253A%252BImidazolium%252BSalts%252Bas%252Ban%252BEmerging%252BAcylating%252BAgent%26aulast%3DMuthuvel%26aufirst%3DKarthick%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D5%26spage%3D769%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cong-Hai  Zhang</span>, <span class="hlFld-ContribAuthor ">Rong  Huang</span>, <span class="hlFld-ContribAuthor ">Xia  Qing</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Cascade reaction of isatins with nitro-substituted enamines: highly selective synthesis of functionalized (
              Z
              )-3-(1-(arylamino)-2-oxoarylidene)indolin-2-ones. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (24)
                                     , 3488-3491. <a href="https://doi.org/10.1039/D0CC00923G" title="DOI URL">https://doi.org/10.1039/D0CC00923G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC00923G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC00923G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DCascade%252Breaction%252Bof%252Bisatins%252Bwith%252Bnitro-substituted%252Benamines%25253A%252Bhighly%252Bselective%252Bsynthesis%252Bof%252Bfunctionalized%252B%252528%252BZ%252B%252529-3-%2525281-%252528arylamino%252529-2-oxoarylidene%252529indolin-2-ones%26aulast%3DZhang%26aufirst%3DCong-Hai%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D24%26spage%3D3488%26epage%3D3491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanming  Zhu</span>, <span class="hlFld-ContribAuthor ">Xu  Zheng</span>, <span class="hlFld-ContribAuthor ">Changyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiuli  Sun</span>, <span class="hlFld-ContribAuthor ">Huijun  Sun</span>, <span class="hlFld-ContribAuthor ">Tengyue  Ma</span>, <span class="hlFld-ContribAuthor ">Yanxia  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Lixue  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activity of thieno[3,2-d]pyrimidines as potent JAK3 inhibitors for the treatment of idiopathic pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (2)
                                     , 115254. <a href="https://doi.org/10.1016/j.bmc.2019.115254" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115254%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivity%252Bof%252Bthieno%25255B3%25252C2-d%25255Dpyrimidines%252Bas%252Bpotent%252BJAK3%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bidiopathic%252Bpulmonary%252Bfibrosis%26aulast%3DZhu%26aufirst%3DYanming%26date%3D2020%26volume%3D28%26issue%3D2%26spage%3D115254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dexin  Deng</span>, <span class="hlFld-ContribAuthor ">Heying  Pei</span>, <span class="hlFld-ContribAuthor ">Tingxuan  Lan</span>, <span class="hlFld-ContribAuthor ">Jiali  Zhu</span>, <span class="hlFld-ContribAuthor ">Minghai  Tang</span>, <span class="hlFld-ContribAuthor ">Linlin  Xue</span>, <span class="hlFld-ContribAuthor ">Zhuang  Yang</span>, <span class="hlFld-ContribAuthor ">Shoujun  Zheng</span>, <span class="hlFld-ContribAuthor ">Haoyu  Ye</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and discovery of new compounds bearing coumarin scaffold for the treatment of pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111790. <a href="https://doi.org/10.1016/j.ejmech.2019.111790" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111790%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bdiscovery%252Bof%252Bnew%252Bcompounds%252Bbearing%252Bcoumarin%252Bscaffold%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Bfibrosis%26aulast%3DDeng%26aufirst%3DDexin%26date%3D2020%26volume%3D185%26spage%3D111790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>151 </em>, 104567. <a href="https://doi.org/10.1016/j.phrs.2019.104567" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104567</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104567%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DThe%252Brole%252Bof%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252B%252528FGFR%252529%252Bprotein-tyrosine%252Bkinase%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Bcancers%252Bincluding%252Bthose%252Bof%252Bthe%252Burinary%252Bbladder%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2020%26volume%3D151%26spage%3D104567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Yu  Wen</span>, <span class="hlFld-ContribAuthor ">Lina  Gao</span>, <span class="hlFld-ContribAuthor ">Liang  Gao</span>, <span class="hlFld-ContribAuthor ">Fengjun  He</span>, <span class="hlFld-ContribAuthor ">Jingxian  Zhou</span>, <span class="hlFld-ContribAuthor ">Junwei  Wang</span>, <span class="hlFld-ContribAuthor ">Rupeng  Dai</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Chen</span>, <span class="hlFld-ContribAuthor ">Di  Kang</span>, <span class="hlFld-ContribAuthor ">Lihong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 1
              H
              -1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors
              via
              fragment-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 72-84. <a href="https://doi.org/10.1080/14756366.2019.1673745" title="DOI URL">https://doi.org/10.1080/14756366.2019.1673745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1673745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1673745%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B1%252BH%252B-1%25252C2%25252C4-triazole%25252C%252Bbenzothiazole%252Band%252Bindazole-based%252Bderivatives%252Bas%252Bpotent%252BFGFR1%252Binhibitors%252Bvia%252Bfragment-based%252Bvirtual%252Bscreening%26aulast%3DLiu%26aufirst%3DJian%26date%3D2020%26date%3D2019%26volume%3D35%26issue%3D1%26spage%3D72%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel  Quintela-Fandino</span>, <span class="hlFld-ContribAuthor ">Juan V.  Apala</span>, <span class="hlFld-ContribAuthor ">Diego  Malon</span>, <span class="hlFld-ContribAuthor ">Silvana  Mouron</span>, <span class="hlFld-ContribAuthor ">Javier  Hornedo</span>, <span class="hlFld-ContribAuthor ">Lucia  Gonzalez-Cortijo</span>, <span class="hlFld-ContribAuthor ">Ramon  Colomer</span>, <span class="hlFld-ContribAuthor ">Juan  Guerra</span>. </span><span class="cited-content_cbyCitation_article-title">Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research</span><span> <strong>2019,</strong> <em>21 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13058-019-1152-x" title="DOI URL">https://doi.org/10.1186/s13058-019-1152-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13058-019-1152-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13058-019-1152-x%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%26atitle%3DNintedanib%252Bplus%252Bletrozole%252Bin%252Bearly%252Bbreast%252Bcancer%25253A%252Ba%252Bphase%252B0%25252FI%252Bpharmacodynamic%25252C%252Bpharmacokinetic%25252C%252Band%252Bsafety%252Bclinical%252Btrial%252Bof%252Bcombined%252BFGFR1%252Band%252Baromatase%252Binhibition%26aulast%3DQuintela-Fandino%26aufirst%3DMiguel%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher P  Wilding</span>, <span class="hlFld-ContribAuthor ">Mark L  Elms</span>, <span class="hlFld-ContribAuthor ">Ian  Judson</span>, <span class="hlFld-ContribAuthor ">Aik-Choon  Tan</span>, <span class="hlFld-ContribAuthor ">Robin L  Jones</span>, <span class="hlFld-ContribAuthor ">Paul H  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2019,</strong> <em>19 </em>
                                    (11)
                                     , 971-991. <a href="https://doi.org/10.1080/14737140.2019.1686979" title="DOI URL">https://doi.org/10.1080/14737140.2019.1686979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2019.1686979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2019.1686979%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DThe%252Blandscape%252Bof%252Btyrosine%252Bkinase%252Binhibitors%252Bin%252Bsarcomas%25253A%252Blooking%252Bbeyond%252Bpazopanib%26aulast%3DWilding%26aufirst%3DChristopher%2BP%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D11%26spage%3D971%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sven  Wind</span>, <span class="hlFld-ContribAuthor ">Ulrike  Schmid</span>, <span class="hlFld-ContribAuthor ">Matthias  Freiwald</span>, <span class="hlFld-ContribAuthor ">Kristell  Marzin</span>, <span class="hlFld-ContribAuthor ">Ralf  Lotz</span>, <span class="hlFld-ContribAuthor ">Thomas  Ebner</span>, <span class="hlFld-ContribAuthor ">Peter  Stopfer</span>, <span class="hlFld-ContribAuthor ">Claudia  Dallinger</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2019,</strong> <em>58 </em>
                                    (9)
                                     , 1131-1147. <a href="https://doi.org/10.1007/s40262-019-00766-0" title="DOI URL">https://doi.org/10.1007/s40262-019-00766-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-019-00766-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-019-00766-0%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DClinical%252BPharmacokinetics%252Band%252BPharmacodynamics%252Bof%252BNintedanib%26aulast%3DWind%26aufirst%3DSven%26date%3D2019%26date%3D2019%26volume%3D58%26issue%3D9%26spage%3D1131%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jee-Youn  Kim</span>, <span class="hlFld-ContribAuthor ">Seulgi  Jeon</span>, <span class="hlFld-ContribAuthor ">Young Jo  Yoo</span>, <span class="hlFld-ContribAuthor ">Hee  Jin</span>, <span class="hlFld-ContribAuthor ">Hee Yeon  Won</span>, <span class="hlFld-ContribAuthor ">Kyeonghee  Yoon</span>, <span class="hlFld-ContribAuthor ">Eun Sook  Hwang</span>, <span class="hlFld-ContribAuthor ">Yoon-Jin  Lee</span>, <span class="hlFld-ContribAuthor ">Younghwa  Na</span>, <span class="hlFld-ContribAuthor ">Jaeho  Cho</span>, <span class="hlFld-ContribAuthor ">Yun-Sil  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">The Hsp27-Mediated IkBα-NFκB Signaling Axis Promotes Radiation-Induced Lung Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2019,</strong> <em>25 </em>
                                    (17)
                                     , 5364-5375. <a href="https://doi.org/10.1158/1078-0432.CCR-18-3900" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-18-3900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-18-3900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-18-3900%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DThe%252BHsp27-Mediated%252BIkB%2525CE%2525B1-NF%2525CE%2525BAB%252BSignaling%252BAxis%252BPromotes%252BRadiation-Induced%252BLung%252BFibrosis%26aulast%3DKim%26aufirst%3DJee-Youn%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D17%26spage%3D5364%26epage%3D5375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mossenta</span>, <span class="hlFld-ContribAuthor ">Busato</span>, <span class="hlFld-ContribAuthor ">Baboci</span>, <span class="hlFld-ContribAuthor ">Cintio</span>, <span class="hlFld-ContribAuthor ">Toffoli</span>, <span class="hlFld-ContribAuthor ">Bo</span>. </span><span class="cited-content_cbyCitation_article-title">New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (8)
                                     , 1086. <a href="https://doi.org/10.3390/cancers11081086" title="DOI URL">https://doi.org/10.3390/cancers11081086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11081086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11081086%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNew%252BInsight%252Binto%252BTherapies%252BTargeting%252BAngiogenesis%252Bin%252BHepatocellular%252BCarcinoma%26aulast%3DMossenta%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D8%26spage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolkarim  Farrokhzadeh</span>, <span class="hlFld-ContribAuthor ">Farideh Badichi  Akher</span>, <span class="hlFld-ContribAuthor ">Fisayo A.  Olotu</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>, <span class="hlFld-ContribAuthor ">Fanie R.  Van Heerden</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing the distinct mechanistic binding and activity of 5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-3-(5-(4-methylpiperazin-1-yl)-1
              H
              -benzo[
              d
              ]imidazol-2-yl)-1
              H
              -indazole enantiomers against FGFR1. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2019,</strong> <em>21 </em>
                                    (27)
                                     , 15120-15132. <a href="https://doi.org/10.1039/C9CP02112D" title="DOI URL">https://doi.org/10.1039/C9CP02112D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CP02112D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CP02112D%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DRevealing%252Bthe%252Bdistinct%252Bmechanistic%252Bbinding%252Band%252Bactivity%252Bof%252B5-%2525281-%2525283%25252C5-dichloropyridin-4-yl%252529ethoxy%252529-3-%2525285-%2525284-methylpiperazin-1-yl%252529-1%252BH%252B-benzo%25255B%252Bd%252B%25255Dimidazol-2-yl%252529-1%252BH%252B-indazole%252Benantiomers%252Bagainst%252BFGFR1%26aulast%3DFarrokhzadeh%26aufirst%3DAbdolkarim%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D27%26spage%3D15120%26epage%3D15132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh V.  Shelar</span>, <span class="hlFld-ContribAuthor ">Narshinha P.  Argade</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective oxidation of indoles to 2-oxindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (27)
                                     , 6671-6677. <a href="https://doi.org/10.1039/C9OB00764D" title="DOI URL">https://doi.org/10.1039/C9OB00764D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00764D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00764D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRegioselective%252Boxidation%252Bof%252Bindoles%252Bto%252B2-oxindoles%26aulast%3DShelar%26aufirst%3DSantosh%2BV.%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D27%26spage%3D6671%26epage%3D6677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hassan  Dianat-Moghadam</span>, <span class="hlFld-ContribAuthor ">Ladan  Teimoori-Toolabi</span>. </span><span class="cited-content_cbyCitation_article-title">Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Targets</span><span> <strong>2019,</strong> <em>20 </em>
                                    (8)
                                     , 852-870. <a href="https://doi.org/10.2174/1389450120666190112145409" title="DOI URL">https://doi.org/10.2174/1389450120666190112145409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389450120666190112145409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389450120666190112145409%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Targets%26atitle%3DImplications%252Bof%252BFibroblast%252BGrowth%252BFactors%252B%252528FGFs%252529%252Bin%252BCancer%25253A%252BFrom%252BPrognostic%252Bto%252BTherapeutic%252BApplications%26aulast%3DDianat-Moghadam%26aufirst%3DHassan%26date%3D2019%26volume%3D20%26issue%3D8%26spage%3D852%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abisola  Tepede</span>, <span class="hlFld-ContribAuthor ">Dinesh  Yogaratnam</span>. </span><span class="cited-content_cbyCitation_article-title">Nintedanib for Idiopathic Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy Practice</span><span> <strong>2019,</strong> <em>32 </em>
                                    (2)
                                     , 199-206. <a href="https://doi.org/10.1177/0897190017735242" title="DOI URL">https://doi.org/10.1177/0897190017735242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0897190017735242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0897190017735242%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520Practice%26atitle%3DNintedanib%252Bfor%252BIdiopathic%252BPulmonary%252BFibrosis%26aulast%3DTepede%26aufirst%3DAbisola%26date%3D2019%26date%3D2017%26volume%3D32%26issue%3D2%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Babita  Aneja</span>, <span class="hlFld-ContribAuthor ">Nashrah Sharif  Khan</span>, <span class="hlFld-ContribAuthor ">Parvez  Khan</span>, <span class="hlFld-ContribAuthor ">Aarfa  Queen</span>, <span class="hlFld-ContribAuthor ">Afzal  Hussain</span>, <span class="hlFld-ContribAuthor ">Md. Tabish  Rehman</span>, <span class="hlFld-ContribAuthor ">Mohamed F.  Alajmi</span>, <span class="hlFld-ContribAuthor ">Hesham R.  El-Seedi</span>, <span class="hlFld-ContribAuthor ">Sher  Ali</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>, <span class="hlFld-ContribAuthor ">Mohammad  Abid</span>. </span><span class="cited-content_cbyCitation_article-title">Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 840-852. <a href="https://doi.org/10.1016/j.ejmech.2018.12.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bdevelopment%252Bof%252BIsatin-triazole%252Bhydrazones%252Bas%252Bpotential%252Binhibitors%252Bof%252Bmicrotubule%252Baffinity-regulating%252Bkinase%252B4%252Bfor%252Bthe%252Btherapeutic%252Bmanagement%252Bof%252Bcell%252Bproliferation%252Band%252Bmetastasis%26aulast%3DAneja%26aufirst%3DBabita%26date%3D2019%26volume%3D163%26spage%3D840%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farideh  Badichi Akher</span>, <span class="hlFld-ContribAuthor ">Abdolkarim  Farrokhzadeh</span>, <span class="hlFld-ContribAuthor ">Fisayo A.  Olotu</span>, <span class="hlFld-ContribAuthor ">Clement  Agoni</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">The irony of chirality – unveiling the distinct mechanistic binding and activities of 1-(3-(4-amino-5-(7-methoxy-5-methylbenzo[
              b
              ]thiophen-2-yl)-7
              H
              -pyrrolo[2,3-
              d
              ]pyrimidin-7-yl)pyrrolidin-1-yl)prop-2-en-1-one enantiomers as irreversible covalent FGFR4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (5)
                                     , 1176-1190. <a href="https://doi.org/10.1039/C8OB02811G" title="DOI URL">https://doi.org/10.1039/C8OB02811G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02811G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02811G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Birony%252Bof%252Bchirality%252B%2525E2%252580%252593%252Bunveiling%252Bthe%252Bdistinct%252Bmechanistic%252Bbinding%252Band%252Bactivities%252Bof%252B1-%2525283-%2525284-amino-5-%2525287-methoxy-5-methylbenzo%25255B%252Bb%252B%25255Dthiophen-2-yl%252529-7%252BH%252B-pyrrolo%25255B2%25252C3-%252Bd%252B%25255Dpyrimidin-7-yl%252529pyrrolidin-1-yl%252529prop-2-en-1-one%252Benantiomers%252Bas%252Birreversible%252Bcovalent%252BFGFR4%252Binhibitors%26aulast%3DBadichi%2BAkher%26aufirst%3DFarideh%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D5%26spage%3D1176%26epage%3D1190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuliana  Pasciuto</span>, <span class="hlFld-ContribAuthor ">Riccardo  Inchingolo</span>, <span class="hlFld-ContribAuthor ">Carola  Condoluci</span>, <span class="hlFld-ContribAuthor ">Daniele  Magnini</span>, <span class="hlFld-ContribAuthor ">Bruno  Iovene</span>, <span class="hlFld-ContribAuthor ">Luca  Richeldi</span>. </span><span class="cited-content_cbyCitation_article-title">Approved and Experimental Therapies for Idiopathic Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Current Pulmonology Reports</span><span> <strong>2018,</strong> <em>7 </em>
                                    (4)
                                     , 107-117. <a href="https://doi.org/10.1007/s13665-018-0209-0" title="DOI URL">https://doi.org/10.1007/s13665-018-0209-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13665-018-0209-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13665-018-0209-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pulmonology%2520Reports%26atitle%3DApproved%252Band%252BExperimental%252BTherapies%252Bfor%252BIdiopathic%252BPulmonary%252BFibrosis%26aulast%3DPasciuto%26aufirst%3DGiuliana%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D4%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucas Milanez  Benicio</span>, <span class="hlFld-ContribAuthor ">Ane Stefano  Simionato</span>, <span class="hlFld-ContribAuthor ">Cláudio Roberto  Novello</span>, <span class="hlFld-ContribAuthor ">Jeconias Rocha  Guimarães</span>, <span class="hlFld-ContribAuthor ">Ingrid  Felicidade</span>, <span class="hlFld-ContribAuthor ">Admilton Gonçalves  de Oliveira</span>, <span class="hlFld-ContribAuthor ">João Carlos Palazzo  de Mello</span>, <span class="hlFld-ContribAuthor ">Mário Sérgio  Mantovani</span>, <span class="hlFld-ContribAuthor ">Andreas Lazaros  Chryssafidis</span>, <span class="hlFld-ContribAuthor ">Galdino  Andrade</span>, <span class="hlFld-ContribAuthor ">Ilce Mara  de Syllos Colus</span>, <span class="hlFld-ContribAuthor ">Marcelo Tempesta  de Oliveira</span>. </span><span class="cited-content_cbyCitation_article-title">RNAm expression profile of cancer marker genes in HepG2 cells treated with different concentrations of a new indolin-3-one from Pseudomonas aeruginosa. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-30893-w" title="DOI URL">https://doi.org/10.1038/s41598-018-30893-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-30893-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-30893-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DRNAm%252Bexpression%252Bprofile%252Bof%252Bcancer%252Bmarker%252Bgenes%252Bin%252BHepG2%252Bcells%252Btreated%252Bwith%252Bdifferent%252Bconcentrations%252Bof%252Ba%252Bnew%252Bindolin-3-one%252Bfrom%252BPseudomonas%252Baeruginosa%26aulast%3DBenicio%26aufirst%3DLucas%2BMilanez%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Guangying  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and bioactivity evaluation of antitumor sorafenib analogues. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (66)
                                     , 37643-37651. <a href="https://doi.org/10.1039/C8RA08246D" title="DOI URL">https://doi.org/10.1039/C8RA08246D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA08246D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA08246D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbioactivity%252Bevaluation%252Bof%252Bantitumor%252Bsorafenib%252Banalogues%26aulast%3DZhou%26aufirst%3DShiyang%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D66%26spage%3D37643%26epage%3D37651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Liu</span>, <span class="hlFld-ContribAuthor ">Tao  Shen</span>, <span class="hlFld-ContribAuthor ">Blaine H M  Mooers</span>, <span class="hlFld-ContribAuthor ">Frank  Hilberg</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Drug resistance profiles of mutations in the RET kinase domain. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2018,</strong> <em>175 </em>
                                    (17)
                                     , 3504-3515. <a href="https://doi.org/10.1111/bph.14395" title="DOI URL">https://doi.org/10.1111/bph.14395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14395%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DDrug%252Bresistance%252Bprofiles%252Bof%252Bmutations%252Bin%252Bthe%252BRET%252Bkinase%252Bdomain%26aulast%3DLiu%26aufirst%3DXuan%26date%3D2018%26date%3D2018%26volume%3D175%26issue%3D17%26spage%3D3504%26epage%3D3515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Grillo</span>, <span class="hlFld-ContribAuthor ">Tullio  Florio</span>, <span class="hlFld-ContribAuthor ">Francesco  Ferraù</span>, <span class="hlFld-ContribAuthor ">Elda  Kara</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Fanciulli</span>, <span class="hlFld-ContribAuthor ">Antongiulio  Faggiano</span>, <span class="hlFld-ContribAuthor ">Annamaria  Colao</span>, <span class="hlFld-ContribAuthor ">_  _</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms. </span><span class="cited-content_cbyCitation_journal-name">Endocrine-Related Cancer</span><span> <strong>2018,</strong> <em>25 </em>
                                    (9)
                                     , R453-R466. <a href="https://doi.org/10.1530/ERC-17-0531" title="DOI URL">https://doi.org/10.1530/ERC-17-0531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1530/ERC-17-0531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1530%2FERC-17-0531%26sid%3Dliteratum%253Aachs%26jtitle%3DEndocrine-Related%2520Cancer%26atitle%3DEmerging%252Bmultitarget%252Btyrosine%252Bkinase%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Bneuroendocrine%252Bneoplasms%26aulast%3DGrillo%26aufirst%3DFederica%26date%3D2018%26volume%3D25%26issue%3D9%26spage%3DR453%26epage%3DR466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshimasa  Itoh</span>, <span class="hlFld-ContribAuthor ">Nobuko  Yoshimoto</span>, <span class="hlFld-ContribAuthor ">Yoshinari  Hirano</span>, <span class="hlFld-ContribAuthor ">Keiko  Yamamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis for the selective inhibition of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) by a selenium-containing inhibitor with chloro-aminopyridine as a basic group. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (13)
                                     , 2256-2260. <a href="https://doi.org/10.1016/j.bmcl.2018.05.042" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252Bbasis%252Bfor%252Bthe%252Bselective%252Binhibition%252Bof%252Bactivated%252Bthrombin-activatable%252Bfibrinolysis%252Binhibitor%252B%252528TAFIa%252529%252Bby%252Ba%252Bselenium-containing%252Binhibitor%252Bwith%252Bchloro-aminopyridine%252Bas%252Ba%252Bbasic%252Bgroup%26aulast%3DItoh%26aufirst%3DToshimasa%26date%3D2018%26volume%3D28%26issue%3D13%26spage%3D2256%26epage%3D2260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geoffrey  Schwertz</span>, <span class="hlFld-ContribAuthor ">Matthias C.  Witschel</span>, <span class="hlFld-ContribAuthor ">Matthias  Rottmann</span>, <span class="hlFld-ContribAuthor ">Ubolsree  Leartsakulpanich</span>, <span class="hlFld-ContribAuthor ">Penchit  Chitnumsub</span>, <span class="hlFld-ContribAuthor ">Aritsara  Jaruwat</span>, <span class="hlFld-ContribAuthor ">Watcharee  Amornwatcharapong</span>, <span class="hlFld-ContribAuthor ">Wanwipa  Ittarat</span>, <span class="hlFld-ContribAuthor ">Anja  Schäfer</span>, <span class="hlFld-ContribAuthor ">Raphael A.  Aponte</span>, <span class="hlFld-ContribAuthor ">Nils  Trapp</span>, <span class="hlFld-ContribAuthor ">Pimchai  Chaiyen</span>, <span class="hlFld-ContribAuthor ">François  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Inhibitors of
              Plasmodial
              Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (9)
                                     , 931-943. <a href="https://doi.org/10.1002/cmdc.201800053" title="DOI URL">https://doi.org/10.1002/cmdc.201800053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800053%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPotent%252BInhibitors%252Bof%252BPlasmodial%252BSerine%252BHydroxymethyltransferase%252B%252528SHMT%252529%252BFeaturing%252Ba%252BSpirocyclic%252BScaffold%26aulast%3DSchwertz%26aufirst%3DGeoffrey%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D9%26spage%3D931%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young-Im  Kim</span>, <span class="hlFld-ContribAuthor ">Hyun-Woo  Shin</span>, <span class="hlFld-ContribAuthor ">Yang-Sook  Chun</span>, <span class="hlFld-ContribAuthor ">Chung-Hyun  Cho</span>, <span class="hlFld-ContribAuthor ">Jaemoon  Koh</span>, <span class="hlFld-ContribAuthor ">Doo Hyun  Chung</span>, <span class="hlFld-ContribAuthor ">Jong-Wan  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     <a href="https://doi.org/10.1038/s41419-018-0530-0" title="DOI URL">https://doi.org/10.1038/s41419-018-0530-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-018-0530-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-018-0530-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DEpithelial%252Bcell-derived%252Bcytokines%252BCST3%252Band%252BGDF15%252Bas%252Bpotential%252Btherapeutics%252Bfor%252Bpulmonary%252Bfibrosis%26aulast%3DKim%26aufirst%3DYoung-Im%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sohita  Dhillon</span>. </span><span class="cited-content_cbyCitation_article-title">Nintedanib in advanced NSCLC of adenocarcinoma histology: a profile of its use. </span><span class="cited-content_cbyCitation_journal-name">Drugs & Therapy Perspectives</span><span> <strong>2018,</strong> <em>34 </em>
                                    (4)
                                     , 157-164. <a href="https://doi.org/10.1007/s40267-018-0481-7" title="DOI URL">https://doi.org/10.1007/s40267-018-0481-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40267-018-0481-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40267-018-0481-7%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%2520%2526%2520Therapy%2520Perspectives%26atitle%3DNintedanib%252Bin%252Badvanced%252BNSCLC%252Bof%252Badenocarcinoma%252Bhistology%25253A%252Ba%252Bprofile%252Bof%252Bits%252Buse%26aulast%3DDhillon%26aufirst%3DSohita%26date%3D2018%26date%3D2018%26volume%3D34%26issue%3D4%26spage%3D157%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinpeng  Jiang</span>, <span class="hlFld-ContribAuthor ">Cong  Zheng</span>, <span class="hlFld-ContribAuthor ">Lijun  Lei</span>, <span class="hlFld-ContribAuthor ">Kai  Lin</span>, <span class="hlFld-ContribAuthor ">Chuanming  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-Oxindoles from Substituted Indoles by Hypervalent-Iodine Oxidation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (12)
                                     , 1437-1442. <a href="https://doi.org/10.1002/ejoc.201701807" title="DOI URL">https://doi.org/10.1002/ejoc.201701807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701807%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-Oxindoles%252Bfrom%252BSubstituted%252BIndoles%252Bby%252BHypervalent-Iodine%252BOxidation%26aulast%3DJiang%26aufirst%3DXinpeng%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D12%26spage%3D1437%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xi-fei  Jiang</span>, <span class="hlFld-ContribAuthor ">Yang  Dai</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Yan-yan  Shen</span>, <span class="hlFld-ContribAuthor ">Yi  Su</span>, <span class="hlFld-ContribAuthor ">Man-man  Wei</span>, <span class="hlFld-ContribAuthor ">Wei-ren  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen-bin  Ding</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying-hong  Shi</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>. </span><span class="cited-content_cbyCitation_article-title">SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2018,</strong> <em>39 </em>
                                    (2)
                                     , 243-250. <a href="https://doi.org/10.1038/aps.2017.96" title="DOI URL">https://doi.org/10.1038/aps.2017.96</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2017.96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2017.96%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DSOMCL-085%25252C%252Ba%252Bnovel%252Bmulti-targeted%252BFGFR%252Binhibitor%25252C%252Bdisplays%252Bpotent%252Banticancer%252Bactivity%252Bin%252BFGFR-addicted%252Bhuman%252Bcancer%252Bmodels%26aulast%3DJiang%26aufirst%3DXi-fei%26date%3D2018%26date%3D2017%26volume%3D39%26issue%3D2%26spage%3D243%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Varone</span>, <span class="hlFld-ContribAuthor ">Giacomo  Sgalla</span>, <span class="hlFld-ContribAuthor ">Bruno  Iovene</span>, <span class="hlFld-ContribAuthor ">Teresa  Bruni</span>, <span class="hlFld-ContribAuthor ">Luca  Richeldi</span>. </span><span class="cited-content_cbyCitation_article-title">Nintedanib for the treatment of idiopathic pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2018,</strong> <em>19 </em>
                                    (2)
                                     , 167-175. <a href="https://doi.org/10.1080/14656566.2018.1425681" title="DOI URL">https://doi.org/10.1080/14656566.2018.1425681</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2018.1425681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2018.1425681%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DNintedanib%252Bfor%252Bthe%252Btreatment%252Bof%252Bidiopathic%252Bpulmonary%252Bfibrosis%26aulast%3DVarone%26aufirst%3DFrancesco%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D2%26spage%3D167%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaokun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Discovery of FGF/FGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 339-383. <a href="https://doi.org/10.1016/B978-0-12-816142-5.00006-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-816142-5.00006-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816142-5.00006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816142-5.00006-0%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Band%252BDiscovery%252Bof%252BFGF%25252FFGFR%252BInhibitors%26aulast%3DLi%26aufirst%3DXiaokun%26date%3D2018%26spage%3D339%26epage%3D383%26pub%3DElsevier%26atitle%3DFibroblast%252BGrowth%252BFactors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumit  Kumar</span>, <span class="hlFld-ContribAuthor ">Liang  Gu</span>, <span class="hlFld-ContribAuthor ">Gabriella  Palma</span>, <span class="hlFld-ContribAuthor ">Mandeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Ashona  Singh-Pillay</span>, <span class="hlFld-ContribAuthor ">Parvesh  Singh</span>, <span class="hlFld-ContribAuthor ">Vipan  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, anti-proliferative evaluation and docking studies of 1
              H
              -1,2,3-triazole tethered ospemifene–isatin conjugates as selective estrogen receptor modulators. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (5)
                                     , 3703-3713. <a href="https://doi.org/10.1039/C7NJ04964A" title="DOI URL">https://doi.org/10.1039/C7NJ04964A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7NJ04964A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7NJ04964A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Banti-proliferative%252Bevaluation%252Band%252Bdocking%252Bstudies%252Bof%252B1%252BH%252B-1%25252C2%25252C3-triazole%252Btethered%252Bospemifene%2525E2%252580%252593isatin%252Bconjugates%252Bas%252Bselective%252Bestrogen%252Breceptor%252Bmodulators%26aulast%3DKumar%26aufirst%3DSumit%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D5%26spage%3D3703%26epage%3D3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongwu  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  Feng</span>, <span class="hlFld-ContribAuthor ">Taiping  Chen</span>, <span class="hlFld-ContribAuthor ">Zicheng  Li</span>, <span class="hlFld-ContribAuthor ">Wencai  Huang</span>, <span class="hlFld-ContribAuthor ">Youfu  Luo</span>, <span class="hlFld-ContribAuthor ">Yinglan  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">(E)-3-(Aryl(arylamino)Methylene)Indolin-2-One Derivatives: An Efficient Synthetic Approach and Evaluation of their Cancer Inhibitory Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2018,</strong> <em>42 </em>
                                    (1)
                                     , 44-49. <a href="https://doi.org/10.3184/174751918X15166485941737" title="DOI URL">https://doi.org/10.3184/174751918X15166485941737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3184/174751918X15166485941737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3184%2F174751918X15166485941737%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3D%252528E%252529-3-%252528Aryl%252528arylamino%252529Methylene%252529Indolin-2-One%252BDerivatives%25253A%252BAn%252BEfficient%252BSynthetic%252BApproach%252Band%252BEvaluation%252Bof%252Btheir%252BCancer%252BInhibitory%252BActivity%26aulast%3DJiang%26aufirst%3DHongwu%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D1%26spage%3D44%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagaraju  Kerru</span>, <span class="hlFld-ContribAuthor ">Parvesh  Singh</span>, <span class="hlFld-ContribAuthor ">Neil  Koorbanally</span>, <span class="hlFld-ContribAuthor ">Raghu  Raj</span>, <span class="hlFld-ContribAuthor ">Vipan  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances (2015–2016) in anticancer hybrids. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 179-212. <a href="https://doi.org/10.1016/j.ejmech.2017.07.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252B%2525282015%2525E2%252580%2525932016%252529%252Bin%252Banticancer%252Bhybrids%26aulast%3DKerru%26aufirst%3DNagaraju%26date%3D2017%26volume%3D142%26spage%3D179%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ekaterina V.  Zaryanova</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Ignatov</span>, <span class="hlFld-ContribAuthor ">Nataly A.  Lozynskaya</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and reactivity of new amide-substituted oxindole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (49)
                                     , 6887-6893. <a href="https://doi.org/10.1016/j.tet.2017.10.049" title="DOI URL">https://doi.org/10.1016/j.tet.2017.10.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.10.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.10.049%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Band%252Breactivity%252Bof%252Bnew%252Bamide-substituted%252Boxindole%252Bderivatives%26aulast%3DZaryanova%26aufirst%3DEkaterina%2BV.%26date%3D2017%26volume%3D73%26issue%3D49%26spage%3D6887%26epage%3D6893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satoshi  Okamori</span>, <span class="hlFld-ContribAuthor ">Takanori  Asakura</span>, <span class="hlFld-ContribAuthor ">Keita  Masuzawa</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Yasuda</span>, <span class="hlFld-ContribAuthor ">Hirofumi  Kamata</span>, <span class="hlFld-ContribAuthor ">Makoto  Ishii</span>, <span class="hlFld-ContribAuthor ">Tomoko  Betsuyaku</span>. </span><span class="cited-content_cbyCitation_article-title">Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Medicine</span><span> <strong>2017,</strong> <em>96 </em>
                                    (49)
                                     , e9081. <a href="https://doi.org/10.1097/MD.0000000000009081" title="DOI URL">https://doi.org/10.1097/MD.0000000000009081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MD.0000000000009081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMD.0000000000009081%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicine%26atitle%3DSuspected%252Baccelerated%252Bdisease%252Bprogression%252Bafter%252Bdiscontinuation%252Bof%252Bnintedanib%252Bin%252Bpatients%252Bwith%252Bidiopathic%252Bpulmonary%252Bfibrosis%26aulast%3DOkamori%26aufirst%3DSatoshi%26date%3D2017%26volume%3D96%26issue%3D49%26spage%3De9081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquel Frenedoso  da Silva</span>, <span class="hlFld-ContribAuthor ">Ellen  Nogueira-Pangrazi</span>, <span class="hlFld-ContribAuthor ">Larissa Akemi  Kido</span>, <span class="hlFld-ContribAuthor ">Fabio  Montico</span>, <span class="hlFld-ContribAuthor ">Sarah  Arana</span>, <span class="hlFld-ContribAuthor ">Dileep  Kumar</span>, <span class="hlFld-ContribAuthor ">Komal  Raina</span>, <span class="hlFld-ContribAuthor ">Rajesh  Agarwal</span>, <span class="hlFld-ContribAuthor ">Valéria Helena Alves  Cagnon</span>. </span><span class="cited-content_cbyCitation_article-title">Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP). </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomedical Science</span><span> <strong>2017,</strong> <em>24 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12929-017-0334-z" title="DOI URL">https://doi.org/10.1186/s12929-017-0334-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12929-017-0334-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12929-017-0334-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomedical%2520Science%26atitle%3DNintedanib%252Bantiangiogenic%252Binhibitor%252Beffectiveness%252Bin%252Bdelaying%252Badenocarcinoma%252Bprogression%252Bin%252BTransgenic%252BAdenocarcinoma%252Bof%252Bthe%252BMouse%252BProstate%252B%252528TRAMP%252529%26aulast%3Dda%2BSilva%26aufirst%3DRaquel%2BFrenedoso%26date%3D2017%26date%3D2017%26volume%3D24%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibrahim  Ismail</span>, <span class="hlFld-ContribAuthor ">Sonu  Nigam</span>, <span class="hlFld-ContribAuthor ">Alan  Parnham</span>, <span class="hlFld-ContribAuthor ">Vinay  Srinivasa</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medical Case Reports</span><span> <strong>2017,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13256-017-1384-2" title="DOI URL">https://doi.org/10.1186/s13256-017-1384-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13256-017-1384-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13256-017-1384-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medical%2520Case%2520Reports%26atitle%3DAnti-glomerular%252Bbasement%252Bmembrane%252Bglomerulonephritis%252Bfollowing%252Bnintedanib%252Bfor%252Bidiopathic%252Bpulmonary%252Bfibrosis%25253A%252Ba%252Bcase%252Breport%26aulast%3DIsmail%26aufirst%3DIbrahim%26date%3D2017%26date%3D2017%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Sun</span>, <span class="hlFld-ContribAuthor ">Simiao  Yu</span>, <span class="hlFld-ContribAuthor ">Juanjuan  Xia</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Haotian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Novel methyl indolinone-6-carboxylates containing an indole moiety as angiokinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 492-502. <a href="https://doi.org/10.1016/j.ejmech.2017.08.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bmethyl%252Bindolinone-6-carboxylates%252Bcontaining%252Ban%252Bindole%252Bmoiety%252Bas%252Bangiokinase%252Binhibitors%26aulast%3DQin%26aufirst%3DMingze%26date%3D2017%26volume%3D139%26spage%3D492%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panayiotis A.  Procopiou</span>, <span class="hlFld-ContribAuthor ">Tim N.  Barrett</span>, <span class="hlFld-ContribAuthor ">Royston C.B.  Copley</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Tame</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of the absolute configuration of two α v β 6 integrin inhibitors for the treatment of idiopathic pulmonary fibrosis and investigations on the asymmetric 1,4-addition of arylboronic acids to crotonate esters bearing a C4-oxygen substituent. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron: Asymmetry</span><span> <strong>2017,</strong> <em>28 </em>
                                    (10)
                                     , 1384-1393. <a href="https://doi.org/10.1016/j.tetasy.2017.08.017" title="DOI URL">https://doi.org/10.1016/j.tetasy.2017.08.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetasy.2017.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetasy.2017.08.017%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%253A%2520Asymmetry%26atitle%3DDetermination%252Bof%252Bthe%252Babsolute%252Bconfiguration%252Bof%252Btwo%252B%2525CE%2525B1%252Bv%252B%2525CE%2525B2%252B6%252Bintegrin%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bidiopathic%252Bpulmonary%252Bfibrosis%252Band%252Binvestigations%252Bon%252Bthe%252Basymmetric%252B1%25252C4-addition%252Bof%252Barylboronic%252Bacids%252Bto%252Bcrotonate%252Besters%252Bbearing%252Ba%252BC4-oxygen%252Bsubstituent%26aulast%3DProcopiou%26aufirst%3DPanayiotis%2BA.%26date%3D2017%26volume%3D28%26issue%3D10%26spage%3D1384%26epage%3D1393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miho J.  Fuse</span>, <span class="hlFld-ContribAuthor ">Koutaroh  Okada</span>, <span class="hlFld-ContribAuthor ">Tomoko  Oh-hara</span>, <span class="hlFld-ContribAuthor ">Hayato  Ogura</span>, <span class="hlFld-ContribAuthor ">Naoya  Fujita</span>, <span class="hlFld-ContribAuthor ">Ryohei  Katayama</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged Cancers. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2017,</strong> <em>16 </em>
                                    (10)
                                     , 2130-2143. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0909" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0909%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DMechanisms%252Bof%252BResistance%252Bto%252BNTRK%252BInhibitors%252Band%252BTherapeutic%252BStrategies%252Bin%252BNTRK1-Rearranged%252BCancers%26aulast%3DFuse%26aufirst%3DMiho%2BJ.%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D10%26spage%3D2130%26epage%3D2143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Manzo</span>, <span class="hlFld-ContribAuthor ">Agnese  Montanino</span>, <span class="hlFld-ContribAuthor ">Guido  Carillio</span>, <span class="hlFld-ContribAuthor ">Raffaele  Costanzo</span>, <span class="hlFld-ContribAuthor ">Claudia  Sandomenico</span>, <span class="hlFld-ContribAuthor ">Nicola  Normanno</span>, <span class="hlFld-ContribAuthor ">Maria  Piccirillo</span>, <span class="hlFld-ContribAuthor ">Gennaro  Daniele</span>, <span class="hlFld-ContribAuthor ">Francesco  Perrone</span>, <span class="hlFld-ContribAuthor ">Gaetano  Rocco</span>, <span class="hlFld-ContribAuthor ">Alessandro  Morabito</span>. </span><span class="cited-content_cbyCitation_article-title">Angiogenesis Inhibitors in NSCLC. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (10)
                                     , 2021. <a href="https://doi.org/10.3390/ijms18102021" title="DOI URL">https://doi.org/10.3390/ijms18102021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18102021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18102021%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DAngiogenesis%252BInhibitors%252Bin%252BNSCLC%26aulast%3DManzo%26aufirst%3DAnna%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D10%26spage%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueqiang  Li</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Guise</span>, <span class="hlFld-ContribAuthor ">Rana  Taghipouran</span>, <span class="hlFld-ContribAuthor ">Yuliana  Yosaatmadja</span>, <span class="hlFld-ContribAuthor ">Amir  Ashoorzadeh</span>, <span class="hlFld-ContribAuthor ">Woo-Kyong  Paik</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Squire</span>, <span class="hlFld-ContribAuthor ">Shuang  Jiang</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Zheng-Chao  Tu</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Ren</span>, <span class="hlFld-ContribAuthor ">Adam V.  Patterson</span>, <span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">2-Oxo-3, 4-dihydropyrimido[4, 5- d ]pyrimidinyl derivatives as new irreversible pan fibroblast growth factor receptor (FGFR) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>135 </em>, 531-543. <a href="https://doi.org/10.1016/j.ejmech.2017.04.049" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Oxo-3%25252C%252B4-dihydropyrimido%25255B4%25252C%252B5-%252Bd%252B%25255Dpyrimidinyl%252Bderivatives%252Bas%252Bnew%252Birreversible%252Bpan%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252B%252528FGFR%252529%252Binhibitors%26aulast%3DLi%26aufirst%3DXueqiang%26date%3D2017%26volume%3D135%26spage%3D531%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Axel  Kleemann</span>. </span><span class="cited-content_cbyCitation_article-title">Antineoplastic and Immunomodulating Agents (L). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-56. <a href="https://doi.org/10.1002/14356007.a05_001.pub3" title="DOI URL">https://doi.org/10.1002/14356007.a05_001.pub3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/14356007.a05_001.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F14356007.a05_001.pub3%26sid%3Dliteratum%253Aachs%26atitle%3DAntineoplastic%252Band%252BImmunomodulating%252BAgents%252B%252528L%252529%26aulast%3DKleemann%26aufirst%3DAxel%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D56%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DUllmann%252527s%252BEncyclopedia%252Bof%252BIndustrial%252BChemistry%26date%3D2000%26date%3D2000%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veerareddy  Arava</span>, <span class="hlFld-ContribAuthor ">Surendrareddy  Gogireddy</span>. </span><span class="cited-content_cbyCitation_article-title">An improved process for the synthesis of nintedanib esylate. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2017,</strong> <em>47 </em>
                                    (10)
                                     , 975-981. <a href="https://doi.org/10.1080/00397911.2017.1297459" title="DOI URL">https://doi.org/10.1080/00397911.2017.1297459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2017.1297459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2017.1297459%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DAn%252Bimproved%252Bprocess%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bnintedanib%252Besylate%26aulast%3DArava%26aufirst%3DVeerareddy%26date%3D2017%26date%3D2017%26volume%3D47%26issue%3D10%26spage%3D975%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramakrishna  Edupuganti</span>, <span class="hlFld-ContribAuthor ">Juliana M.  Taliaferro</span>, <span class="hlFld-ContribAuthor ">Qiantao  Wang</span>, <span class="hlFld-ContribAuthor ">Xuemei  Xie</span>, <span class="hlFld-ContribAuthor ">Eun Jeong  Cho</span>, <span class="hlFld-ContribAuthor ">Fnu  Vidhu</span>, <span class="hlFld-ContribAuthor ">Pengyu  Ren</span>, <span class="hlFld-ContribAuthor ">Eric V.  Anslyn</span>, <span class="hlFld-ContribAuthor ">Chandra  Bartholomeusz</span>, <span class="hlFld-ContribAuthor ">Kevin N.  Dalby</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (9)
                                     , 2609-2616. <a href="https://doi.org/10.1016/j.bmc.2017.03.018" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.03.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.03.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bpotent%252Binhibitor%252Bof%252BMELK%252Bthat%252Binhibits%252Bexpression%252Bof%252Bthe%252Banti-apoptotic%252Bprotein%252BMcl-1%252Band%252BTNBC%252Bcell%252Bgrowth%26aulast%3DEdupuganti%26aufirst%3DRamakrishna%26date%3D2017%26volume%3D25%26issue%3D9%26spage%3D2609%26epage%3D2616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Shuang  Yan</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Haotian  Zhang</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 6-methoxycarbonyl indolinones bearing a pyrrole Mannich base moiety as angiokinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (6)
                                     , 1778-1786. <a href="https://doi.org/10.1016/j.bmc.2017.01.039" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.01.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.01.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.01.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B6-methoxycarbonyl%252Bindolinones%252Bbearing%252Ba%252Bpyrrole%252BMannich%252Bbase%252Bmoiety%252Bas%252Bangiokinase%252Binhibitors%26aulast%3DQin%26aufirst%3DMingze%26date%3D2017%26volume%3D25%26issue%3D6%26spage%3D1778%26epage%3D1786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luis  Corrales</span>, <span class="hlFld-ContribAuthor ">Amanda  Nogueira</span>, <span class="hlFld-ContribAuthor ">Francesco  Passiglia</span>, <span class="hlFld-ContribAuthor ">Angela  Listi</span>, <span class="hlFld-ContribAuthor ">Christian  Caglevic</span>, <span class="hlFld-ContribAuthor ">Marco  Giallombardo</span>, <span class="hlFld-ContribAuthor ">Luis  Raez</span>, <span class="hlFld-ContribAuthor ">Edgardo  Santos</span>, <span class="hlFld-ContribAuthor ">Christian  Rolfo</span>. </span><span class="cited-content_cbyCitation_article-title">Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Medicine</span><span> <strong>2017,</strong> <em>4 </em><a href="https://doi.org/10.3389/fmed.2017.00013" title="DOI URL">https://doi.org/10.3389/fmed.2017.00013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmed.2017.00013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmed.2017.00013%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Medicine%26atitle%3DSecond-Line%252BTreatment%252Bof%252BNon-Small%252BCell%252BLung%252BCancer%25253A%252BClinical%25252C%252BPathological%25252C%252Band%252BMolecular%252BAspects%252Bof%252BNintedanib%26aulast%3DCorrales%26aufirst%3DLuis%26date%3D2017%26date%3D2017%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marjorie G.  Zauderer</span>. </span><span class="cited-content_cbyCitation_article-title">Standard Chemotherapy Options and Clinical Trials of Novel Agents for Mesothelioma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 313-345. <a href="https://doi.org/10.1007/978-3-319-53560-9_15" title="DOI URL">https://doi.org/10.1007/978-3-319-53560-9_15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-53560-9_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-53560-9_15%26sid%3Dliteratum%253Aachs%26atitle%3DStandard%252BChemotherapy%252BOptions%252Band%252BClinical%252BTrials%252Bof%252BNovel%252BAgents%252Bfor%252BMesothelioma%26aulast%3DZauderer%26aufirst%3DMarjorie%2BG.%26date%3D2017%26date%3D2017%26spage%3D313%26epage%3D345%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAsbestos%252Band%252BMesothelioma%26aulast%3DTesta%26aufirst%3DJoseph%2BR.%26date%3D2017%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amandeep  Singh</span>, <span class="hlFld-ContribAuthor ">Nisha  Nisha</span>, <span class="hlFld-ContribAuthor ">Trpta  Bains</span>, <span class="hlFld-ContribAuthor ">Hye Jee  Hahn</span>, <span class="hlFld-ContribAuthor ">Nicole  Liu</span>, <span class="hlFld-ContribAuthor ">Christina  Tam</span>, <span class="hlFld-ContribAuthor ">Luisa W.  Cheng</span>, <span class="hlFld-ContribAuthor ">Jong  Kim</span>, <span class="hlFld-ContribAuthor ">Anjan  Debnath</span>, <span class="hlFld-ContribAuthor ">Kirkwood M.  Land</span>, <span class="hlFld-ContribAuthor ">Vipan  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and preliminary antimicrobial evaluation of N-alkyl chain-tethered C-5 functionalized bis-isatins. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1982-1992. <a href="https://doi.org/10.1039/C7MD00434F" title="DOI URL">https://doi.org/10.1039/C7MD00434F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00434F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00434F%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bpreliminary%252Bantimicrobial%252Bevaluation%252Bof%252BN-alkyl%252Bchain-tethered%252BC-5%252Bfunctionalized%252Bbis-isatins%26aulast%3DSingh%26aufirst%3DAmandeep%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D10%26spage%3D1982%26epage%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luyi  Zhu</span>, <span class="hlFld-ContribAuthor ">Peipei  Yan</span>, <span class="hlFld-ContribAuthor ">Lvye  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhangtao  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Zeng</span>, <span class="hlFld-ContribAuthor ">Guofu  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">TiCl
              4
              /DMAP mediated Z-selective knovenagel condensation of isatins with nitroacetates and related compounds. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (81)
                                     , 51352-51358. <a href="https://doi.org/10.1039/C7RA09951G" title="DOI URL">https://doi.org/10.1039/C7RA09951G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA09951G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA09951G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DTiCl%252B4%252B%25252FDMAP%252Bmediated%252BZ-selective%252Bknovenagel%252Bcondensation%252Bof%252Bisatins%252Bwith%252Bnitroacetates%252Band%252Brelated%252Bcompounds%26aulast%3DZhu%26aufirst%3DLuyi%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D81%26spage%3D51352%26epage%3D51358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Manzo</span>, <span class="hlFld-ContribAuthor ">Guido  Carillio</span>, <span class="hlFld-ContribAuthor ">Agnese  Montanino</span>, <span class="hlFld-ContribAuthor ">Raffaele  Costanzo</span>, <span class="hlFld-ContribAuthor ">Claudia  Sandomenico</span>, <span class="hlFld-ContribAuthor ">Gaetano  Rocco</span>, <span class="hlFld-ContribAuthor ">Alessandro  Morabito</span>. </span><span class="cited-content_cbyCitation_article-title">Focus on Nintedanib in NSCLC and Other Tumors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Medicine</span><span> <strong>2016,</strong> <em>3 </em><a href="https://doi.org/10.3389/fmed.2016.00068" title="DOI URL">https://doi.org/10.3389/fmed.2016.00068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmed.2016.00068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmed.2016.00068%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Medicine%26atitle%3DFocus%252Bon%252BNintedanib%252Bin%252BNSCLC%252Band%252BOther%252BTumors%26aulast%3DManzo%26aufirst%3DAnna%26date%3D2016%26date%3D2016%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gerald J.  Roth</span>, <span class="hlFld-ContribAuthor ">Rudolf  Binder</span>, <span class="hlFld-ContribAuthor ">Florian  Colbatzky</span>, <span class="hlFld-ContribAuthor ">Claudia  Dallinger</span>, <span class="hlFld-ContribAuthor ">Rozsa  Schlenker-Herceg</span>, <span class="hlFld-ContribAuthor ">Frank  Hilberg</span>, <span class="hlFld-ContribAuthor ">Lutz  Wollin</span>, <span class="hlFld-ContribAuthor ">John  Park</span>, <span class="hlFld-ContribAuthor ">Alexander  Pautsch</span>, <span class="hlFld-ContribAuthor ">Rolf  Kaiser</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Nintedanib: A Novel Antiangiogenic and Antifibrotic Agent. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 235-266. <a href="https://doi.org/10.1002/9783527800315.ch11" title="DOI URL">https://doi.org/10.1002/9783527800315.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527800315.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527800315.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BNintedanib%25253A%252BA%252BNovel%252BAntiangiogenic%252Band%252BAntifibrotic%252BAgent%26aulast%3DRoth%26aufirst%3DGerald%2BJ.%26date%3D2016%26date%3D2016%26spage%3D235%26epage%3D266%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2016%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuang  Song</span>, <span class="hlFld-ContribAuthor ">Cai-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoan  Wen</span>, <span class="hlFld-ContribAuthor ">Hongbin  Sun</span>, <span class="hlFld-ContribAuthor ">Haoliang  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of (2E)-(2-oxo-1, 2-dihydro-3 H -indol-3-ylidene)acetate derivatives as anti-proliferative agents through ROS-induced cell apoptosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 809-819. <a href="https://doi.org/10.1016/j.ejmech.2016.09.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B%2525282E%252529-%2525282-oxo-1%25252C%252B2-dihydro-3%252BH%252B-indol-3-ylidene%252529acetate%252Bderivatives%252Bas%252Banti-proliferative%252Bagents%252Bthrough%252BROS-induced%252Bcell%252Bapoptosis%26aulast%3DSong%26aufirst%3DZhuang%26date%3D2016%26volume%3D124%26spage%3D809%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vasileios S.  Skouras</span>, <span class="hlFld-ContribAuthor ">Charis  Maragkos</span>, <span class="hlFld-ContribAuthor ">Dimitra  Grapsa</span>, <span class="hlFld-ContribAuthor ">Konstantinos N.  Syrigos</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">BioDrugs</span><span> <strong>2016,</strong> <em>30 </em>
                                    (5)
                                     , 421-439. <a href="https://doi.org/10.1007/s40259-016-0194-1" title="DOI URL">https://doi.org/10.1007/s40259-016-0194-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40259-016-0194-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40259-016-0194-1%26sid%3Dliteratum%253Aachs%26jtitle%3DBioDrugs%26atitle%3DTargeting%252BNeovasculature%252Bwith%252BMultitargeted%252BAntiangiogenesis%252BTyrosine%252BKinase%252BInhibitors%252Bin%252BNon-small%252BCell%252BLung%252BCancer%26aulast%3DSkouras%26aufirst%3DVasileios%2BS.%26date%3D2016%26date%3D2016%26volume%3D30%26issue%3D5%26spage%3D421%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Slobbe</span>, <span class="hlFld-ContribAuthor ">Alex J.  Poot</span>, <span class="hlFld-ContribAuthor ">Rianne  Haumann</span>, <span class="hlFld-ContribAuthor ">Robert C.  Schuit</span>, <span class="hlFld-ContribAuthor ">Albert D.  Windhorst</span>, <span class="hlFld-ContribAuthor ">Guus A.M.S.  van Dongen</span>. </span><span class="cited-content_cbyCitation_article-title">Two anti-angiogenic TKI-PET tracers, [ 11 C]axitinib and [ 11 C]nintedanib: Radiosynthesis, in vivo metabolism and initial biodistribution studies in rodents. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2016,</strong> <em>43 </em>
                                    (10)
                                     , 612-624. <a href="https://doi.org/10.1016/j.nucmedbio.2016.07.003" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2016.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2016.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2016.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DTwo%252Banti-angiogenic%252BTKI-PET%252Btracers%25252C%252B%25255B%252B11%252BC%25255Daxitinib%252Band%252B%25255B%252B11%252BC%25255Dnintedanib%25253A%252BRadiosynthesis%25252C%252Bin%252Bvivo%252Bmetabolism%252Band%252Binitial%252Bbiodistribution%252Bstudies%252Bin%252Brodents%26aulast%3DSlobbe%26aufirst%3DPaul%26date%3D2016%26volume%3D43%26issue%3D10%26spage%3D612%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew C.  Flick</span>, <span class="hlFld-ContribAuthor ">Hong X.  Ding</span>, <span class="hlFld-ContribAuthor ">Carolyn A.  Leverett</span>, <span class="hlFld-ContribAuthor ">Robert E.  Kyne</span>, <span class="hlFld-ContribAuthor ">Kevin K.-C.  Liu</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Fink</span>, <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approaches to the 2014 new drugs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (9)
                                     , 1937-1980. <a href="https://doi.org/10.1016/j.bmc.2016.03.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bapproaches%252Bto%252Bthe%252B2014%252Bnew%252Bdrugs%26aulast%3DFlick%26aufirst%3DAndrew%2BC.%26date%3D2016%26volume%3D24%26issue%3D9%26spage%3D1937%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Pisarsky</span>, <span class="hlFld-ContribAuthor ">Ruben  Bill</span>, <span class="hlFld-ContribAuthor ">Ernesta  Fagiani</span>, <span class="hlFld-ContribAuthor ">Sarah  Dimeloe</span>, <span class="hlFld-ContribAuthor ">Ryan William  Goosen</span>, <span class="hlFld-ContribAuthor ">Jörg  Hagmann</span>, <span class="hlFld-ContribAuthor ">Christoph  Hess</span>, <span class="hlFld-ContribAuthor ">Gerhard  Christofori</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2016,</strong> <em>15 </em>
                                    (6)
                                     , 1161-1174. <a href="https://doi.org/10.1016/j.celrep.2016.04.028" title="DOI URL">https://doi.org/10.1016/j.celrep.2016.04.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2016.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2016.04.028%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DTargeting%252BMetabolic%252BSymbiosis%252Bto%252BOvercome%252BResistance%252Bto%252BAnti-angiogenic%252BTherapy%26aulast%3DPisarsky%26aufirst%3DLaura%26date%3D2016%26volume%3D15%26issue%3D6%26spage%3D1161%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liesbeth  Lemmens</span>. </span><span class="cited-content_cbyCitation_article-title">Nintedanib in advanced NSCLC: management of adverse events. </span><span class="cited-content_cbyCitation_journal-name">Lung Cancer Management</span><span> <strong>2016,</strong> <em>5 </em>
                                    (1)
                                     , 29-41. <a href="https://doi.org/10.2217/lmt.15.33" title="DOI URL">https://doi.org/10.2217/lmt.15.33</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/lmt.15.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Flmt.15.33%26sid%3Dliteratum%253Aachs%26jtitle%3DLung%2520Cancer%2520Management%26atitle%3DNintedanib%252Bin%252Badvanced%252BNSCLC%25253A%252Bmanagement%252Bof%252Badverse%252Bevents%26aulast%3DLemmens%26aufirst%3DLiesbeth%26date%3D2016%26volume%3D5%26issue%3D1%26spage%3D29%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gustav  Steinemann</span>, <span class="hlFld-ContribAuthor ">Christine  Jacobsen</span>, <span class="hlFld-ContribAuthor ">Mirjam  Gerwing</span>, <span class="hlFld-ContribAuthor ">Jessica  Hauschild</span>, <span class="hlFld-ContribAuthor ">Gunhild  von Amsberg</span>, <span class="hlFld-ContribAuthor ">Michael  Höpfner</span>, <span class="hlFld-ContribAuthor ">Bianca  Nitzsche</span>, <span class="hlFld-ContribAuthor ">Friedemann  Honecker</span>. </span><span class="cited-content_cbyCitation_article-title">Activity of nintedanib in germ cell tumors. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Drugs</span><span> <strong>2016,</strong> <em>27 </em>
                                    (2)
                                     , 89-98. <a href="https://doi.org/10.1097/CAD.0000000000000305" title="DOI URL">https://doi.org/10.1097/CAD.0000000000000305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/CAD.0000000000000305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCAD.0000000000000305%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Drugs%26atitle%3DActivity%252Bof%252Bnintedanib%252Bin%252Bgerm%252Bcell%252Btumors%26aulast%3DSteinemann%26aufirst%3DGustav%26date%3D2016%26volume%3D27%26issue%3D2%26spage%3D89%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cong-Min  Kang</span>, <span class="hlFld-ContribAuthor ">Dong-Qing  Liu</span>, <span class="hlFld-ContribAuthor ">Xu-Hao  Zhao</span>, <span class="hlFld-ContribAuthor ">Ying-Jie  Dai</span>, <span class="hlFld-ContribAuthor ">Jia-Gao  Cheng</span>, <span class="hlFld-ContribAuthor ">Ying-Tao  Lv</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR and molecular docking studies on oxindole derivatives as VEGFR-2 tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2016,</strong> <em>36 </em>
                                    (1)
                                     , 103-109. <a href="https://doi.org/10.3109/10799893.2015.1049364" title="DOI URL">https://doi.org/10.3109/10799893.2015.1049364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/10799893.2015.1049364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F10799893.2015.1049364%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DQSAR%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bon%252Boxindole%252Bderivatives%252Bas%252BVEGFR-2%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DKang%26aufirst%3DCong-Min%26date%3D2016%26date%3D2015%26volume%3D36%26issue%3D1%26spage%3D103%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beatrix  Wulkersdorfer</span>, <span class="hlFld-ContribAuthor ">Markus  Zeitlinger</span>, <span class="hlFld-ContribAuthor ">Monika  Schmid</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic Aspects of Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2016,</strong> <em>55 </em>
                                    (1)
                                     , 47-77. <a href="https://doi.org/10.1007/s40262-015-0302-2" title="DOI URL">https://doi.org/10.1007/s40262-015-0302-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-015-0302-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-015-0302-2%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DPharmacokinetic%252BAspects%252Bof%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DWulkersdorfer%26aufirst%3DBeatrix%26date%3D2016%26date%3D2015%26volume%3D55%26issue%3D1%26spage%3D47%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niall A.  Anderson</span>, <span class="hlFld-ContribAuthor ">Ian B.  Campbell</span>, <span class="hlFld-ContribAuthor ">Brendan J.  Fallon</span>, <span class="hlFld-ContribAuthor ">Sean M.  Lynn</span>, <span class="hlFld-ContribAuthor ">Simon J. F.  Macdonald</span>, <span class="hlFld-ContribAuthor ">John M.  Pritchard</span>, <span class="hlFld-ContribAuthor ">Panayiotis A.  Procopiou</span>, <span class="hlFld-ContribAuthor ">Steven L.  Sollis</span>, <span class="hlFld-ContribAuthor ">Lee R.  Thorp</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and determination of absolute configuration of a non-peptidic α
              v
              β
              6
              integrin antagonist for the treatment of idiopathic pulmonary fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (25)
                                     , 5992-6009. <a href="https://doi.org/10.1039/C6OB00496B" title="DOI URL">https://doi.org/10.1039/C6OB00496B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00496B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00496B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Band%252Bdetermination%252Bof%252Babsolute%252Bconfiguration%252Bof%252Ba%252Bnon-peptidic%252B%2525CE%2525B1%252Bv%252B%2525CE%2525B2%252B6%252Bintegrin%252Bantagonist%252Bfor%252Bthe%252Btreatment%252Bof%252Bidiopathic%252Bpulmonary%252Bfibrosis%26aulast%3DAnderson%26aufirst%3DNiall%2BA.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D25%26spage%3D5992%26epage%3D6009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nivesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Santanu  Ghosh</span>, <span class="hlFld-ContribAuthor ">Subhajit  Bhunia</span>, <span class="hlFld-ContribAuthor ">Alakesh  Bisai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-oxindoles via 'transition-metal-free' intramolecular dehydrogenative coupling (IDC) of sp
              2
              C–H and sp
              3
              C–H bonds. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>12 </em>, 1153-1169. <a href="https://doi.org/10.3762/bjoc.12.111" title="DOI URL">https://doi.org/10.3762/bjoc.12.111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.12.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.12.111%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-oxindoles%252Bvia%252B%252527transition-metal-free%252527%252Bintramolecular%252Bdehydrogenative%252Bcoupling%252B%252528IDC%252529%252Bof%252Bsp%252B2%252BC%2525E2%252580%252593H%252Band%252Bsp%252B3%252BC%2525E2%252580%252593H%252Bbonds%26aulast%3DKumar%26aufirst%3DNivesh%26date%3D2016%26date%3D2016%26volume%3D12%26spage%3D1153%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruben  Bill</span>, <span class="hlFld-ContribAuthor ">Ernesta  Fagiani</span>, <span class="hlFld-ContribAuthor ">Adrian  Zumsteg</span>, <span class="hlFld-ContribAuthor ">Helena  Antoniadis</span>, <span class="hlFld-ContribAuthor ">David  Johansson</span>, <span class="hlFld-ContribAuthor ">Simon  Haefliger</span>, <span class="hlFld-ContribAuthor ">Imke  Albrecht</span>, <span class="hlFld-ContribAuthor ">Frank  Hilberg</span>, <span class="hlFld-ContribAuthor ">Gerhard  Christofori</span>. </span><span class="cited-content_cbyCitation_article-title">Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2015,</strong> <em>21 </em>
                                    (21)
                                     , 4856-4867. <a href="https://doi.org/10.1158/1078-0432.CCR-14-3036" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-14-3036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-14-3036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-14-3036%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DNintedanib%252BIs%252Ba%252BHighly%252BEffective%252BTherapeutic%252Bfor%252BNeuroendocrine%252BCarcinoma%252Bof%252Bthe%252BPancreas%252B%252528PNET%252529%252Bin%252Bthe%252BRip1Tag2%252BTransgenic%252BMouse%252BModel%26aulast%3DBill%26aufirst%3DRuben%26date%3D2015%26date%3D2015%26volume%3D21%26issue%3D21%26spage%3D4856%26epage%3D4867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruixue  Xu</span>, <span class="hlFld-ContribAuthor ">Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Lingling  Peng</span>, <span class="hlFld-ContribAuthor ">Xuehai  Pang</span>, <span class="hlFld-ContribAuthor ">Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongxia  Jiang</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of deuterated nintedanib for improving pharmacokinetic properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2015,</strong> <em>58 </em>
                                    (7)
                                     , 308-312. <a href="https://doi.org/10.1002/jlcr.3299" title="DOI URL">https://doi.org/10.1002/jlcr.3299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3299%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bdeuterated%252Bnintedanib%252Bfor%252Bimproving%252Bpharmacokinetic%252Bproperties%26aulast%3DXu%26aufirst%3DRuixue%26date%3D2015%26date%3D2015%26volume%3D58%26issue%3D7%26spage%3D308%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sohita  Dhillon</span>. </span><span class="cited-content_cbyCitation_article-title">Nintedanib: A Review of Its Use as Second-Line Treatment in Adults with Advanced Non-Small Cell Lung Cancer of Adenocarcinoma Histology. </span><span class="cited-content_cbyCitation_journal-name">Targeted Oncology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (2)
                                     , 303-310. <a href="https://doi.org/10.1007/s11523-015-0367-8" title="DOI URL">https://doi.org/10.1007/s11523-015-0367-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11523-015-0367-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11523-015-0367-8%26sid%3Dliteratum%253Aachs%26jtitle%3DTargeted%2520Oncology%26atitle%3DNintedanib%25253A%252BA%252BReview%252Bof%252BIts%252BUse%252Bas%252BSecond-Line%252BTreatment%252Bin%252BAdults%252Bwith%252BAdvanced%252BNon-Small%252BCell%252BLung%252BCancer%252Bof%252BAdenocarcinoma%252BHistology%26aulast%3DDhillon%26aufirst%3DSohita%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D2%26spage%3D303%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Reck</span>. </span><span class="cited-content_cbyCitation_article-title">Nintedanib: examining the development and mechanism of action of a novel triple angiokinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2015,</strong> <em>15 </em>
                                    (5)
                                     , 579-594. <a href="https://doi.org/10.1586/14737140.2015.1031218" title="DOI URL">https://doi.org/10.1586/14737140.2015.1031218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/14737140.2015.1031218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F14737140.2015.1031218%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DNintedanib%25253A%252Bexamining%252Bthe%252Bdevelopment%252Band%252Bmechanism%252Bof%252Baction%252Bof%252Ba%252Bnovel%252Btriple%252Bangiokinase%252Binhibitor%26aulast%3DReck%26aufirst%3DMartin%26date%3D2015%26date%3D2015%26volume%3D15%26issue%3D5%26spage%3D579%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zijian  Liu</span>, <span class="hlFld-ContribAuthor ">Yunlei  Hou</span>, <span class="hlFld-ContribAuthor ">Guogang  Zhang</span>, <span class="hlFld-ContribAuthor ">Ning  Xu</span>, <span class="hlFld-ContribAuthor ">Bin  Mi</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antitumor activity of novel indolin-2-one derivatives containing 4-thiazolidinone moiety. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Chinese Universities</span><span> <strong>2015,</strong> <em>31 </em>
                                    (2)
                                     , 235-243. <a href="https://doi.org/10.1007/s40242-015-4335-8" title="DOI URL">https://doi.org/10.1007/s40242-015-4335-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40242-015-4335-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40242-015-4335-8%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Chinese%2520Universities%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantitumor%252Bactivity%252Bof%252Bnovel%252Bindolin-2-one%252Bderivatives%252Bcontaining%252B4-thiazolidinone%252Bmoiety%26aulast%3DLiu%26aufirst%3DZijian%26date%3D2015%26date%3D2015%26volume%3D31%26issue%3D2%26spage%3D235%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuhui  Huang</span>, <span class="hlFld-ContribAuthor ">David P.  Carbone</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of and strategies for overcoming resistance to anti-vascular endothelial growth factor therapy in non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2015,</strong> <em>1855 </em>
                                    (2)
                                     , 193-201. <a href="https://doi.org/10.1016/j.bbcan.2015.01.003" title="DOI URL">https://doi.org/10.1016/j.bbcan.2015.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2015.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2015.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DMechanisms%252Bof%252Band%252Bstrategies%252Bfor%252Bovercoming%252Bresistance%252Bto%252Banti-vascular%252Bendothelial%252Bgrowth%252Bfactor%252Btherapy%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DHuang%26aufirst%3DYuhui%26date%3D2015%26volume%3D1855%26issue%3D2%26spage%3D193%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Enzyme Inhibitor, Part I, Tyrosine Kinases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 117-160. <a href="https://doi.org/10.1002/9781118892572.ch8" title="DOI URL">https://doi.org/10.1002/9781118892572.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118892572.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118892572.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DEnzyme%252BInhibitor%25252C%252BPart%252BI%25252C%252BTyrosine%252BKinases%26date%3D2015%26date%3D2015%26spage%3D117%26epage%3D160%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DAntineoplastic%252BDrugs%26aulast%3DLednicer%26aufirst%3DDaniel%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm900431g&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm900431g%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-14&amp;citedByCount=149&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. VEGFR-2 Hit Compound <b>1</b> and Clinical Candidates <b>2</b> (BIBF 1000) and <b>3</b> (BIBF 1120)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 6-Substituted Indolinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NH<sub>4</sub>NO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, −5 °C; (b) H<sub>2</sub>, Pd/C, AcOH, rt; (c) methyl chloroacetate, KO<i>t</i>Bu, DMF, −10 °C, then <b>6</b>, −2 °C; (d) <i>tert</i>-butyl chloroacetate, KO<i>t</i>Bu, DMF, then <b>8</b>, −10 °C; (e) H<sub>2</sub>, Ra−Ni, MeOH, rt; (f) 1 N HCl, MeOH, reflux; (g) dimethyl malonate, KO<i>t</i>Bu, DMSO, rt, then <b>10</b>, 100 °C; (h) LiCl, DMSO, H<sub>2</sub>O, 100 °C; (i) H<sub>2</sub>, Lindlar catalyst, MeOH, rt.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Aniline or Cycloalkylamine Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>N</i>-Methylpiperazine or imidazole or dimethylamine·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, then <b>64</b> or <b>68</b>, rt; (b) H<sub>2</sub>, Pd/C, MeOH, rt; (c) Ac<sub>2</sub>O, 140 °C; (d) 2-chloro-<i>N</i>,<i>N</i>-dimethylethylamine·HCl, K<sub>2</sub>CO<sub>3</sub>, NaI, acetone, 50 °C; (e) MeI, KO<i>t</i>Bu, DMSO, rt; (f) <i>N</i>,<i>N</i>,<i>N</i>′-trimethylpropane-1,3-diamine, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, then <b>79</b> or <b>80</b>, rt; (g) chloroacetyl chloride, NEt<sub>3</sub>, THF, rt; (h) dimethylamine·HCl, K<sub>2</sub>CO<sub>3</sub>, acetone, rt; (i) trifluoroacetic acid, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Final Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Ac<sub>2</sub>O, 130 °C; (b) (EtO)<sub>3</sub>CPh, Ac<sub>2</sub>O, 130 °C; (c) (EtO)<sub>3</sub>CPh, Ac<sub>2</sub>O, 120 °C; (d) R<sup>3</sup>NH<sub>2</sub>, DMF, 80-100 °C, then piperidine, rt.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Specific 6-Substituted Indolinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 1 N NaOH, EtOH, 80 °C; (b) R<sup>4</sup>NH<sub>2</sub>, TBTU, HOBT, NEt<sub>3</sub>, or EtN(iPr)<sub>2</sub>, DMF, rt; (c) CDI, DMF, 80 °C, then MeOH, 50 °C; (d) H<sub>2</sub>, Ra−Ni, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, rt; (e) AcCl, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (f) 2,5-dimethoxy tetrahydrofuran, AcOH, 100 °C.</p></p></figure><figure data-id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Proposed binding mode of <b>1</b> in VEGFR-2. (A) The hydrogen bonds to the hinge region residues and the proposed additional hydrogen bond of the amide moiety at the indolinone scaffold to Lys<sup>868</sup> are shown. The gatekeeper Val<sup>916</sup> and Phe<sup>1047</sup> from the DFG motif are additionally highlighted. (B) Zoom into the hydrophobic kinase selectivity pocket of the ATP pocket that binds to the back part of the indolinone scaffold and the amide substituent. The coloring of the Connolly surface is shown as follows: hydrophobic (brown), hydrophilic (blue), in between (white).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/medium/jm-2009-00431g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2.  Compound <b>2</b> inhibits human tumor xenograft growth in a model of human head and neck SCC (FaDu). Effect of <b>2</b> (◼ 100 mg/kg qd, ▲ 2 × 50 mg/kg bid, and ◆ 50 mg/kg qd) or vehicle (○) on growth of tumor xenografts. Xenografts were established sc in athymic NMRI-nu/nu female mice and allowed to reach a volume of ∼50 mm<sup>3</sup> before treatment. Once or twice daily, oral administration of compound <b>2</b> or vehicle then commenced and was continued for the duration of the experiment. Data points represent the mean of five mice, bars represent the SD. The compound was administered in 0.5% (w/v) hydroxypropyl methylcellulose solution.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-14/jm900431g/production/images/large/jm-2009-00431g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900431g&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i107">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">Tumor angiogenesis: therapeutic implications</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1182</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1056%2FNEJM197111182852108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=4938153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1971&pages=1182-1186&author=J.+Folkman&title=Tumor+angiogenesis%3A+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor angiogenesis: therapeutic implications</span></div><div class="casAuthors">Folkman J</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1182-6</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRA0C6odtE1LPxQvRxYU81tfW6udTcc2eZq44rDlDLDOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE38%252FgvVCqsQ%253D%253D&md5=efdddcba0c04be542edd51fef2ef27b9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1056%2FNEJM197111182852108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM197111182852108%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DTumor%2520angiogenesis%253A%2520therapeutic%2520implications%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1971%26volume%3D285%26spage%3D1182%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillan, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span> </span><span class="NLM_article-title">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1038%2Fnrd1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=15136787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=391-400&author=N.+Ferraraauthor=K.+J.+Hillanauthor=H.-P.+Gerberauthor=W.+Novotny&title=Discovery+and+development+of+bevacizumab%2C+an+anti-VEGF+antibody+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span></div><div class="casAuthors">Ferrara, Napoleone; Hillan, Kenneth J.; Gerber, Hans-Peter; Novotny, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The existence of factors that stimulate blood vessel growth, thereby recruiting a neovascular supply to nourish a growing tumor, was postulated many decades ago, although the identification and isolation of these factors proved elusive.  Now, vascular endothelial growth factor (VEGF), which was identified in the 1980s, is recognized as an essential regulator of normal and abnormal blood vessel growth.  In 1993, it was shown that a monoclonal antibody that targeted VEGF results in a dramatic suppression of tumor growth in vivo, which led to the development of bevacizumab (Avastin; Genentech), a humanized variant of this anti-VEGF antibody, as an anticancer agent.  The recent approval of bevacizumab by the US FDA as a first-line therapy for metastatic colorectal cancer validates the ideas that VEGF is a key mediator of tumor angiogenesis and that blocking angiogenesis is an effective strategy to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphaLbfhdBKOLVg90H21EOLACvtfcHk0lgAitTPOdkbuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D&md5=4b1f647db4dfe2a24449cdf59b874e7c</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1381%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DHillan%26aufirst%3DK.%2BJ.%26aulast%3DGerber%26aufirst%3DH.-P.%26aulast%3DNovotny%26aufirst%3DW.%26atitle%3DDiscovery%2520and%2520development%2520of%2520bevacizumab%252C%2520an%2520anti-VEGF%2520antibody%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug.%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Panares, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. A.</span><span> </span><span class="NLM_article-title">Bevacizumab in the management of solid tumors</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1586%2F14737140.7.4.433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=17428164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1Wqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=433-445&author=R.+L.+Panaresauthor=A.+A.+Garcia&title=Bevacizumab+in+the+management+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab in the management of solid tumors</span></div><div class="casAuthors">Panares, Roy L.; Garcia, Agustin A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">433-445</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is defined as the formation of new blood vessels from a pre-existing vascular bed.  By supplying nutrients and oxygen and removing waste products in malignant tumors, it is an essential process that regulates cancer growth and dissemination.  This process is regulated by both pro- and antiangiogenic compds.  Vascular endothelial growth factor is one of the most important and best-studied proangiogenic factors.  Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has been shown to inhibit angiogenesis and is proving to be of clin. benefit in a variety of tumor types.  The strongest evidence comes from studies in advanced colorectal and non-small-cell lung cancer, with growing evidence in breast and epithelial ovarian tumors.  The duration and timing of bevacizumab's use is currently the focus of several ongoing clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3gqfS8ed2N7Vg90H21EOLACvtfcHk0liMf97ix3ubcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1Wqs74%253D&md5=27084acb248645b4ff4c7b4fd4b70aab</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1586%2F14737140.7.4.433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.7.4.433%26sid%3Dliteratum%253Aachs%26aulast%3DPanares%26aufirst%3DR.%2BL.%26aulast%3DGarcia%26aufirst%3DA.%2BA.%26atitle%3DBevacizumab%2520in%2520the%2520management%2520of%2520solid%2520tumors%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2007%26volume%3D7%26spage%3D433%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lowinger, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span> </span><span class="NLM_article-title">Design and discovery of small molecules targeting Raf-1 kinase</span> <span class="citation_source-journal">Curr. Pharm. Des</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.2174%2F1381612023393125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=12369855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVGntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2269-2278&author=T.+B.+Lowingerauthor=B.+Riedlauthor=J.+Dumasauthor=R.+A.+Smith&title=Design+and+discovery+of+small+molecules+targeting+Raf-1+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of small molecules targeting raf-1 kinase</span></div><div class="casAuthors">Lowinger, Timothy B.; Riedl, Bernd; Dumas, Jacques; Smith, Roger A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2269-2278</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Raf kinase, an enzyme which acts downstream in the Ras signaling pathway, is involved in cancerous cell proliferation.  Thus, small mol. inhibitors of Raf kinase activity may be important agents for the treatment of cancer.  A novel class of Raf-1 inhibitors was discovered, using a combination of medicinal and combinatorial chem. approaches.  This effort culminated in the identification of the clin. candidate BAY 43-9006, currently undergoing Phase I clin. trials.  The present review summarizes the medicinal chem. development of ureas as highly potent inhibitors of Raf-1 kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqviNIBK_IYW7Vg90H21EOLACvtfcHk0liMf97ix3ubcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVGntrk%253D&md5=a62445c3fb50083175ee4863ae84f6ce</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.2174%2F1381612023393125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612023393125%26sid%3Dliteratum%253Aachs%26aulast%3DLowinger%26aufirst%3DT.%2BB.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26atitle%3DDesign%2520and%2520discovery%2520of%2520small%2520molecules%2520targeting%2520Raf-1%2520kinase%26jtitle%3DCurr.%2520Pharm.%2520Des%26date%3D2002%26volume%3D8%26spage%3D2269%26epage%3D2278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wilhelm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simantov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S.</span><span> </span><span class="NLM_article-title">Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1038%2Fnrd2130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=17016424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=835-844&author=S.+Wilhelmauthor=C.+Carterauthor=M.+Lynchauthor=T.+Lowingerauthor=J.+Dumasauthor=R.+A.+Smithauthor=B.+Schwartzauthor=R.+Simantovauthor=S.+Kelley&title=Discovery+and+development+of+sorafenib%3A+a+multikinase+inhibitor+for+treating+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of sorafenib: a multikinase inhibitor for treating cancer</span></div><div class="casAuthors">Wilhelm, Scott; Carter, Christopher; Lynch, Mark; Lowinger, Timothy; Dumas, Jacques; Smith, Roger A.; Schwartz, Brian; Simantov, Ronit; Kelley, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">835-844</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the mol. revolution of the 1980s, knowledge of the etiol. of cancer has increased considerably, which has led to the discovery and development of targeted therapies tailored to inhibit cancer-specific pathways.  The introduction and refinement of rapid, high-throughput screening technologies over the past decade has greatly facilitated this targeted discovery and development process.  Here, the authors describe the discovery and continuing development of sorafenib (previously known as BAY 43-9006), the first oral multikinase inhibitor that targets Raf and affects tumor signaling and the tumor vasculature.  The discovery cycle of sorafenib (Nexavar; Bayer Pharmaceuticals) - from initial screening for a lead compd. to FDA approval for the treatment of advanced renal cell carcinoma in Dec. 2005 - was completed in just 11 years, with approval being received ∼5 years after the initiation of the first Phase I trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6WjjfgNSCtbVg90H21EOLACvtfcHk0liMf97ix3ubcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajsbbM&md5=490d4995170f3a7270ae9bbdd24b12e5</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2130%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DLowinger%26aufirst%3DT.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DSimantov%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520development%2520of%2520sorafenib%253A%2520a%2520multikinase%2520inhibitor%2520for%2520treating%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D835%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Faivre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sargent, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, E.</span><span> </span><span class="NLM_article-title">Molecular basis for sunitinib efficacy and future clinical development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=734-745&author=S.+Faivreauthor=G.+Demetriauthor=W.+Sargentauthor=E.+Raymond&title=Molecular+basis+for+sunitinib+efficacy+and+future+clinical+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaivre%26aufirst%3DS.%26aulast%3DDemetri%26aufirst%3DG.%26aulast%3DSargent%26aufirst%3DW.%26aulast%3DRaymond%26aufirst%3DE.%26atitle%3DMolecular%2520basis%2520for%2520sunitinib%2520efficacy%2520and%2520future%2520clinical%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D734%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ellis, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span> </span><span class="NLM_article-title">VEGF-targeted therapy: mechanisms of anti-tumour activity</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1038%2Fnrc2403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=18596824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovV2lsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=579-591&author=L.+M.+Ellisauthor=D.+J.+Hicklin&title=VEGF-targeted+therapy%3A+mechanisms+of+anti-tumour+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">VEGF-targeted therapy: mechanisms of anti-tumour activity</span></div><div class="casAuthors">Ellis, Lee M.; Hicklin, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">579-591</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several vascular endothelial growth factor (VEGF)-targeted agents, administered either as single agents or in combination with chemotherapy, have been shown to benefit patients with advanced-stage malignancies.  VEGF-targeted therapies were initially developed with the notion that they would inhibit new blood vessel growth and thus starve tumors of necessary oxygen and nutrients.  It has become increasingly apparent, however, that the therapeutic benefit assocd. with VEGF-targeted therapy is complex, and probably involves multiple mechanisms.  A better understanding of these mechanisms will lead to future advances in the use of these agents in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8uQwKsLU3FbVg90H21EOLACvtfcHk0lg-Q9G6dhB56g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovV2lsro%253D&md5=0eab1dfbcb026754bf8b7e252eafd04a</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2403%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DL.%2BM.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26atitle%3DVEGF-targeted%2520therapy%253A%2520mechanisms%2520of%2520anti-tumour%2520activity%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D579%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ferrara, N.</span><span> </span><span class="NLM_article-title">VEGF and the quest for tumour angiogenesis factors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1038%2Fnrc909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=12360282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=795-803&author=N.+Ferrara&title=VEGF+and+the+quest+for+tumour+angiogenesis+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: VEGF and the quest for tumor angiogenesis factors</span></div><div class="casAuthors">Ferrara, Napoleone</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">795-803</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The ability of tumors to induce new blood-vessel formation has been a major focus of cancer research over the past few decades, and vascular endothelial growth factor (VEGF) is now known to be central to this process.  The quest for VEGF and other factors that promote tumor angiogenesis was initiated many decades ago, and a long and complicated path has led to the development of inhibitors of these mols. as anticancer agents.  How did this field begin, and how have we arrived at our present understanding of the role of VEGF in tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFHN1T3vtAELVg90H21EOLACvtfcHk0lg-Q9G6dhB56g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVGrtbk%253D&md5=b0f6d2bde63351fae496d743a9a7e4bf</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnrc909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc909%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DVEGF%2520and%2520the%2520quest%2520for%2520tumour%2520angiogenesis%2520factors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D795%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Östman, A.</span><span> </span><span class="NLM_article-title">PDGF-receptors—mediators of autocrine tumor growth and regulators of tumor vasculature and stroma</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1016%2Fj.cytogfr.2004.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=15207817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A280%3ADC%252BD2czgsFegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=275-286&author=A.+%C3%96stman&title=PDGF-receptors%E2%80%94mediators+of+autocrine+tumor+growth+and+regulators+of+tumor+vasculature+and+stroma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma</span></div><div class="casAuthors">Ostman Arne</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & growth factor reviews</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">275-86</span>
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    </div><div class="casAbstract">PDGFs and their cognate tyrosine kinase alpha- and beta-receptors are involved in multiple tumor-associated processes including autocrine growth stimulation of tumor cells, stimulation of tumor angiogenesis and recruitment and regulation of tumor fibroblasts.  The recent development of clinically useful PDGF antagonists, like STI571/Glivec, has increased the interest in PDGF receptors as cancer drug targets.  Autocrine PDGF receptor signaling occurs in certain malignancies characterized by mutational activation of PDGF or PDGF receptors, for instance, dermatofibrosaracoma protuberans, gastrointestinal stromal tumors, and hypereosinophilic syndrome.  The roles of PDGF in regulation of tumor angiogenesis and tumor fibroblasts are more general, and probably occur in most common solid tumors.  Concerning tumor angiogenesis recent studies have predominantly focused on the importance of PDGF receptor signaling for tumor pericyte recruitment.  PDGF receptors in the tumor stroma have also attracted attention as interesting drug targets because of their function as regulators of tumor interstitial fluid pressure, tumor transvascular transport and tumor drug uptake.  In summary, the improved understanding of the role of PDGF signaling in tumor biology, and the introduction of PDGF antagonists, has set the stage for a continued development of PDGF antagonists as novel cancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAed3RzDrPsRdUSIfHIn4FfW6udTcc2ebPJn4WkrncPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czgsFegsA%253D%253D&md5=909b8842f7f5297781226fc85e0e42d5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2004.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2004.03.002%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2596stman%26aufirst%3DA.%26atitle%3DPDGF-receptors%25E2%2580%2594mediators%2520of%2520autocrine%2520tumor%2520growth%2520and%2520regulators%2520of%2520tumor%2520vasculature%2520and%2520stroma%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2004%26volume%3D15%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kuhnert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, B. Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jocson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayak, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, C. J.</span><span> </span><span class="NLM_article-title">Soluble receptor-mediated selective inhibition of VEGFR and PDGFRβ signaling during physiologic and tumor angiogensis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">10185</span><span class="NLM_x">–</span> <span class="NLM_lpage">10190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=10185-10190&author=F.+Kuhnertauthor=B.+Y.+Y.+Tamauthor=B.+Senninoauthor=J.+T.+Grayauthor=J.+Yuanauthor=A.+Jocsonauthor=N.+R.+Nayakauthor=R.+C.+Mulliganauthor=D.+M.+McDonaldauthor=C.+J.+Kuo&title=Soluble+receptor-mediated+selective+inhibition+of+VEGFR+and+PDGFR%CE%B2+signaling+during+physiologic+and+tumor+angiogensis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuhnert%26aufirst%3DF.%26aulast%3DTam%26aufirst%3DB.%2BY.%2BY.%26aulast%3DSennino%26aufirst%3DB.%26aulast%3DGray%26aufirst%3DJ.%2BT.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DJocson%26aufirst%3DA.%26aulast%3DNayak%26aufirst%3DN.%2BR.%26aulast%3DMulligan%26aufirst%3DR.%2BC.%26aulast%3DMcDonald%26aufirst%3DD.%2BM.%26aulast%3DKuo%26aufirst%3DC.%2BJ.%26atitle%3DSoluble%2520receptor-mediated%2520selective%2520inhibition%2520of%2520VEGFR%2520and%2520PDGFR%25CE%25B2%2520signaling%2520during%2520physiologic%2520and%2520tumor%2520angiogensis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D10185%26epage%3D10190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Casanovas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanahan, D.</span><span> </span><span class="NLM_article-title">Drug resistance by evasion of anti-angiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=299-309&author=O.+Casanovasauthor=D.+J.+Hicklinauthor=G.+Bergersauthor=D.+Hanahan&title=Drug+resistance+by+evasion+of+anti-angiogenic+targeting+of+VEGF+signaling+in+late-stage+pancreatic+islet+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCasanovas%26aufirst%3DO.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DBergers%26aufirst%3DG.%26aulast%3DHanahan%26aufirst%3DD.%26atitle%3DDrug%2520resistance%2520by%2520evasion%2520of%2520anti-angiogenic%2520targeting%2520of%2520VEGF%2520signaling%2520in%2520late-stage%2520pancreatic%2520islet%2520tumors%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D8%26spage%3D299%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hilberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krssak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kautschitsch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommergruber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontsch-Grunt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoephel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">4774</span><span class="NLM_x">–</span> <span class="NLM_lpage">4782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=4774-4782&author=F.+Hilbergauthor=G.+J.+Rothauthor=M.+Krssakauthor=S.+Kautschitschauthor=W.+Sommergruberauthor=U.+Tontsch-Gruntauthor=P.+Garin-Chesaauthor=G.+Baderauthor=A.+Zoephelauthor=J.+Quantauthor=A.+Heckelauthor=W.+J.+Rettig&title=BIBF+1120%3A+triple+angiokinase+inhibitor+with+sustained+receptor+blockade+and+good+antitumor+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHilberg%26aufirst%3DF.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DKrssak%26aufirst%3DM.%26aulast%3DKautschitsch%26aufirst%3DS.%26aulast%3DSommergruber%26aufirst%3DW.%26aulast%3DTontsch-Grunt%26aufirst%3DU.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DBader%26aufirst%3DG.%26aulast%3DZoephel%26aufirst%3DA.%26aulast%3DQuant%26aufirst%3DJ.%26aulast%3DHeckel%26aufirst%3DA.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DBIBF%25201120%253A%2520triple%2520angiokinase%2520inhibitor%2520with%2520sustained%2520receptor%2520blockade%2520and%2520good%2520antitumor%2520efficacy%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D4774%26epage%3D4782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mudryk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makosza, M.</span><span> </span><span class="NLM_article-title">A simple and efficient synthesis of alkyl (2-nitroaryl)acetates and alkyl 2-(2-nitroaryl)propanoates via vicarious nucleophilic substitution of hydrogen in nitroarenes by carbanions of alkyl chloroacetates or alykl 2-chloropropanoates</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1055%2Fs-1988-27789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADyaL1MXitFahu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=1007-1009&author=B.+Mudrykauthor=M.+Makosza&title=A+simple+and+efficient+synthesis+of+alkyl+%282-nitroaryl%29acetates+and+alkyl+2-%282-nitroaryl%29propanoates+via+vicarious+nucleophilic+substitution+of+hydrogen+in+nitroarenes+by+carbanions+of+alkyl+chloroacetates+or+alykl+2-chloropropanoates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Reactions of organic anions. 156. A simple and efficient synthesis of alkyl (2-nitroaryl)acetates and alkyl 2-(2-nitroaryl)propanoates via vicarious nucleophilic substitution of hydrogen in nitroarenes by carbanions of alkyl chloroacetates or alkyl 2-chloropropanoates</span></div><div class="casAuthors">Mudryk, B.; Makosza, M.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1007-9</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Reaction of RC6H4NO2 (R = 4-Cl, 4-F, H, 3-CF3) with ClCHR1CO2R2 (R1 = H, Me; R2 = CMe3, Et) gave the 2-nitroarylalkanoates I.  Small amts. of the 4-nitroarylalkanoates II (R = H, CF3, R1 = H, R2 = CMe3; R = H, R1 = Me, R2 = Et) were also formed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQzEGNIYOcPrVg90H21EOLACvtfcHk0lhstMNL-KSO_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXitFahu7g%253D&md5=617a46684ba5e2b0d7dad382e8ba06b0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1055%2Fs-1988-27789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1988-27789%26sid%3Dliteratum%253Aachs%26aulast%3DMudryk%26aufirst%3DB.%26aulast%3DMakosza%26aufirst%3DM.%26atitle%3DA%2520simple%2520and%2520efficient%2520synthesis%2520of%2520alkyl%2520%25282-nitroaryl%2529acetates%2520and%2520alkyl%25202-%25282-nitroaryl%2529propanoates%2520via%2520vicarious%2520nucleophilic%2520substitution%2520of%2520hydrogen%2520in%2520nitroarenes%2520by%2520carbanions%2520of%2520alkyl%2520chloroacetates%2520or%2520alykl%25202-chloropropanoates%26jtitle%3DSynthesis%26date%3D1988%26spage%3D1007%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980123i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2588-2603&author=L.+Sunauthor=N.+Tranauthor=F.+Tangauthor=H.+Appauthor=P.+Hirthauthor=G.+McMahonauthor=C.+Tang&title=Synthesis+and+biological+evaluations+of+3-substituted+indolin-2-ones%3A+a+novel+class+of+tyrosine+kinase+inhibitors+that+exhibit+selectivity+toward+particular+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases</span></div><div class="casAuthors">Sun, Li; Tran, Ngoc; Tang, Flora; App, Harald; Hirth, Peter; McMahon, Gerald; Tang, Cho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2588-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Substituted indolin-2-ones have been designed and synthesized as a novel class of tyrosine kinase inhibitors which exhibit selectivity toward different receptor tyrosine kinases (RTKs).  These compds. have been evaluated for their relative inhibitory properties against a panel of RTKs in intact cells.  By modifying the 3-substituted indolin-2-ones, we have identified compds. which showed selective inhibition of the ligand-dependent autophosphorylation of various RTKs at submicromolar levels in cells.  Structure-activity anal. for these compds. and their relative potency and selectivity to inhibit particular RTKs has detd. that (1) 3-[(five-membered heteroaryl ring)methylidenyl]indolin-2-ones are highly specific against the VEGF (Flk-1) RTK activity, (2) 3-(substituted benzylidenyl)indolin-2-ones contg. bulky group(s) in the Ph ring at the C-3 position of indolin-2-ones showed high selectivity toward the EGF and Her-2 RTKs, and (3) the compd. contg. an extended side chain at the C-3 position of the indolin-2-one exhibited high potency and selectivity when tested against the PDGF and VEGF (Flk-1) RTKs.  Recent published crystallog. data for two of these 3-substituted indolin-2-ones provides a rationale to suggest that these compds. may bind in the ATP binding pocket of RTKs.  The structure-activity anal. supports the use of subsets of these compds. as specific chem. leads for the development of RTK-specific drugs with broad application for the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJoPixq8Am5rVg90H21EOLACvtfcHk0lhstMNL-KSO_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D&md5=536302b717170a630008dac14832204c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm980123i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980123i%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluations%2520of%25203-substituted%2520indolin-2-ones%253A%2520a%2520novel%2520class%2520of%2520tyrosine%2520kinase%2520inhibitors%2520that%2520exhibit%2520selectivity%2520toward%2520particular%2520receptor%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2588%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bordwell, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fried, H. E.</span><span> </span><span class="NLM_article-title">Heterocyclic aromatic anions with 4<i>n</i> + 2 π-electrons</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4218</span><span class="NLM_x">–</span> <span class="NLM_lpage">4223</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00013a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1991&pages=4218-4223&author=F.+G.+Bordwellauthor=H.+E.+Fried&title=Heterocyclic+aromatic+anions+with+4n+%2B+2+%CF%80-electrons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjo00013a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00013a027%26sid%3Dliteratum%253Aachs%26aulast%3DBordwell%26aufirst%3DF.%2BG.%26aulast%3DFried%26aufirst%3DH.%2BE.%26atitle%3DHeterocyclic%2520aromatic%2520anions%2520with%25204n%2520%252B%25202%2520%25CF%2580-electrons%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1991%26volume%3D56%26spage%3D4218%26epage%3D4223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Behringer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissauer, H.</span><span> </span><span class="NLM_article-title">Zur Darstellung des Oxindol-aldehyds(3) (Oxymethylene-oxindols) und einiger funktioneller Abkömmlinge</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1952&pages=774-777&author=H.+Behringerauthor=H.+Weissauer&title=Zur+Darstellung+des+Oxindol-aldehyds%283%29+%28Oxymethylene-oxindols%29+und+einiger+funktioneller+Abk%C3%B6mmlinge"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBehringer%26aufirst%3DH.%26aulast%3DWeissauer%26aufirst%3DH.%26atitle%3DZur%2520Darstellung%2520des%2520Oxindol-aldehyds%25283%2529%2520%2528Oxymethylene-oxindols%2529%2520und%2520einiger%2520funktioneller%2520Abk%25C3%25B6mmlinge%26jtitle%3DChem.%2520Ber.%26date%3D1952%26volume%3D85%26spage%3D774%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bramson, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corona, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gampe, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovejoy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocque, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuyper, L. F.</span><span> </span><span class="NLM_article-title">Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4339</span><span class="NLM_x">–</span> <span class="NLM_lpage">4358</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010117d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvFGnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4339-4358&author=H.+N.+Bramsonauthor=J.+Coronaauthor=S.+T.+Davisauthor=S.+H.+Dickersonauthor=M.+Edelsteinauthor=S.+V.+Fryeauthor=R.+T.+Gampeauthor=P.+A.+Harrisauthor=A.+Hassellauthor=W.+D.+Holmesauthor=R.+N.+Hunterauthor=K.+E.+Lackeyauthor=B.+Lovejoyauthor=M.+J.+Luzzioauthor=V.+Montanaauthor=W.+J.+Rocqueauthor=D.+Rusnakauthor=L.+Shewchukauthor=J.+M.+Vealauthor=D.+H.+Walkerauthor=L.+F.+Kuyper&title=Oxindole-based+inhibitors+of+cyclin-dependent+kinase+2+%28CDK2%29%3A+design%2C+synthesis%2C+enzymatic+activities%2C+and+X-ray+crystallographic+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis</span></div><div class="casAuthors">Bramson, H. Neal; Corona, John; Davis, Stephen T.; Dickerson, Scott H.; Edelstein, Mark; Frye, Stephen V.; Gampe, Robert T., Jr.; Harris, Phil A.; Hassell, Anne; Holmes, William D.; Hunter, Robert N.; Lackey, Karen E.; Lovejoy, Brett; Luzzio, Michael J.; Montana, Val; Rocque, Warren J.; Rusnak, David; Shewchuk, Lisa; Veal, James M.; Walker, Duncan H.; Kuyper, Lee F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4339-4358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two closely related classes of oxindole-based compds., 1H-indole-2,3-dione 3-phenylhydrazones and 3-(anilinomethylene)-1,3-dihydro-2H-indol-2-ones, were shown to potently inhibit cyclin-dependent kinase 2 (CDK2).  The initial lead compd. was prepd. as a homolog of the 3-benzylidene-1,3-dihydro-2H-indol-2-one class of kinase inhibitor.  Crystallog. anal. of the lead compd. bound to CDK2 provided the basis for analog design.  A semiautomated method of ligand docking was used to select compds. for synthesis, and a no. of compds. with low nanomolar inhibitory activity vs. CDK2 were identified.  Enzyme binding determinants for several analogs were evaluated by X-ray crystallog.  Compds. in this series inhibited CDK2 with a potency ∼10-fold greater than that for CDK1.  Members of this class of inhibitor cause an arrest of the cell cycle and have shown potential utility in the prevention of chemotherapy-induced alopecia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppOmtXxUWKlrVg90H21EOLACvtfcHk0ljern1H5al8rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvFGnt7Y%253D&md5=d628549913ca46f9edf6b4692c82419d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm010117d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010117d%26sid%3Dliteratum%253Aachs%26aulast%3DBramson%26aufirst%3DH.%2BN.%26aulast%3DCorona%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DS.%2BT.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DEdelstein%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGampe%26aufirst%3DR.%2BT.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DHassell%26aufirst%3DA.%26aulast%3DHolmes%26aufirst%3DW.%2BD.%26aulast%3DHunter%26aufirst%3DR.%2BN.%26aulast%3DLackey%26aufirst%3DK.%2BE.%26aulast%3DLovejoy%26aufirst%3DB.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DMontana%26aufirst%3DV.%26aulast%3DRocque%26aufirst%3DW.%2BJ.%26aulast%3DRusnak%26aufirst%3DD.%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DWalker%26aufirst%3DD.%2BH.%26aulast%3DKuyper%26aufirst%3DL.%2BF.%26atitle%3DOxindole-based%2520inhibitors%2520of%2520cyclin-dependent%2520kinase%25202%2520%2528CDK2%2529%253A%2520design%252C%2520synthesis%252C%2520enzymatic%2520activities%252C%2520and%2520X-ray%2520crystallographic%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4339%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Heckel, A.; Walter, R.; Grell, W.; van Meel, J. C. A.; Redemann, N.</span><span> </span><span class="NLM_article-title">Substituted indolinones having an inhibiting effect on kinases and cyclin/CDK complexes</span>. Patent WO9952869 A1 19991021, CAN 131:299364,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=A.+Heckel&author=R.+Walter&author=W.+Grell&author=J.+C.+A.+van+Meel&author=N.+Redemann&title=Substituted+indolinones+having+an+inhibiting+effect+on+kinases+and+cyclin%2FCDK+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHeckel%26aufirst%3DA.%26atitle%3DSubstituted%2520indolinones%2520having%2520an%2520inhibiting%2520effect%2520on%2520kinases%2520and%2520cyclin%252FCDK%2520complexes%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">Assay conditions as described in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Computational modeling was originally performed using a homology model based on the X-ray structure of FGFR-1. For better accuracy, the representations shown in this paper have been retrospectively modeled using the X-ray structure of VEGFR-2 recently reported in ref (<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">Twenty-three kinases were analyzed at 10 μmol/L with 100 μmol/L ATP as described in ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>: GSK3β, ROCKII, DYRK1A, PKCα, MAPK2ERK2, MSK1, PDK1, CHK1, MAPKAPK2, SAPK2AP38, S6K1, SGK, CK1, CK2, PKA, SAPK2BP38β2, SAPK3P38γ, JNK1A1, SAPK4P38δ, PHK, PKBα, CSK, PRAK. In contrast to <b>45</b>, <b>35</b> inhibited CHK1, DYRK1A, MSK1, and PHK in the same panel significantly (<10% CTRL at 10 μmol/L).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bisping, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kropff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenning, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessonov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munzert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stelljes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Tidow, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebisch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchinda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serve, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesters, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdel, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienast, J.</span><span> </span><span class="NLM_article-title">Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">2079</span><span class="NLM_x">–</span> <span class="NLM_lpage">2089</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=2079-2089&author=G.+Bispingauthor=M.+Kropffauthor=D.+Wenningauthor=B.+Dreyerauthor=S.+Bessonovauthor=F.+Hilbergauthor=G.+J.+Rothauthor=G.+Munzertauthor=M.+Stefanicauthor=M.+Stelljesauthor=C.+Scheffoldauthor=C.+M%C3%BCller-Tidowauthor=P.+Liebischauthor=N.+Langauthor=J.+Tchindaauthor=H.+L.+Serveauthor=R.+M.+Mestersauthor=W.+E.+Berdelauthor=J.+Kienast&title=Targeting+receptor+kinases+by+a+novel+indolinone+derivative+in+multiple+myeloma%3A+abrogation+of+stroma-derived+interleukin-6+secretion+and+induction+of+apoptosis+in+cytogenetically+defined+subgroups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBisping%26aufirst%3DG.%26aulast%3DKropff%26aufirst%3DM.%26aulast%3DWenning%26aufirst%3DD.%26aulast%3DDreyer%26aufirst%3DB.%26aulast%3DBessonov%26aufirst%3DS.%26aulast%3DHilberg%26aufirst%3DF.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DMunzert%26aufirst%3DG.%26aulast%3DStefanic%26aufirst%3DM.%26aulast%3DStelljes%26aufirst%3DM.%26aulast%3DScheffold%26aufirst%3DC.%26aulast%3DM%25C3%25BCller-Tidow%26aufirst%3DC.%26aulast%3DLiebisch%26aufirst%3DP.%26aulast%3DLang%26aufirst%3DN.%26aulast%3DTchinda%26aufirst%3DJ.%26aulast%3DServe%26aufirst%3DH.%2BL.%26aulast%3DMesters%26aufirst%3DR.%2BM.%26aulast%3DBerdel%26aufirst%3DW.%2BE.%26aulast%3DKienast%26aufirst%3DJ.%26atitle%3DTargeting%2520receptor%2520kinases%2520by%2520a%2520novel%2520indolinone%2520derivative%2520in%2520multiple%2520myeloma%253A%2520abrogation%2520of%2520stroma-derived%2520interleukin-6%2520secretion%2520and%2520induction%2520of%2520apoptosis%2520in%2520cytogenetically%2520defined%2520subgroups%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26spage%3D2079%26epage%3D2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Reinmuth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rensinghoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raedel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehrman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwöppe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisping, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesters, R. M.</span><span> </span><span class="NLM_article-title">Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=17671690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVagurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=621-626&author=N.+Reinmuthauthor=S.+Rensinghoffauthor=M.+Raedelauthor=N.+Fehrmanauthor=C.+Schw%C3%B6ppeauthor=T.+Kesslerauthor=G.+Bispingauthor=F.+Hilbergauthor=G.+J.+Rothauthor=W.+Berdelauthor=M.+Thomasauthor=R.+M.+Mesters&title=Paracrine+interactions+of+vascular+endothelial+growth+factor+and+platelet-derived+growth+factor+in+endothelial+and+lung+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells</span></div><div class="casAuthors">Reinmuth, Niels; Rensinghoff, Sonja; Raedel, Miriam; Fehrmann, Nicole; Schwoeppe, Christian; Kessler, Torsten; Bisping, Guido; Hilberg, Frank; Roth, Gerald J.; Berdel, Wolfgang; Thomas, Michael; Mesters, Rolf M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621-626</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">While the effects of single growth factors on endothelial cells (ECs) have been extensively studied, the importance of induction of growth factors such as PDGF-BB (platelet derived growth factor) in ECs and its impact on tumor cell functions are only partly understood.  Human umbilical vein endothelial cells (HUVECs) were cultured under serum-free conditions and stimulated by 20 ng/mL VEGF (vascular endothelial growth factor) or 20 ng/mL bFGF (basic fibroblastic growth factor).  As detd. by real-time PCR, both VEGF and bFGF induced a significant (up to 4-fold) increase in PDGF-B RNA expression which was time- and dose-dependent (p<0.05).  Similarly, conditioned medium (CM) from lung cancer cells (A549) which is known to contain multiple growth factors including VEGF and bFGF also induced PDGF-B RNA expression.  Using ELISA assays, VEGF and bFGF significantly increased PDGF-BB protein secretion in HUVECs (p<0.01).  By addn. of BIBF 1000, a novel inhibitor of the VEGF and bFGF receptor kinases, the effect of VEGF on PDGF-B RNA induction was significantly antagonized (p<0.01).  Furthermore, we studied the biol. significance of EC-derived PDGF-BB on lung cancer cells.  Interestingly, HUVEC-derived CM significantly stimulated migration of A549 cells (p<0.001) with a trend to further increased migration with the use of VEGF-stimulated (PDGF-BB rich) CM (p=0.2).  Collectively, endothelial and lung cancer cells seem to interact via various paracrine pathways, e.g. by the reciprocal induction of VEGF and PDGF-BB.  Thus, targeting key mols. would result in expression alterations of multiple factors and alter the biol. functions of both stromal and tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa1-OohY8UJbVg90H21EOLACvtfcHk0lhd7bXC7ILrag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVagurnP&md5=e15d5eab7a494145be0fb0cec88d3102</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReinmuth%26aufirst%3DN.%26aulast%3DRensinghoff%26aufirst%3DS.%26aulast%3DRaedel%26aufirst%3DM.%26aulast%3DFehrman%26aufirst%3DN.%26aulast%3DSchw%25C3%25B6ppe%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DT.%26aulast%3DBisping%26aufirst%3DG.%26aulast%3DHilberg%26aufirst%3DF.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DBerdel%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DMesters%26aufirst%3DR.%2BM.%26atitle%3DParacrine%2520interactions%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520platelet-derived%2520growth%2520factor%2520in%2520endothelial%2520and%2520lung%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2007%26volume%3D31%26spage%3D621%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kulimova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oelmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisping, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienast, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesters, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwäble, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munzert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Tidow, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolkmeyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büchner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serve, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdel, W. E.</span><span> </span><span class="NLM_article-title">Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3105</span><span class="NLM_x">–</span> <span class="NLM_lpage">3112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1158%2F1535-7163.MCT-06-0323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=17172413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlagsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=3105-3112&author=E.+Kulimovaauthor=E.+Oelmannauthor=G.+Bispingauthor=J.+Kienastauthor=R.+M.+Mestersauthor=J.+Schw%C3%A4bleauthor=F.+Hilbergauthor=G.+J.+Rothauthor=G.+Munzertauthor=M.+Stefanicauthor=B.+Steffenauthor=C.+Brandtsauthor=C.+M%C3%BCller-Tidowauthor=A.+Kolkmeyerauthor=T.+B%C3%BCchnerauthor=H.+Serveauthor=W.+E.+Berdel&title=Growth+inhibition+and+induction+of+apoptosis+in+acute+myeloid+leukemia+cells+by+new+indolinone+derivatives+targeting+fibroblast+growth+factor%2C+platelet-derived+growth+factor%2C+and+vascular+endothelial+growth+factor+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors</span></div><div class="casAuthors">Kulimova, Emma; Oelmann, Elisabeth; Bisping, Guido; Kienast, Joachim; Mesters, Rolf M.; Schwaeble, Joachim; Hilberg, Frank; Roth, Gerald J.; Munzert, Gerd; Stefanic, Martin; Steffen, Bjoern; Brandts, Christian; Mueller-Tidow, Carsten; Kolkmeyer, Astrid; Buechner, Thomas; Serve, Hubert; Berdel, Wolfgang E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3105-3112</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In acute myeloid leukemia (AML), receptor tyrosine kinase ligands promote growth and survival and contribute to AML-assocd. marrow neo-angiogenesis.  We have tested simultaneous inhibition of vascular endothelial growth factor, fibroblast growth factor, and platelet-derived growth factor receptor signaling by novel indolinone derivs. using 14 myeloid, including 11 human leukemic, cell lines.  Compds. inhibited colony formation of all cell lines in a dose-dependent fashion.  Inhibitory concns. for 50% of the colony formation/survival (IC50) for BIBF1000 were <100 nmol/L for 3 of 11, ≤500 nmol/L for 6 of 11, and <1,000 nmol/L for 10 of 11 leukemic cell lines, with one cell line being resistant in the dose range <1,000 nmol/L.  BIBF1120 was less effective with 4 of 11 leukemic cell lines being resistant within the dose range <1,000 nmol/L.  Testing of myeloid 32D cells transfected with empty vector, wild-type Flt3, or Flt3 carrying an internal tandem duplication mutation revealed higher resistance for the internal tandem duplication mutant.  These effects of the compds. were assocd. with inhibition of tyrosine phosphorylation and the mitogen-activated protein kinase pathway.  Furthermore, both compds. induced apoptosis in the sensitive cell lines.  In Mono-Mac1 cells, the compds. had a direct proapoptotic effect that was increasing the proapoptotic effect of 1-β-D-arabinofuranosylcytosine.  The data provide a rationale for clin. evaluation of these tyrosine kinase inhibitors in AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxCviJXgd7y7Vg90H21EOLACvtfcHk0lhd7bXC7ILrag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlagsbrL&md5=1d5fc32b0953fa46bfba0ce3b5af58b2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0323%26sid%3Dliteratum%253Aachs%26aulast%3DKulimova%26aufirst%3DE.%26aulast%3DOelmann%26aufirst%3DE.%26aulast%3DBisping%26aufirst%3DG.%26aulast%3DKienast%26aufirst%3DJ.%26aulast%3DMesters%26aufirst%3DR.%2BM.%26aulast%3DSchw%25C3%25A4ble%26aufirst%3DJ.%26aulast%3DHilberg%26aufirst%3DF.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DMunzert%26aufirst%3DG.%26aulast%3DStefanic%26aufirst%3DM.%26aulast%3DSteffen%26aufirst%3DB.%26aulast%3DBrandts%26aufirst%3DC.%26aulast%3DM%25C3%25BCller-Tidow%26aufirst%3DC.%26aulast%3DKolkmeyer%26aufirst%3DA.%26aulast%3DB%25C3%25BCchner%26aufirst%3DT.%26aulast%3DServe%26aufirst%3DH.%26aulast%3DBerdel%26aufirst%3DW.%2BE.%26atitle%3DGrowth%2520inhibition%2520and%2520induction%2520of%2520apoptosis%2520in%2520acute%2520myeloid%2520leukemia%2520cells%2520by%2520new%2520indolinone%2520derivatives%2520targeting%2520fibroblast%2520growth%2520factor%252C%2520platelet-derived%2520growth%2520factor%252C%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D3105%26epage%3D3112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Mross, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmehling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strecker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopfer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Rossi, L.</span><span> </span><span class="NLM_article-title">A clinical phase I, pharmacokinetic (PK), and pharmacodynamic study of twice daily BIBF 1120 in advanced cancer patients</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3031</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=3031&author=K.+B.+Mrossauthor=D.+Gmehlingauthor=A.+Frostauthor=F.+Baasauthor=R.+Streckerauthor=J.+Hennigauthor=P.+Stopferauthor=M.+Stefanicauthor=G.+Stehleauthor=L.+de+Rossi&title=A+clinical+phase+I%2C+pharmacokinetic+%28PK%29%2C+and+pharmacodynamic+study+of+twice+daily+BIBF+1120+in+advanced+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMross%26aufirst%3DK.%2BB.%26aulast%3DGmehling%26aufirst%3DD.%26aulast%3DFrost%26aufirst%3DA.%26aulast%3DBaas%26aufirst%3DF.%26aulast%3DStrecker%26aufirst%3DR.%26aulast%3DHennig%26aufirst%3DJ.%26aulast%3DStopfer%26aufirst%3DP.%26aulast%3DStefanic%26aufirst%3DM.%26aulast%3DStehle%26aufirst%3DG.%26aulast%3Dde%2BRossi%26aufirst%3DL.%26atitle%3DA%2520clinical%2520phase%2520I%252C%2520pharmacokinetic%2520%2528PK%2529%252C%2520and%2520pharmacodynamic%2520study%2520of%2520twice%2520daily%2520BIBF%25201120%2520in%2520advanced%2520cancer%2520patients%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D3031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Von Pawel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschbach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatzemeier, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reck, M.</span><span> </span><span class="NLM_article-title">A double-blind phase II study of BIBF 1120 in patients suffering from relapsed advanced non-small cell lung cancer (NSCLC)</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">7635</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=7635&author=J.+Von+Pawelauthor=R.+Kaiserauthor=C.+Eschbachauthor=M.+Stefanicauthor=J.+Loveauthor=U.+Gatzemeierauthor=M.+Reck&title=A+double-blind+phase+II+study+of+BIBF+1120+in+patients+suffering+from+relapsed+advanced+non-small+cell+lung+cancer+%28NSCLC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BPawel%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DR.%26aulast%3DEschbach%26aufirst%3DC.%26aulast%3DStefanic%26aufirst%3DM.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DGatzemeier%26aufirst%3DU.%26aulast%3DReck%26aufirst%3DM.%26atitle%3DA%2520double-blind%2520phase%2520II%2520study%2520of%2520BIBF%25201120%2520in%2520patients%2520suffering%2520from%2520relapsed%2520advanced%2520non-small%2520cell%2520lung%2520cancer%2520%2528NSCLC%2529%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D7635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Chaudhary, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Quernheim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zissel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnapp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span> </span><span class="NLM_article-title">Inhibition of PDGF, VEGF, and FGF signalling attenuates fibrosis</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1183%2F09031936.00152106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm900431g&amp;key=17301095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2007&pages=976-985&author=N.+I.+Chaudharyauthor=G.+J.+Rothauthor=F.+Hilbergauthor=J.+M%C3%BCller-Quernheimauthor=A.+Prasseauthor=G.+Zisselauthor=A.+Schnappauthor=J.+E.+Park&title=Inhibition+of+PDGF%2C+VEGF%2C+and+FGF+signalling+attenuates+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis</span></div><div class="casAuthors">Chaudhary, N. I.; Roth, G. J.; Hilberg, F.; Mueller-Quernheim, J.; Prasse, A.; Zissel, G.; Schnapp, A.; Park, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">976-985</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">BIBF 1000 is a small mol. inhibitor targeting the receptor kinases of platelet-derived growth factor (PDGF), basic fibroblast growth factor and vascular endothelial growth factor, which have known roles in the pathogenesis of pulmonary fibrosis.  The anti-fibrotic potential of BIBF 1000 was detd. in a rat model of bleomycin-induced lung fibrosis and in an ex vivo fibroblast differentiation assay.  Rats exposed to a single intra-tracheal injection of bleomycin were treated with BIBF 1000 starting 10 days after bleomycin administration.  To gauge for anti-fibrotic activity, collagen deposition and pro-fibrotic growth factor gene expression was analyzed in isolated lungs.  Furthermore, the activity of BIBF 1000 was compared with imatinib mesylate (combined PDGF receptor, c-kit and c-abl kinase inhibitor) and SB-431542 (transforming growth factor (TGF)-β receptor I kinase inhibitor) in an ex vivo TGF-β-driven fibroblast to myofibroblast differentiation assay, performed in primary human bronchial fibroblasts.  Treatment of rats with BIBF 1000 resulted in the attenuation of fibrosis as assessed by the redn. of collagen deposition and the inhibition of pro-fibrotic gene expression.  In the cellular assay both SB-431542 and BIBF 1000 showed dose-dependent inhibition of TGF-β-induced differentiation, whereas imatinib mesylate was inactive.  BIBF 1000, or related small mols. with a similar kinase inhibition profile, may represent a novel therapeutic approach for the treatment of idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKuwMAPritBrVg90H21EOLACvtfcHk0lis2mCerj4kYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFOhurw%253D&md5=fdaef254b5e6a2d950ffb47cdf2d3bbb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1183%2F09031936.00152106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00152106%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DN.%2BI.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26aulast%3DHilberg%26aufirst%3DF.%26aulast%3DM%25C3%25BCller-Quernheim%26aufirst%3DJ.%26aulast%3DPrasse%26aufirst%3DA.%26aulast%3DZissel%26aufirst%3DG.%26aulast%3DSchnapp%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26atitle%3DInhibition%2520of%2520PDGF%252C%2520VEGF%252C%2520and%2520FGF%2520signalling%2520attenuates%2520fibrosis%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2007%26volume%3D29%26spage%3D976%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Grell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurnaus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griss, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittneben, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, P.</span><span> </span><span class="NLM_article-title">Repaglinide and related hypoglycemic benzoic acid derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">5219</span><span class="NLM_x">–</span> <span class="NLM_lpage">5246</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9810349" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5219-5246&author=W.+Grellauthor=R.+Hurnausauthor=G.+Grissauthor=R.+Sauterauthor=E.+Rupprechtauthor=M.+Markauthor=P.+Lugerauthor=H.+Narauthor=H.+Wittnebenauthor=P.+M%C3%BCller&title=Repaglinide+and+related+hypoglycemic+benzoic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9810349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9810349%26sid%3Dliteratum%253Aachs%26aulast%3DGrell%26aufirst%3DW.%26aulast%3DHurnaus%26aufirst%3DR.%26aulast%3DGriss%26aufirst%3DG.%26aulast%3DSauter%26aufirst%3DR.%26aulast%3DRupprecht%26aufirst%3DE.%26aulast%3DMark%26aufirst%3DM.%26aulast%3DLuger%26aufirst%3DP.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DWittneben%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DP.%26atitle%3DRepaglinide%2520and%2520related%2520hypoglycemic%2520benzoic%2520acid%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5219%26epage%3D5246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Petersen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, J.</span><span> </span><span class="NLM_article-title">Phenazines and natural products; novel synthesis of saphenic acid</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_fpage">1763</span><span class="NLM_x">–</span> <span class="NLM_lpage">1766</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm900431g&amp;key=10.1055%2Fs-1999-3587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm900431g&amp;key=1%3ACAS%3A528%3ADyaK1MXmsVKht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1763-1766&author=L.+Petersenauthor=K.+J.+Jensenauthor=J.+Nielsen&title=Phenazines+and+natural+products%3B+novel+synthesis+of+saphenic+acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Phenazines and natural products. Novel synthesis of saphenic acid</span></div><div class="casAuthors">Petersen, Lars; Jensen, Knud J.; Nielsen, John</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1763-1766</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Saphenic acid, 6-(1-hydroxyethyl)-1-phenazinecarboxylate, was synthesized from readily accessible starting materials.  The desired product was obtained with 22% overall yield in 4 steps with the key steps being formation of a diphenylamine, followed by cyclization under alk. and reducting conditions.  Assignments of 1H NMR spectra were achieved by homo- and heteronuclear 1D and 2D correlations.  Double pulsed field gradient spin-echo 1D NOESY proved esp. valuable for assignment of arom. protons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLbF98L1QNTbVg90H21EOLACvtfcHk0lis2mCerj4kYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsVKht7s%253D&md5=d63c745a6a4540ab3c2875aa0a980316</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-1999-3587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1999-3587%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DL.%26aulast%3DJensen%26aufirst%3DK.%2BJ.%26aulast%3DNielsen%26aufirst%3DJ.%26atitle%3DPhenazines%2520and%2520natural%2520products%253B%2520novel%2520synthesis%2520of%2520saphenic%2520acid%26jtitle%3DSynthesis%26date%3D1999%26spage%3D1763%26epage%3D1766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Tercel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Synthesis of nitrogen and sulfur analogues of the seco-CI alkylating agent</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1998&pages=509-519&author=M.+Tercelauthor=W.+A.+Denny&title=Synthesis+of+nitrogen+and+sulfur+analogues+of+the+seco-CI+alkylating+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTercel%26aufirst%3DM.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DSynthesis%2520of%2520nitrogen%2520and%2520sulfur%2520analogues%2520of%2520the%2520seco-CI%2520alkylating%2520agent%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%26date%3D1998%26volume%3D1%26spage%3D509%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Varma, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, K. K.</span><span> </span><span class="NLM_article-title">Synthesis of 3-[4-(<i>N</i>-morpholino/-piperidino-methyl)phenylaminomethyl]-benzazoles as potential antibacterial agents</span> <span class="citation_source-journal">Indian J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">25B</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25B&publication_year=1986&pages=877-879&author=R.+S.+Varmaauthor=K.+K.+Verma&title=Synthesis+of+3-%5B4-%28N-morpholino%2F-piperidino-methyl%29phenylaminomethyl%5D-benzazoles+as+potential+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarma%26aufirst%3DR.%2BS.%26aulast%3DVerma%26aufirst%3DK.%2BK.%26atitle%3DSynthesis%2520of%25203-%255B4-%2528N-morpholino%252F-piperidino-methyl%2529phenylaminomethyl%255D-benzazoles%2520as%2520potential%2520antibacterial%2520agents%26jtitle%3DIndian%2520J.%2520Chem.%26date%3D1986%26volume%3D25B%26spage%3D877%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Moorhouse, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, J. E.</span><span> </span><span class="NLM_article-title">Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">15972</span><span class="NLM_x">–</span> <span class="NLM_lpage">15973</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0661919" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=15972-15973&author=A.+D.+Moorhouseauthor=A.+M.+Santosauthor=M.+Gunaratnamauthor=M.+Mooreauthor=S.+Neidleauthor=J.+E.+Moses&title=Stabilization+of+G-quadruplex+DNA+by+highly+selective+ligands+via+click+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja0661919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0661919%26sid%3Dliteratum%253Aachs%26aulast%3DMoorhouse%26aufirst%3DA.%2BD.%26aulast%3DSantos%26aufirst%3DA.%2BM.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DNeidle%26aufirst%3DS.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26atitle%3DStabilization%2520of%2520G-quadruplex%2520DNA%2520by%2520highly%2520selective%2520ligands%2520via%2520click%2520chemistry%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D15972%26epage%3D15973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Reppe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Äthinylierung, V. I.</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1955</span><span class="NLM_x">, </span> <span class="NLM_volume">596</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Reppe%2C+W.%3B+%C3%84thinylierung%2C+V.+I.Justus+Liebigs+Ann.+Chem.+1955%2C+596%2C+158%E2%80%93224"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReppe%26aufirst%3DW.%26aulast%3D%25C3%2584thinylierung%26aufirst%3DV.%2BI.%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1955%26volume%3D596%26spage%3D158%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gilman, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternbach, L. H.</span><span> </span><span class="NLM_article-title">An extension of the Smiles rearrangement. The displacement of an aromatic amide group by an amine nitrogen</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00942a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=373-377&author=N.+W.+Gilmanauthor=P.+Levitanauthor=L.+H.+Sternbach&title=An+extension+of+the+Smiles+rearrangement.+The+displacement+of+an+aromatic+amide+group+by+an+amine+nitrogen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo00942a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00942a035%26sid%3Dliteratum%253Aachs%26aulast%3DGilman%26aufirst%3DN.%2BW.%26aulast%3DLevitan%26aufirst%3DP.%26aulast%3DSternbach%26aufirst%3DL.%2BH.%26atitle%3DAn%2520extension%2520of%2520the%2520Smiles%2520rearrangement.%2520The%2520displacement%2520of%2520an%2520aromatic%2520amide%2520group%2520by%2520an%2520amine%2520nitrogen%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D373%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinov, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrickson, W. A.</span><span> </span><span class="NLM_article-title">Structure−activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4898</span><span class="NLM_x">–</span> <span class="NLM_lpage">4908</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070564e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4898-4908&author=H.+Xieauthor=D.+Ngauthor=S.+N.+Savinovauthor=B.+Deyauthor=P.+D.+Kwongauthor=R.+Wyattauthor=A.+B.+Smithauthor=W.+A.+Hendrickson&title=Structure%E2%88%92activity+relationships+in+the+binding+of+chemically+derivatized+CD4+to+gp120+from+human+immunodeficiency+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm070564e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070564e%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DD.%26aulast%3DSavinov%26aufirst%3DS.%2BN.%26aulast%3DDey%26aufirst%3DB.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DWyatt%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DHendrickson%26aufirst%3DW.%2BA.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520in%2520the%2520binding%2520of%2520chemically%2520derivatized%2520CD4%2520to%2520gp120%2520from%2520human%2520immunodeficiency%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4898%26epage%3D4908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Gabbay, E. J.</span><span> </span><span class="NLM_article-title">Topography of nucleic acid helices in solutions. XII. The origin of the oppositely induced circular dichroism of reporter molecules bound to ribo- and deoxyribonucleic acid</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">5136</span><span class="NLM_x">–</span> <span class="NLM_lpage">5150</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01046a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1969&pages=5136-5150&author=E.+J.+Gabbay&title=Topography+of+nucleic+acid+helices+in+solutions.+XII.+The+origin+of+the+oppositely+induced+circular+dichroism+of+reporter+molecules+bound+to+ribo-+and+deoxyribonucleic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja01046a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01046a035%26sid%3Dliteratum%253Aachs%26aulast%3DGabbay%26aufirst%3DE.%2BJ.%26atitle%3DTopography%2520of%2520nucleic%2520acid%2520helices%2520in%2520solutions.%2520XII.%2520The%2520origin%2520of%2520the%2520oppositely%2520induced%2520circular%2520dichroism%2520of%2520reporter%2520molecules%2520bound%2520to%2520ribo-%2520and%2520deoxyribonucleic%2520acid%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1969%26volume%3D91%26spage%3D5136%26epage%3D5150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kil, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, M.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundberg, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumberg, P. M.</span><span> </span><span class="NLM_article-title">Analysis of structure−activity relationships with the <i>N</i>-(3-acyloxy-2-benzylpropyl)-<i>N</i>′-[4-(methylsulfonylamino)benzyl]thiourea template for vanilloid receptor 1 antagonism</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3411</span><span class="NLM_x">–</span> <span class="NLM_lpage">3420</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=3411-3420&author=J.+Leeauthor=S.+Y.+Kimauthor=J.+Leeauthor=M.+Kangauthor=M.-J.+Kilauthor=H.-K.+Choiauthor=M.-K.+Jinauthor=Y.+Wangauthor=A.+Tothauthor=L.+V.+Pearceauthor=D.+J.+Lundbergauthor=R.+Tranauthor=P.+M.+Blumberg&title=Analysis+of+structure%E2%88%92activity+relationships+with+the+N-%283-acyloxy-2-benzylpropyl%29-N%E2%80%B2-%5B4-%28methylsulfonylamino%29benzyl%5Dthiourea+template+for+vanilloid+receptor+1+antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DKil%26aufirst%3DM.-J.%26aulast%3DChoi%26aufirst%3DH.-K.%26aulast%3DJin%26aufirst%3DM.-K.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DToth%26aufirst%3DA.%26aulast%3DPearce%26aufirst%3DL.%2BV.%26aulast%3DLundberg%26aufirst%3DD.%2BJ.%26aulast%3DTran%26aufirst%3DR.%26aulast%3DBlumberg%26aufirst%3DP.%2BM.%26atitle%3DAnalysis%2520of%2520structure%25E2%2588%2592activity%2520relationships%2520with%2520the%2520N-%25283-acyloxy-2-benzylpropyl%2529-N%25E2%2580%25B2-%255B4-%2528methylsulfonylamino%2529benzyl%255Dthiourea%2520template%2520for%2520vanilloid%2520receptor%25201%2520antagonism%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D3411%26epage%3D3420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3C7Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3C7Q','PDB','3C7Q'); return false;">PDB: 3C7Q</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900431g&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm900431g%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-14" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900431g" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799e516b83f3c64","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
